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Antimicrobial peptides (AMPs) are a major part of the innate immune 
defence system which shows a broad spectrum of activity, defending the host 
against invading microbes. The aim of this work was to identify the AMPs present 
in yellowtail kingfish (Seriola lalandi) and pouched lamprey (Geotria 
australis) and use molecular techniques to fully sequence their cDNA and 
quantify their expression in adult individuals. 
 
Using bioinformatic approaches candidate AMP genes were ascertained 
from available S. lalandi and G. australis RNA-seq transcriptomic databases, 
obtained from various tissues. Selected AMPs were chosen to have their full 
cDNA sequence amplified using RACE-PCR, which were then cloned and 
sequenced. Complete cDNA sequences were obtained for S. lalandi hepcidin and 
moronecidin, whereas attempts to complete the G. australis defensin-like cDNA 
were unsuccessful. Comparison of the S. lalandi hepcidin and moronecidin 
protein sequences with proteins already characterised in other fish showed good 
homology and conservation of important features. In addition, specific primers 
were designed to examine the expression levels of S. lalandi hepcidin and 
moronecidin in gill, liver or spleens of three fish. Analysis showed hepcidin 
expression to be highest in liver tissues, whereas moronecidin expression was 
highest in the gills and spleens. 
 
This study provides a comprehensive overview of the AMP genes present 
in S. lalandi and G. australis and some initial characterisation of S. lalandi 
hepcidin and moronecidin, which will permit the development of future research 
applications. Overall, characterising AMP genes in jawed and jawless vertebrates 
is vital for economical and successful fish farming, while also providing possible 
therapeutic benefits associated with AMP research in biomedicine and disease in 
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Chapter One: Introduction and Literature 
Review 
 
1.1 Vertebrate Immunity 
The immune system is an organisation of biological structures that 
processes within an organism protecting them against disease such as renegade 
body cells (cancer cells) and invading pathogens such as viruses, bacteria, fungi, 
and parasites (Buchmann, 2014). For a pathogen, the vertebrate body is an ideal 
habitat offering nutrients and a protected environment for growth, reproduction, 
and transportation to new hosts (Campbell et al., 2009). Therefore, vertebrates 
have evolved a specialised means of searching out and destroying foreign cells 
(Pough et al., 2009). In all vertebrate species including humans, the immune 
system can be classified into two subsystems, the innate immune system and the 
adaptive immune system (Zhu, et al., 2013). The innate immune system is a non-
specific line of defence and considered a primitive form of immunity as aspects of 
it can also be found in plants and invertebrates (Buchmann, 2014). The innate 
immune system is active immediately upon infection, where the response is the 
same each time regardless of whether the pathogen has been encountered before 
(Campbell, et al., 2009). In contrast, the adaptive immune system provides 
specific responses to infection where each response is tailored to a particular 
invader taking time to develop following infection (Pough, et al., 2009). This 
system is restricted to vertebrates and composed of highly specialised cells with 
immunological memory (Rauta et al., 2012). Jawed vertebrates are the only 
phylum to have an adaptive immune system where each response is based on the 
coordinated activities of specialised cells, T and B lymphocytes (Chaplin, 2010). 
These cell types carry out two major types of adaptive immunity, cell mediated 
immunity and antibody mediated immunity (Martini & Nath, 2009). Cell 
mediated immunity is T cell activated which provides defence against abnormal 
cell types and intracellular pathogens (Pough, et al., 2009). Whereas, antibody 
mediated immunity is B cell activated and works extracellularly (does not enter 
cells), defending against antigens and pathogens in the body fluids (Martini & 
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Nath, 2009). Jawless vertebrates also possess an adaptive immune response, 
although unique cells and effector molecules are involved (Zhu, et al., 2013). 
Understanding vertebrate immunology provides a fascinating insight into the 
interaction between animals, and the organisms that infect them (Buonocore, 
2011). Overall, vertebrate immunity is a complex network of systems integral to 
the survival and success of vertebrate organisms (Chaplin, 2010; Buchmann, 
2014).  
 
1.2 Why Study Non-Mammalian Immunology? 
A large amount of research has been conducted over the last 20 years to 
characterise the immune responses that organisms outside of mammals are 
capable of. As well as providing a fascinating insight into the interactions between 
animals, and the organisms that infect them (Buonocore, 2011), there are a 
number of useful applications, which are outlined below.  
 
1.2.1 Understanding Immune System Evolution 
The innate immune system has origins in ancient evolutionary history 
reaching as far back as early metazoan (proifera) over 1 billion years ago (Litman 
& Cooper, 2007). Whereas, the origin of the adaptive immune system can be 
traced back to jawed vertebrates 450 million years ago with the appearance of 
RAG genes (Magnadóttir, 2006). The vital role played by the innate immune 
system is evident by the efficient immune defence found in invertebrates, as they 
are dependent exclusively on their innate immune system to protect them from a 
wide range of pathogens in diverse environmental conditions (Magnadóttir, 2006).  
Increased diversity, maturation and memory has enhanced the evolution of the 
adaptive immune system as seen in mammals (Chaplin, 2010). Non classical 
animal models are useful in defining the evolutionary history of immune systems 
and provide the basis for discovery of unknown molecules and biochemical 
pathways in mammalian immunity (Sunyer, 2013). There is significant overlap in 
the complex immune systems of amphibians, reptiles, aves and mammals (Table 
1).  Thus, knowledge of overlapping immune parameters between multicellular 
organisms highlights functionally interconnected immune systems with shared 
ancestry and co-evolution (Litman & Cooper, 2007). Overall, understanding 
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descent is indicative of the evolutionary forces which underlie diversification of 
immune parameters (Boehm, 2012). 
 
Table 1: Comparative overview of amphibian, reptilian, avian and mammalian 
immune systems.Table re-created from information retrieved from Zimmerman et 
al. (2010). 
 Amphibians Reptiles Aves Mammals 
Innate     
Antimicrobial peptides     
Complement     
Non-specific leukocytes     
Macrophages     
Heterophils/neutrophils     
Basophils     
Eosinophils     
Inflammation     
Fever  (behavioural) (behavioural)   
Adaptive     
Cell-mediated     
MHC (Class I, II)     
T-cell receptor     
Humoral     
Antibody heavy chain 
isotypes 
IgM, IgX, IgY, IgD, 
IgF 
IgM, IgY, IgA?, 
IgD? 
IgM, IgY, IgA, 
IgD 
IgM, IgG, IgA, 
IgD, IgE 
Light chain isotypes λ, κ, σ λ, κ λ λ, κ 
Phagocytic B cells   ?  
RAG     
Class switching     
Affinity maturation   Poor  
Somatic hypermutation     
 
1.2.2 Discovering Novel Mechanisms of Immunity 
The use of non-mammalian models to uncover novel mechanisms of 
immunity has improved with the recent advances in genetic technologies (Sunyer, 
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2013). Using these technologies researchers are able to use more accessible and 
less expensive non-mammalian models to gain insight into the vertebrate immune 
system. This has allowed similarities in immune parameters between mammalian 
vertebrates and their non-mammalian counterparts to be elucidated (Boehm, 
2012). Elie Metchnikoff contributed to the birth of immunology in 1882 with the 
discovery of phagocytosis by amoebocytes found in echinoderms (Sunyer, 2013). 
From Metchinkoff’s discovery self versus non-self immune cell recognition was 
proposed, thus highlighting the importance of non-mammalian models as far back 
as the 1800’s (Litman & Cooper, 2007). Toll receptors are another example, 
which were first discovered in the fruit fly Drosophila melanogaster from which 
toll-like genes were consequently discovered in vertebrates (Magnadóttir, 2006). 
These receptors which are a part of the innate immune system have been found to 
be crucial mediators in immune responses (Litman & Cooper, 2007). A recent 
example of non-mammalian immune discoveries is highlighted by the finding that 
teleost B cells are professional phagocytes (Sunyer, 2013). This finding in teleost 
B cells led to the discovery that mammalian B cells are also phagocytic. Overall, 
non-mammalian immune research has greatly expanded the knowledge of the 
diverse vertebrate immune system through the discovery of novel immune 
mechanisms. 
 
1.2.3 Developing Alternative Models for Immune Research 
Using non-mammalian models for scientific research is preferable as they 
have faster reproduction rates than mammals, they are inexpensive to house, and 
typically they are genetically simpler (Tobia et al., 2011; Kounatidis & 
Ligoxygakis, 2012). Therefore, when studying aspects of mammalian disease 
using other vertebrate species as animal models may be preferential. As an 
example, from a human perspective, zebrafish (Danio rerio) have been used to 
study primary immunodeficiency (PID) which is characterised by a functionally 
abnormal immune system (Iwanami, 2014). Zebrafish posses several immune 
parameters including T and B lymphocytes which resemble their mammalian 
counterparts and, therefore, genetic manipulation can be used to mimic these PID 
disorders (Trede et al., 2004). Using this model, drug therapies can be tested, one 
such being haematopoietic stem cell transplantation which has emerged as a 
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treatment option for PID patients (Iwanami, 2014). Mutagenesis screenings can 
also be applied to specific developmental pathways to understand disease 
pathology and identify immune aspects as potential therapeutic agents (Litman & 
Cooper, 2007). For example, human short and long QT syndrome can be 
mimicked via mutation in the zebrafish homolog hERG potassium channel gene 
(Staudt & Stainier, 2012). Thus, various drug treatment schemes can be carried 
out on these zebrafish models to determine their effects on the mimicked short or 
long QT syndrome (Staudt & Stainier, 2012). 
 
1.2.4 Understanding Immunity in Commercial Species 
In the commercial world, farming of non-mammalian organisms is mainly 
dominated by poultry farming and aquaculture (Chemineau et al., 2007). 
Aquaculture is the farming of fresh and salt water aquatic species for human 
consumption, including organisms such as molluscs, crustaceans, fish and aquatic 
plants (Naylor et al., 2001). Approximately 600 aquatic species are farmed 
worldwide, with three species currently farmed in New Zealand, King salmon 
(Oncorhynchus tshawytscha), green lipped mussel (Perna canaliculi) and Pacific 
oyster (Crassostrea gigas) (Brudeseth et al., 2013). Aquaculture is becoming 
increasingly necessary in the developed world because of both rising population 
sizes and decreasing wild fish stocks from recreational and commercial fishing 
(Dimitroglou et al., 2011). Aquaculture is a promising field for global food 
production but growth in this industry has been constrained by high mortality rate 
in young fish, abnormalities during development and adult disease (Miller et al., 
2011). Therefore, it is vital to develop tools that will increase survival and quality 
of these fish under farmed conditions (Stewart Fielder, 2013). Greater success of 
species in aquaculture will be possible through the understanding the immune 
system of farmed species which will give insights into their development, health, 
growth and reproduction (Agawa et al., 1991). An example of a method currently 
being used to improve aquaculture success is vaccination (Brudeseth, et al., 2013). 
A number of countries in the world have implemented vaccine administration in 
aquaculture (Figure 1). In Norway all Atlantic salmon (Salmo salar) and rainbow 
trout (Oncorhynchus mykiss) are vaccinated against the three major bacterial 
diseases, vibriosis, cold water vibriosis, and furunculosis (Hastein et al., 2005). 
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Vaccination of fish has reduced the use of antibiotics in aquaculture, which has 
been highlighted in Norway within the salmon industry (Brudeseth, et al., 2013). 
In 1987, 50,000kg of antibiotics were being used, however, the introduction of a 
water-in-oil emulsion vaccine drastically reduced antibiotic use to 1000kg by 
1997 (Brudeseth, et al., 2013). During this same period salmon fish production 
increased from 50,000 tonnes to 350,000 tonnes. Despite vaccines improving the 
survival rate of farmed fish they still need a significant amount of improvement 
which will be achieved by further understanding the immune system of farmed 
fish species (Van Muiswinkel, 2008). 
 
 
Figure 1: Countries that have implemented vaccination in aquaculture categorised 
by colour. Green shows common use of vaccines, orange highlights countries that 
use vaccines although are not fully implemented, and red shows countries where 
vaccination is under development. Retrieved from Brudeseth, et al. (2013). 
 
1.2.5 Why fish? 
Fish immunology is of particular interest because fish are the earliest 
known vertebrate class with the presence of both innate and adaptive immunity 
(Magnadóttir, 2006). It is assumed 1029 prokaryotic organisms exist in the ocean 
environment (Tort et al., 2003) and, therefore, a fishes body is continuously 
subjected to contact with micro-organisms, making them crucial in the search for 
potential pharmaceuticals (Cantisani et al., 2014). Studying immunity in fish 
provides us with insights into immune system evolution as fish are significantly 
more primitive than popular mammalian research models (Zhu, et al., 2013). In 
particular innate immune parameters, where fish share aspects with both 
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invertebrates and higher vertebrates such as mammals (Falco et al., 2012). Fish 
also represent 43% of extant vertebrates and investigating the immune system of a 
range of fish species will provide insight into how they maintain such diversity 
within a huge range of environments (deep sea, lakes, rivers) (Tort, et al., 2003; 
Scapigliati, 2013). Studying fish innate immunity will also allow for 
improvements to aquaculture systems around the world, as understanding the 
immune system of a fish will allow the management of diseases and pathogens 
that are prevalent within current aquaculture systems (Alvarez-Pellitero, 2008). 
Overall, understanding fish immune parameters is of significant importance in 
many areas including biomedical therapeutics, evolutionary research, and 
commercial successes in aquaculture. 
 
1.3 Immunity in Fish 
The innate immune system in fish is a fundamental defence mechanism as it 
precedes adaptive immunity, determines the nature of the adaptive immune 
response, and is vital for the maintenance of homeostasis (Magnadóttir, 2006). 
Fishes depend heavily on their innate immune system considerably more 
throughout their lives than mammals, which is primarily due to their evolutionary 
status and poikilothermic nature (Ravichandran et al., 2010; Uribe et al., 2011). 
The innate immune system in fish plays a central role in the response to infections 
as fish become free living at an early embryonic stage, therefore, relying on their 
innate immune defences for extended periods of time (Uribe, et al., 2011). The 
adaptive immune system in fish is inactive until they are completely developed 
and even at that point their adaptive immune system only displays rudimentary 
immunological memory, where memory is significantly more developed in higher 
vertebrates (Buonocore, 2011). This is due to the evolutionary status of fish, as 
they mainly exhibit immunoglobulin-M (IgM) like responses (produced by B 
cells), in contrast to the complex response seen in mammals (Falco, et al., 2012). 
In addition, the resulting adaptive immune system has restricted memory, and 
slow lymphocyte proliferation (Magnadóttir, 2006). The adaptive immune 
response in fish is, therefore, more sluggish, sometimes taking up to 12 weeks to 
develop, compared to the relatively instant and temperature independent innate 
immune system (Magnadóttir, 2006). Therefore, understanding the innate immune 
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system and how it functions in fish will provide vital information on the evolution, 
working mechanisms and various components of immune responses applicable to 




Within fish the immune system is made up of several lymphoid tissues 
(Figure 2), with the largest being the thymus, kidney (anterior and middle) and the 
spleen (Uribe, et al., 2011). The kidney is a Y-shaped organ that is dispersed 
along the body axis where the lower part of the kidney (tail end) works as a renal 
system and the head-kidney is the active immune part of the organ (Tort, et al., 
2003). The head-kidney assumes haematopoietic functions similar to that seen in 
the bone marrow of mammals producing erythrocytes, macrophages and plasma 
cells (Zapata et al., 2006). The head-kidney is also the principle immune organ 
responsible for phagocytosis, antigen processing and immune memory (Uribe, et 
al., 2011). The thymus located near the opercula cavity in fish is generally 
considered an aggregation of macrophages and this is where T and B lymphocytes 
are produced (Tort, et al., 2003). Myeloid cells and eosinophilic granular cells are 
also found here, although functionally the thymus cannot be universally 
generalised as the thymic structure is highly variable throughout different fish 
species  (Uribe, et al., 2011). The spleen in fish is similar in structure and function 
as a large mammalian lymph node, where they principally operate as a filter for 
circulating blood (Zapata, et al., 2006). Red blood cells, lymphocytes and 
Figure 2: Major immune organs in teleosts with approximate sites overlaid onto a 
rainbow trout (Oncorhynchus mykiss). Taken from Secombes and Wang (2012). 
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macrophages are also developed and housed here (Iwanami, 2014). Agnatha are 
the only vertebrates that do not contain a spleen and instead contain 
haematopoietic tissue within the gut wall which is assumed to have homologous 
functions to the vertebrate spleen (Tort, et al., 2003). Interestingly, fish are a 
heterogeneous group where immune organs can vary between species, although 
overall there is some similar homology to immune organs found within mammals.  
 
1.4 Innate Immunity in Fish 
The innate immune system is the front line of defence, playing a major role 
in pathogen resistance (Secombes & Wang, 2012). Innate immunity begins with 
discrimination of self from non-self cells followed by an immune response which 
can be broadly divided into three groups; physical barriers, cellular components 




1.4.1 Discrimination of Self from Non-Self 
In order for a successful immune response, an organism must first 
distinguish self from non-self (Buchmann, 2014). The innate immune system 




distinguishes self and non-self cells through germ line encoded pattern recognition 
receptors (PRRs) that recognise specific molecular patterns characteristic of 
microbes, referred to as pathogen associated molecular patterns (PAMPs) 
(Magnadóttir, 2006). PAMPs are ideal structures for PRRs to detect, as they are 
essential for the survival of a pathogen. PAMPs are molecules that are highly 
conserved within the prokaryotic phylum and are not normally found in 
eukaryotic cells, for example, lipopolysaccharides (LPS), double stranded viral 
RNA, peptidoglycan, bacterial DNA, and polysaccharides (Magnadóttir, 2006). 
Once PRRs are activated recognition molecules can signal for destruction or 
phagocytosis of the pathogen (Buchmann, 2014). There are four main families of 
PRRs that have been described in vertebrates, including Toll-like receptors 
(TLRs), retinoic acid inducible gene 1-like receptors (RLRs), nucleotide-binding 
oligomerisation domain-like receptors (NLRs) and C-type lectin receptors (CLRs) 
(Zhu, et al., 2013). TLRs were the first type of PRRs described and are 
consequently the most understood. TLRs are type-1 transmembrane proteins that 
are typically expressed on sentinel cells which recognise the structurally 
conserved PAMPs expressed on microbes (Alvarez-Pellitero, 2008). TLRs are 
composed of an intracellular complex and extracellular domain where receptor 
ligand binding initiates a complex series of steps, resulting in the activation of an 
immune response consequently inactivating or eliminating an invader (Buchmann, 
2014). Various TLR types can be found within vertebrates where each receptor 
shows individual affinities for a range of PAMPs (Alvarez-Pellitero, 2008). 
Recent research has established that fish TLRs have distinct features and greater 
diversity in comparison to mammals (Zhu, et al., 2013). At least eighteen TLRs 
have been found in teleosts and seven in agnatha, in comparison to thirteen found 
in mammals (Chaplin, 2010). TLRs have also been linked to some of the most 
primitive multicellular organisms such as sponges, molluscs (snails and octopus) 
and oligochaetes (earthworms) (Alvarez-Pellitero, 2008; Chaplin, 2010; Zhu, et 
al., 2013; Buchmann, 2014). Fish have been shown to contain a unique family of 
TLRs which likely arose through gene duplication, although the functionality of 
these TLRs are largely unknown (Palti, 2011). Future research into fish specific 
TLRs and immunity will aid in developing the understanding of disease resistance 
in fish (Palti, 2011). Overall, PRRs are vital for vertebrates to distinguish self 
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from non-self cells in order to initiate an immune response to destroy or inactivate 
an invader. 
 
1.4.2 Physical Barriers 
The first line of defence a pathogen must evade before attempting to 
colonise the host is barrier defences, also known as the integumentary system. The 
integumentary system in fish is made up of scales, skin and mucosal surfaces of 
the gills and epidermis (Tort, et al., 2003; Magnadóttir, 2006). Each aspect of the 
integumentary system acts as a physical obstacle for invading pathogens (Martini 
& Nath, 2009). This form of simple defence is one of the most primitive but has 
been shown to be surprisingly successful. Experimentally, it has been shown that 
salmon immersed in water inoculated with a potent fish pathogen, Aeromonas 
salmonidica, can resist microbial invasion into the body simply through the 
presence of physical barriers (Tort, et al., 2003; Magnadóttir, 2006). In addition to 
skin, mucus is also an important physical barrier in fish (Anbuchezhian et al., 
2011). Mucus is a viscous fluid that acts by trapping microbes and other particles 
while also providing substrate for antibacterial mechanisms to act (Campbell, et 
al., 2009). It has been shown that mucus contains several immune products, 
(Cantisani, et al., 2014) such as, lysozyme, pentraxins, antimicrobial peptides 
(AMPs), and complement proteins, which can act directly on invading pathogens 
and kill them (Magnadóttir, 2006). Mucus is produced by mucosal membranes 
where it is secreted to cover most external surfaces including skin and within the 
mouth (Tort, et al., 2003; Alvarez-Pellitero, 2008). In addition, microbes that 
attempt to enter the body through ingested food and water have to contend with 
the acidity of the stomach, which kills most microbes before they can move 
further through the digestive tract (Campbell, et al., 2009). Overall, physical 
barriers are the first line of defence in fish where all orifices show some form of 
defence aiding in the prevention of pathogen colonisation (Martini & Nath, 2009). 
However, some pathogens are able to evade this form of defence, which is where 





1.4.3 Cellular Components 
Cell mediated immunity is a protective function associated with cells, 
where specialised cells such as macrophages directly destroy pathogens or secrete 
various cytokines and proteins resulting in pathogen death. The key cells in the 
innate immune response of fish are non-specific cytotoxic cells (NCC), 
monocytes, macrophages, dendritic cells, and other phagocytic cells such as 
granulocytes (Figure 4).  
 
Fish NCCs are thought to be an evolutionary precursor to mammalian 
natural killer (NK) cells which are large granular lymphocytes (Alvarez-Pellitero, 
2008). NCCs are seen as morphologically distinct from mammalian NK cells 
although they are thought to be functionally similar (Uribe, et al., 2011). In fish 
NCCs are localised in lymphoid tissues such as the anterior kidney and spleen 
(Shen et al., 2002) where their role is to target and kill invading parasitic 
organisms, such as protozoan parasites, virally transformed cells and tumour cells 
(Secombes & Wang, 2012). NCCs have been found in an array of fish species 
including, tilapia (Oreochromis mossambicus) (Faisal et al., 1989), crucian carp 
(Carassius auratus langsdorfii) (Somamoto et al., 2013) and rainbow trout 
(Oncorhynchus mykiss) (Greenlee et al., 1991). 
 
Figure 4: Lymphocytes of fish. From the blood of a skate (Raja ocellata), large 
lymphocytes (A&B), neutrophil granulocytes (D&E) and an eosinophilic granulocyte 
F&G). From the kidney cells of a goldfish (Carassius auratus) a macrophage 
containing a haemoglobin globule (C). Lastly, from the kidney cells of a buffalo fish 
(Ictiobus bubalis) a pseudo-eosinophilic granulocyte (H). Taken from Jordan and 
Speidel (1924). 
A B 
F G H 
D C E 
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Monocytes are the largest of all leukocytes, where high numbers are found 
to be stored in the spleen of a fish (Uribe, et al., 2011). They are phagocytic cells 
which circulate throughout the body of a fish with the ability to differentiate into 
macrophages or dendritic cells, both of which are antigen presenting cells 
(Secombes & Wang, 2012). Initial detection of pathogens is typically carried out 
by tissue resident macrophages that ubiquitously express PRRs (Secombes & 
Wang, 2012). Macrophages are antigen presenting cells that are able to bind to 
invading pathogens and directly phagocytose them (Neumann et al., 2001), while 
also releasing cytokines to further increase the immune response (Secombes & 
Wang, 2012). Macrophages also show remarkable plasticity and even when not 
fighting infection can play an important role in homeostasis where they clear 
cellular debris and foreign waste products (Buchmann, 2014). Dendritic cells are 
typically expressed in tissues that are in contact with the external environment 
(Bassity & Clark, 2012), they are also phagocytic antigen presenting cells, acting 
as a messenger between innate and adaptive immunity (Shao et al., 2015).  
 
Another group of immune cells are granulocytes which includes 
neutrophils, eosinophils, basophils and mast cells. Neutrophils are the first 
immune cells recruited during a pathogen invasion and migrate to the site of 
infection. They have been shown to kill pathogens via phagocytosis and the 
release of AMPs, degenerative enzymes and toxic metabolites at the site of 
infection (Neumann, et al., 2001). The main purpose of neutrophils is to destroy 
pathogens at the site of infection and recruit other immune cells (Uribe, et al., 
2011). Neutrophils have been found in several fish species including, zebrafish 
(Keightley et al., 2014), Atlantic cod (Øverland et al., 2010), and channel catfish 
(Bly et al., 1990). Eosinophils are granular leukocytes that are a vital part of 
mammalian immunity maintaining antimicrobial and ribonuclease properties, 
while also playing a major role in allergic reactions (Ainsworth, 1992). 
Eosinophils have been implicated in many aspects of fish immunity including 
parasite killing and attraction of leukocytes to the area (Ainsworth, 1992), 
however, their precise function remains enigmatic (Alvarez-Pellitero, 2008). 
Eosinophilic-like cells have been observed in zebrafish (Danio rerio) (Balla et al., 
2010), sturgeon (Acipenser brevirostrum) (Hine, 1992), striped bass (Morone 




Basophils found in mammals are utilised in helminth (parasitic worm) 
infection, and also release histamine in response to an allergic reaction 
(Ainsworth, 1992). They are similar in appearance to mast cells, although differ 
due to their location, as mast cells are tissue resident, whereas, basophils are 
found in blood (Hine, 1992). In fish basophil existence has previously been 
debated, attributed to difficulty in defining cells based on various parameters, 
such as function, morphology, and/or ontogeny. However, basophil-like cells have 
been identified in several marine and freshwater fish species which include, 
zebrafish (Danio rerio) (Balla, et al., 2010), carp (Cyprinus carpio) (Hamers, 
1995), pond loach (Misgurnus anguillicaudatus) (Ainsworth, 1992) and sturgeon 
(Acipenser brevirostrum) (Hine & Wain, 1988). It is important to note that 
functional aspects of fish basophils have not yet been explored, due to studies 
focusing mainly on basophilic morphology and because only limited amounts of 
basophils can be isolated from fish, restricting the possibility of functional assays 
(Ainsworth, 1992). 
 
Mammalian mast cells originate in bone marrow and mature in peripheral 
tissues where they play a role in inflammation, defence against invading 
pathogens, and in allergic reactions as they release histamine (Secombes & Wang, 
2012). Mast cells are important functionally in immunity and are active against a 
wide range of pathogens due to the expression of biologically active proteins such 
as lysozyme, AMPs and alkaline and acid phosphatases (Silphaduang & Noga, 
2001). The presence of mammalian-like mast cells in fish has strongly been 
debated due to differences in tissue distribution and histochemical staining 
(Sfacteria et al., 2015). It has now been widely accepted that fish contain 
analogous mast cells to mammals as the main functional roles exploited by the 
immune system are similar (Reite & Evensen, 2006). Fish mast cells are 
sometimes referred to as eosinophilic granule cells (EGC), as historical studies 
have shown the presence of an eosinophilic domain through histochemical 
staining (Reite & Evensen, 2006; Dezfuli et al., 2012). In fish, mast cells have 
been found in the intestine, gills, skin, respiratory system and reproductive 
systems (Secombes & Wang, 2012), their presence has also been associated with 
the hypothalamus and pancreas (Sfacteria, et al., 2015). Investigations into mast 
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cells propose there are two main populations found in fish, tissue resident mast 
cells and highly motile circulating mast cells (Dezfuli, et al., 2012). It has been 
suggested that the range and distribution that mast cells exhibit is likely explained 
by the large number of fish living in a wide range of environments (Sfacteria, et 
al., 2015). Fish mast cell properties are highly associated with other cells of the 
innate immune system including eosinophils and basophils as they are all granular 
leukocytes (Secombes & Wang, 2012).  
 
In summary, cell mediated innate immunity is made up of a vast array of 
cell types, where structure and function differ from mammals to fish, and even 
significantly within fish themselves. Research into each aspect of cell mediated 
immunity in fish still has a long way to go and this knowledge will improve with 
investigation and exploration into their vast array of unique immune parameters. 
 
1.4.4 Humoral Components 
Humoral immunity refers to non-cellular immune components found in 
blood and other tissues. It is a non-specific line of defence that aids in the 
prevention of pathogen invasion within the body. These mechanisms are found in 
most domains of life and although are considered primitive they still offer 
extremely effective defence against invading pathogens. This type of immunity is 
mediated by macromolecules found in extracellular fluids (body fluid), which is 
made up of secreted compounds such as lysozyme, complement proteins, 
cytokines and AMPs. Lysozyme is a bacteriolytic enzyme which acts on the 
peptidoglycan layer of a bacterial cell wall causing cell lysis (Alvarez-Pellitero, 
2008). It is a non-specific primitive defence mechanism found in most animals 
with a wide distribution throughout the body (Tort, et al., 2003). Fish lysozyme is 
secreted by leukocytes, predominantly monocytes, macrophages and neutrophils 
where potency is dependent on the species and tissue affected (Uribe, et al., 2011).  
 
The complement system is a major component of innate defences found in 
fish and higher vertebrates, composed of a complex protein cascade. In fish the 
complement system is made up of over 35 plasma proteins which play a role in 
immune effector functions such as, inflammation, promotion of pathogen 
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phagocytosis, chemotaxis, clearance of apoptotic cells and modulation of the 
adaptive immune response (Tort, et al., 2003; Uribe, et al., 2011; Secombes & 
Wang, 2012; Zhu, et al., 2013). Proteins belonging to the complement system can 
be divided into three biochemical pathways, the classical pathway, alternative 
pathway, and the lectin pathway. The classical pathway is activated by antigen-
antibody interactions, the alternative pathway is initiated directly by foreign 
micro-organisms, and the lectin pathway is triggered by a complex made up of 
mannose/mannan binding to mannose residues on the pathogen cell surface (Uribe, 
et al., 2011). Although each pathway is initiated by different elements they all 
produce the same anti-infectious effects (Zhu, et al., 2013). Firstly, opsonisation, 
which is the recruitment of phagocytic cells to sites of inflammation and 
promotion of their activity. Secondly, the formation of a membrane attacking 
complex (MAC) causing pathogen cell lysis. Lastly, anaphylatoxic leukocyte 
stimulation producing local inflammation which further enhances the immune 
response (Tort, et al., 2003; Alvarez-Pellitero, 2008; Secombes & Wang, 2012; 
Zhu, et al., 2013). 
 
Cytokines are low molecular weight proteins that act in a network as 
signalling molecules to control and coordinate innate and adaptive immune 
responses (Magnadóttir, 2006). Cytokines are secreted by cells of the immune 
system including granulocytes, dendritic cells and macrophages (Figure 5) which 
bind to specific cellular receptors through autocrine and paracrine mechanisms 
(Secombes et al., 2011). Fish cytokines can be broadly divided into three groups, 
interleukins (ILs), interferons (IFNs) and tumour necrosis factors (TNFs) (Tort, et 
al., 2003). The function of ILs includes cell differentiation, growth and motility, 
and are also vital in the regulation of inflammation where different ILs may have 
pro- or anti-inflammatory effects (Uribe, et al., 2011). IL families found in 
mammals predominantly have had direct homologues identified in fish, although 
some novel proteins do exist, likely due to gene duplication events (Secombes, et 
al., 2011). TNFs identified in fish have experimentally been shown to directly 
enhance neutrophil migration, induce apoptosis and heighten macrophage activity 
(Tort, et al., 2003). Nineteen mammalian TNF members have been described, 
with only several currently identified in fish, TNF-α and β being the most 
prominent (Uribe, et al., 2011; Zhu, et al., 2013). IFNs identified in fish and 
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mammals play a vital role in defence against viral infections, upon recognition of 
viral nucleic acids IFNs are secreted by vertebrate host cells (Zhu, et al., 2013). 
IFNs act to protect other cells by altering the regulation of mRNA transcription to 
produce an antiviral state in a cell. This includes induction of genes that encode 
antiviral proteins such as protein MX1 (Uribe, et al., 2011). 
 
 
AMPs are an ancient mechanism of immunity, found in microorganisms, 
plants, invertebrates and vertebrates. They show a wide range of activity against 
viruses, fungi, bacteria, parasites and in some cases also antitumor activity. In 
depth discussion of these peptides will be explored further in the next section. 
 
Figure 5: Known cytokines found in fish that play a role in regulating 
inflammatory cell functions, including differentiation, apoptosis, cell proliferation, 
and gene expression (Zhu et al., 2013). 
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1.5 Antimicrobial Peptides 
AMP’s are naturally occurring low molecular weight polypeptides that play 
a major role in host immunity (Buonocore, 2011; Masso-Silva & Diamond, 2014). 
AMPs are highly conserved throughout nature where they show a broad spectrum 
of activity defending their host against invading bacteria, viruses and fungi (Uribe, 
et al., 2011; Zhang & Gallo, 2016). In some cases antitumor activity has also been 
shown toward carcinogenic cells (Perez Espitia et al., 2012). These peptides are 
considered a primitive mechanism of immunity as they are found in all domains 
of life (Wiesner 2010). Two physical features are common for AMPs which are 
thought to be important in how they target certain pathogens, which are: 1) Being 
cationic (positively charged) which attracts them to negatively charged 
pathogenic membranes, they are not attracted to mammalian cells which have a 
zwitterionic charge. 2) Containing a significant proportion of hydrophobic 
residues facilitating interactions between fatty acyl chains (Izadpanah & Gallo, 
2005; Guaní-Guerra et al., 2010; Wiesner & Vilcinskas, 2010; Nguyen, et al., 
2011; Noga et al., 2011; Rakers et al., 2013; Valero et al., 2013; Masso-Silva & 
Diamond, 2014). AMPs are typically expressed onto primary physical barriers 
such as mucosal epithelia and skin of an organism to prevent pathogen 
colonisation of host tissues (Guaní-Guerra, et al., 2010). These peptides can also 
be stored in cells of the immune system such as macrophages and granulocytes 
which assist in micro-organism destruction (Kościuczuk et al., 2012).  
 
1.5.1 Mode of Action 
The mode of action of AMPs can vary dependent on the invading micro-
organism, displaying antibacterial, antiviral and antifungal properties (Perez 
Espitia, et al., 2012). The antibacterial effects of AMPs have been shown to 
destroy gram positive and gram negative bacteria through two main mechanisms 
(Zhang & Gallo, 2016), firstly targeting bacterial membranes, and secondly 
penetrating the membrane where they interfere with important cellular 
components or processes such as DNA and protein synthesis (Nguyen, et al., 
2011).  After initial attachment of AMPs to the bacterial cell wall, several models 





The exact mechanism of AMP action is not fully understood, although the 
most widely accepted and popular theories are the barrel stave model, carpet 
model and the toroidal pore model (Wiesner & Vilcinskas, 2010). The barrel stave 
model describes the formation of a pore or transmembrane channel (Pasupuleti et 
al., 2012). This is where the hydrophobic side of the peptide binds to the lipid 
core of the bacterial membrane while the hydrophilic side is orientated to the 
inside (Nguyen, et al., 2011). The recruitment of several peptides results in the 
formation of aqueous pores causing loss of cell contents and the inability to 
maintain a proton motive force resulting in cell death (Perez Espitia, et al., 2012). 
The carpet model is characterised by peptides covering the membrane surface in a 
carpet like manner by remaining parallel in orientation (Nguyen, et al., 2011). At 
a critical concentration, the peptides disrupt the membrane surface where the 
hydrophilic surface is in contact with phospholipids causing reorientation of these 
peptides, resulting in the formations of small peptide-lipid aggregates with a 
Figure 6: Examples of AMP action against bacterial membranes. Taken from 
Nguyen et al. (2011). 
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hydrophobic core (Wiesner & Vilcinskas, 2010). This disintegration of the 
bacterial cell membrane results in cell death (Pasupuleti, et al., 2012). The 
toroidal pore model is similar to the barrel stave model, although it differs in that 
AMPs are always associated with the phospholipid head groups and 
perpendicularly inserted, causing the membrane to be bent inward, therefore, 
resulting in a pore that is lined with both lipid head groups and AMPs (Wiesner & 
Vilcinskas, 2010). The ultimate result, similar to that of the barrel stave model, is 
the generated pore disrupts the cellular contents of the pathogen causing depletion 
of the proton motive force and, therefore, no ATP synthesis eventually killing the 
cell (Pasupuleti, et al., 2012). In contrast, it has been shown that some AMPs have 
no activity on the cell membrane but instead are able to translocate through the 
pathogenic membrane (Rajanbabu & Chen, 2011). The translocated AMPs 
accumulate inside the bacterial cell where they can disrupt essential cellular 
processes resulting in cell death (Pasupuleti, et al., 2012). These AMPs can target 
processes such as DNA synthesis, enzyme activity and proteins involved in cell 
wall amalgamation (Podda et al., 2006). It has also been hypothesised that these 
AMPs can interact with transport systems within the bacterial membrane in 
contrast to non-specific membrane integrity disruption (Carnicelli et al., 2013). 
An example of this type of peptide is Bac7 a proline rich mammalian AMP which 
through TEM localisation assays was shown to accumulate in the cytoplasm of 
Escherichia coli and Salmonella enterica, where changes in cellular morphology 
were observed (Podda, et al., 2006). Similar to antibacterial AMPs, antifungal 
peptides work in much the same way through interaction with the cell wall or 
action on an intracellular target (Bahar & Ren, 2013). 
 
In addition to targeting bacterial and fungal cells, AMPs have proven 
dynamic in their activity showing various mechanisms of action against viruses. 
Antiviral AMPs are peptides that have been shown to have direct action against 
invading viruses, with greater efficiency against enveloped viruses (Falco, et al., 
2012). Experimental analysis has concluded that AMPs are able to target viruses 
via two main mechanisms, firstly by assimilating into viral envelopes causing 
membrane instability, and secondly by reducing the binding efficiency of viruses 
to the host cell by integrating into the host cell membranes (Bahar & Ren, 2013). 
An example of an AMP blocking viral entry through interaction with the host cell 
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rather than inhibition of viral replication is lactoferrin, a common AMP found in 
the milk of mammals (Perez Espitia, et al., 2012). Lactoferrins mode of action is 
through interaction with heparin sulphate a linear polysaccharide found in animal 
tissue (van der Strate et al., 2001). Heparin sulphate is utilised by a range of 
viruses to gain access to mammalian cells. It is proposed lactoferrin interacts with 
heparin inhibiting viral infection (van der Strate, et al., 2001; Perez Espitia, et al., 
2012). In contrast, an example of an AMP that interacts with a virus to prevent 
entry into vertebrate cells is α-lactalbumin which has been shown to inhibit 
infection of herpes simplex virus (Oevermann et al., 2003). The antiviral activity 
of this peptide is based on direct interaction with viral glycoproteins which are 
responsible for penetration and absorption into host cells. Therefore, AMPs that 
interact with these glycoproteins prevent viral activity (Perez Espitia, et al., 2012). 
 
Apart from their direct antibacterial, antifungal and antiviral activity AMPs 
also have immunomodulatory functions which are considered an equally 
important immune function as direct antimicrobial destruction (Falco, et al., 2012). 
Immunomodulation is the adjustment of an immune response to a desired level, 
leading to immunosuppression and/or immunoenhancement (Bowdish et al., 
2005). AMPs are able to modulate immune responses through induction of 
cytokines, chemokines, alteration of gene expression and inhibition of 
proinflammatory responses (Falco, et al., 2012). In addition, AMPs have been 




shown to recruit neutrophil and fibroblasts, enhance activity of phagocytic cells 
and promote mast cell degranulation (Secombes & Wang, 2012). An example of 
an immunomodulatory AMP is the human cathelicidin LL-37 (Figure 7), which is 
secreted in sweat and airway surfaces, and is upregulated in response to injury 
and/or cutaneous infection (Bowdish, et al., 2005; Steinstraesser, et al., 2011).  
 
1.5.2 Antimicrobial Peptides in Mammals and Other Organisms 
The first reported animal AMP was in 1956 where a defensin was isolated 
from rabbit leukocytes (Hirsch, 1956). In the following years, the presence of 
lactoferrin in cows milk was shown, bombinin was isolated from frog epithelia, 
and it was proven that the lysozyme found in human leucocytes contains various 
AMPs (Bahar & Ren, 2013). It is now understood that the range of AMPs found 
in various organisms is extensive (Figure 8). 
 
 
AMP classification is difficult and can be attributed to their considerable 
diversity in sequence, structure and mode of action. AMPs can loosely be divided 
into categories based on their size, conformational structure and amino acid 
Figure 8: Summary of, (A) the number of AMPs isolated from a variety of kingdoms 
and (B) the number of AMPs identified from a range of animal families. Taken from 
Wang et al. (2010). 
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composition (Guaní-Guerra, et al., 2010). The range of structure, distribution and 
activity of various AMPs are outlined in Table 2 (Ganz, 2003). One of the most 
prominent reasons for investigating vertebrate AMPs is antibiotic resistance. This 
is a significant and growing issue in contemporary medicine, highlighted by the 
rise in hospital acquired infections caused by microbes displaying resistance to 
antibiotics (Mazel & Davies, 1999). It is estimated that routine operations will 
become deadly within the next 20 years as the ability to fight conventional 
infections is lost due to the rise in antibiotic resistant microbes. Therefore, much 
research has been focused on discovery and isolation of alternative compounds to 
supercede traditional antibiotics (Nguyen, et al., 2011). AMPs have been 
identified as a promising candidate for biomedical uses in order to combat the 
issue of antibiotic resistance (Wiesner 2010, Buonocore 2011). 
 
Table 2: Structures, distributions and activities of AMPs found in a wide range of 
organisms. Table recreated from (Ganz, 2003) 
 




4-disulfide α-helix + β-
sheet 
Plant defensins Plants 
Fungi 
Drosomycin Arthropod haemolymph 
3-disulfide β-sheet rich 
α-defensins Vertebrate neutrophils Bacteria, fungi, and 
enveloped viruses β-defensins Mammalian epithelia 





Gram positive bacteria 
3-disulfide 2α-helicies + 
β-sheet 
γ-thionins Plants 
Bacteria, fungi and 
mammalian cells 
2-disulfide β-sheet 
Protegrins Pig neutrophils 




Horseshoe crab haemocytes 
1-disulfide cyclic 




Ranalexin and brevinin Amphibian skin 
α-helix 
Cecropins Insect Haemolymph 
Bacteria Maganin and PGLa Amphibian skin 
LL-37 Mammalian leukocytes 
Linear with repeating 
motifs 
Bactenecins 5 and 7, PR-
39, and indolicidin 
Mammalian leukocytes 
Bacteria 
Diptericin and apidaecin Insect haemolymph 
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1.6 Antimicrobial Peptides in Fish 
The ocean contains significant organism diversity and is, therefore, an 
important source of novel AMP discovery (Cantisani, et al., 2014). Fish like other 
organisms secrete various kinds of AMPs. Although, unlike other vertebrates the 
antimicrobial activity of fish AMPs was not discovered until 1996 (Masso-Silva 
& Diamond, 2014). Fish AMPs exhibit many, if not all of the same characteristics 
as higher vertebrates showing a broad spectrum of antimicrobial activity and 
immunomodulatory functions. In fish AMPs have been divided into a number of 
groups that include; linear amphipathic α-helical peptides (piscidins & 
cathelicidins), peptides derived from larger proteins (histone derived & 
haemoglobin derived), peptides with cysteine’s that form intramolecular bonding 
(defensins & hepcidins), and cationic peptides with diverse structures (high 
density lipoproteins & NK-lysin) (Valero, et al., 2013; Masso-Silva & Diamond, 
2014). A number of these AMPs will be discussed below and their role in host 
defence highlighted.  
 
1.6.1 Piscidins  
Piscidins are a family of AMPs containing a range of fish proteins, which 
includes piscidin (Valero, et al., 2013), pleurocidin (Cole, et al., 2000), 
moronecidin (Lauth et al., 2002), dicentracin (Salerno et al., 2007), paradaxin 
(Oren & Shai, 1996), gaduscidin (Browne et al., 2011) and epinecidin (Yin et al., 
2006). Each protein belonging to the piscidin family are characterised by 
similarities in secondary peptide structure, as well as high gene sequence 
homology (Valero, et al., 2013). Piscidins and pleurocidins are two of most 
extensively studied AMP sequences within this family and, therefore, will be 
discussed further. 
 
Piscidin is a linear, amphipathic, α-helical peptide antibiotic that is found 
in a variety fish species (Figure 9),  showing an evolutionarily related relationship 
to AMPs found in amphibian skin, and insects (Rakers, et al., 2013; Masso-Silva 
& Diamond, 2014). Piscidin has been isolated from Atlantic cod (Gadus morhua) 
(Fernandes, et al., 2010), hybrid striped bass (Morone chrysops x Morone 
saxatilis) (Salger et al., 2011), mandarin fish (Synchiropus splendidus) (Sun et al., 
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2007) and many other fish taxa (Valero, et al., 2013; Masso-Silva & Diamond, 
2014). Piscidin expression has been linked specifically to mast cells, skin, gills 
and the gastrointestinal tract of fish, although some traces of piscidin have also 




The gene structure of piscidin is made of four exons and three introns 
which encode a signal peptide, mature peptide, and carboxyl-terminal pro-domain 
(Masso-Silva & Diamond, 2014). The mature piscidin peptide is 18-26 amino 
acids long and is defined by it’s N-terminus which is rich in histidine and 
phenylalanine (Falco, et al., 2012). Piscidin shows potent antimicrobial activity 
against a range of microbes including fungi (Niu et al., 2013), viruses (Park et al., 
2011), and parasites (Niu, et al., 2013), although it is especially significant against 
gram positive and gram negative bacterial species (Sun, et al., 2007), with the 
most potent antimicrobial activity recorded against Streptococcus, Pseudomonas, 
Vibrio, and Bacillus species (Masso-Silva & Diamond, 2014). Piscidin is 
hypothesised to kill microbial cells through membrane disruption via toroidal pore 
formation where membrane lipids are inserted between the α-helicies causing 
material efflux (Valero, et al., 2013; Masso-Silva & Diamond, 2014).  
 
Figure 9: The amphipathic α-helical structure of cod piscidin. Hydrophilic residues 
are highlighted by blue pentagons and very hydrophobic residues are represented 
by green diamonds. Taken from Fernandes et al. (2010). 
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Pleurocidin is a cationic, amphipathic peptide, exhibiting an α-helical 
structure, and was one of the first AMP sequences to be sequestered from a teleost 
(Cole et al., 1997). Initial isolation of pleurocidin was from mucous cells in 
flounder skin where bioactivity assays highlighted this peptide to have a broad 
spectrum of antimicrobial activity (Cole, et al., 1997; Anbuchezhian, et al., 2011). 
Pleurocidin has subsequently been isolated from several fish species including, 
Atlantic halibut (Hippoglossus hippoglossus) (Patrzykat et al., 2003), common 
dab (Limanda limanda) (Brocal et al., 2006), and American plaice 
(Hippoglossoides platessoides) (Falco, et al., 2012). Pleurocidin expression in fish 
tissues has been described in the goblet cells of the small intestine, epidermal 
mucus, skin epithelium and eosinophils of the gills (Cole, et al., 2000; Falco, et 
al., 2012). It has been shown that pleurocidin plays a significant role in mucosal 
defence where immunohistochemical studies localised high pleurocidin 
expression in skin mucous cells (Cole, et al., 2000).  
 
 
Pleurocidin gene structure consists of four exons and three introns (Figure 
10) encoding a signal peptide, mature peptide and pro-peptide (Falco, et al., 
2012). Most AMPs have an anionic pro-peptide attached to the NH2-end of the 
mature protein, which is involved in charge neutralisation and cellular trafficking 
(Cole, et al., 2000). However, pleurocidin is predicted to have anionic properties 
attached to the COOH terminal end of the mature peptide (Falco, et al., 2012). 
This is a very unusual configuration but works in a similar way to pro-peptide 
attachment to the NH2-end where post-translational enzymatic cleavage releases 
the mature peptide, activating it (Cole, et al., 2000). Although pleurocidin does 
Figure 10: Pleurocidin gene structure and the putative pleurocidin precursor (Cole 
et al., 2000). 
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not express the highly conserved N-terminus characteristic of a piscidin, it shows 
significant sequence homology at the genomic level and, therefore, suggests it is a 
members of the piscidin family (Sun, et al., 2007). The mature pleurocidin peptide 
is 25 amino acids long which exerts its function by forming pores in bacterial cell 
membranes (Rakers, et al., 2013). The mode of action of pleurocidin due to its 
positive charge is predicted to disrupt outer bacterial membranes forming 
transmembrane channels resulting in permeability of the phospholipid bilayer 
(Sun, et al., 2007). It has been shown that pleurocidin likely acts via the toroidal 
pore model through determination of its single channel characteristics, and by 
measuring its pore forming activity (Saint et al., 2002). Pleurocidin shows a wide 
range of bacteriostatic and bacteriocidal activity with strong action against 
Bacillus subtilis and Escherichia coli (Cole, et al., 1997). Pleurocidin has also 
shown weaker antibacterial activity against, Leucothrix mucor, Pseudomonas 
aeruginosa and Serratia marcescens (Cole, et al., 1997). Further to this 
pleurocidin has shown significant antifungal (Jung et al., 2007) and anticancer 
activity (Morash et al., 2011). Overall, the piscidin family are an evolutionarily 
conserved group of AMPs specifically found in fish, although show a broad 
homology to classes of AMPs found in other vertebrate species.  
 
1.6.2 Defensins 
Defensins are one of the most well studied AMP families and are found in 
fungi, plants, invertebrates and vertebrates (Zhu & Gao, 2013). Vertebrate 
defensins are classified into three main groups, α-defensins, β-defensins and θ-
defensins based on structure, location and distribution (Falco, et al., 2012; Zhu & 
Gao, 2013). To date, α-defensins and θ-defensins have only been described in 
mammals, with θ-defensins limited to primates (Falco, et al., 2012). As β-
defensins are the only universal defensin group, found in more primitive 
vertebrates and invertebrates (Zhu & Gao, 2013), it is hypothesised that the other 
defensin groups evolved from an ancestral β-defensin (Falco, et al., 2012; Masso-
Silva & Diamond, 2014). In fish, β-defensins have been isolated from a variety of 
species including, pufferfish (Tetraodon nigroviridis), rainbow trout 
(Oncorhynchus mykiss) and zebrafish (Danio rerio) (Falco, et al., 2012), where it 
is found to be expressed in the pituitary, testis, skin epithelium, head-kidney and 
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spleen (Rakers, et al., 2013). Constitutive expression of β-defensin in fish has 
been shown to begin early in development likely due to the vulnerability of 
juvenile fish where they rely heavily on their innate immune system (Masso-Silva 
& Diamond, 2014). Genomic analysis of β-defensin in a range of fish species has 
highlighted a similar gene organisation between species, with three exons divided 
by two introns encoding a pre-pro-peptide (signal peptide, pro-peptide, and 
mature peptide). The pre-pro-peptide is comprised of 60 to 77 amino acids, with 
the mature peptide ranging in size from 38 to 45 amino acids in length (Falco, et 
al., 2012). As in mammals, fish β-defensins are characterised by their cationic 
charge, presence of six cysteine rich residues and exhibition of stabilised β-sheet 
structure (Valero, et al., 2013). Apart from the conserved six cysteine residues 
(Figure 11), there is very little amino acid conservation in the mature peptides 
(Zhu & Gao, 2013). 
 
 
Figure 11: Alignment of β-defensin proteins from teleosts comparing them to an 
Atlantic cod β-defensin. The dots (*) represent amino acids that are identical to the 
cod, the six conserved cysteine residues are highlighted in blue. Taken from 
Ruangsri et al. (2013).  
 
β-Defensins have been shown to kill both gram positive and gram negative 
bacteria, but more potent antimicrobial activity is found towards gram negative 
species such as Escherichia coli, Vibrio fluvialis, Bacillus cereus and 
Pseudomonas aeruginosa (Jin et al., 2010). In addition to antibacterial activity, β-
defensin also shows antimicrobial activity against fish specific viruses including 
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nervous necrosis virus (NNV) and haemorrhagic septicaemia virus (VHSV) 
(Valero, et al., 2013; Masso-Silva & Diamond, 2014). So far no studies have been 
published about the antiparasitic nature of fish β-defensin (Masso-Silva & 
Diamond, 2014), although these types of studies have been carried out using 
human defensin 1 (HD1). HD1 was successfully shown to kill the parasite 
Trypanosoma cruzi via pore formation and DNA fragmentation (Madison et al., 
2007). β-Defensin has also been shown to have immunomodulatory properties 
which was highlighted in a study looking at a defensin isolated from a gilthead 
seabream (Sparus aurata) (Cuesta et al., 2011). The isolated defensin was shown 
to have chemotactic activity where it was able to attract head-kidney leukocytes 
(Cuesta, et al., 2011; Masso-Silva & Diamond, 2014). Similarly, a β-defensin 
isolated from Atlantic cod (Gadus morhua) was experimentally shown to have 
chemotactic action while also stimulating phagocytic activity of head kidney 
leukocytes (Ruangsri, et al., 2013). Overall, fish β-defensins demonstrate 
structural and functional similarities to mammalian defensins, thus, highlighting 
that β-defensins are an ancient and highly conserved mechanism of host defence 
throughout eukaryotic organisms. 
 
1.6.3 Hepcidins 
Hepcidin or liver expressed antimicrobial peptide (LEAP), was first 
discovered in humans but has been consecutively identified in many other 
vertebrates including, reptiles, fish and amphibians (Valero, et al., 2013). 
Hepcidin in humans exists as a pre-pro-peptide (84 amino acids), a pro-peptide 
(60 amino acids) and a mature peptide (25 amino acids) (Hunter et al., 2002). Fish 
hepcidin was first isolated from the hybrid striped bass (Shike, et al., 2002) and 
has subsequently has been identified in at least 37 other fish species including 
medaka (Oryzias latipes), Japanese flounder (Paralichthys olivaceus) and 
zebrafish (Danio rerio) (Noga, et al., 2011; Falco, et al., 2012). Like pleurocidins, 
hepcidin is highly similar between species suggesting a relatively recent 
duplication of the ancestral gene (Douglas et al., 2003). The general structure of 
fish hepcidins is a β-sheet hairpin shape, with conserved cysteine residues forming 
disulphide bridges (Douglas, et al., 2003). Within fish tissues hepcidin is 
constitutively expressed in peritoneal leukocytes, head, kidney, liver, skin 
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epithelium, gills, heart and gonads (Rakers, et al., 2013; Valero, et al., 2013). 
Hepcidin expression has also been detected in turbot (Scophthalamus maximus) 
embryonic cell lines as early as 2 hours after fertilisation with increasing 
expression throughout embryonic development (Chen et al., 2007). Thus, 
highlighting the importance of AMPs in innate immunity even before hatching 
(Valero, et al., 2013). The gene structure of hepcidin is composed of three exons 
and two introns (Figure 12), and the pre-pro-peptide ranging in size from 81 to 96 
amino acids (Falco, et al., 2012), with a mature peptide that is 19 to 31 amino 
acids in length (Masso-Silva & Diamond, 2014).  
 
 
Fish hepcidin has experimentally been shown to have antibacterial activity 
against both gram negative (Escherichia coli and Pasteurella damelae) and gram 
positive (Lactococcus garvieae and Staphylococcus aureus) bacterium (Hirono et 
al., 2005). Unlike most other AMPs the mode of action of hepcidin is non-
membranolytic (Cai et al., 2012) and, therefore, is hypothesised to work 
intracellularly (Masso-Silva & Diamond, 2014). The human mature peptide 
(hepcidin 25) has been shown via a retardation assay to bind to DNA therefore 
causing disruption of cellular processes (Masso-Silva & Diamond, 2014), 
however, this mode of action still needs to be confirmed with fish hepcidin. 
Antiviral activity of hepcidin has also been recorded where the presence of a 
tilapia (Oreochromis mossambicus) hepcidin increased survival of cells exposed 
to infectious pancreatic necrosis virus (IPNV) (Valero, et al., 2013). Other 
functional characteristics of hepcidin include immunomodulatory aspects and 
regulation of intestinal iron absorption (Douglas, et al., 2003; Wiesner & 
Vilcinskas, 2010; Falco, et al., 2012; Valero, et al., 2013). Overall, hepcidin is a 
Figure 12: White bass (Morone chrysops) hepcidin gene organisation and peptide 
composition. Taken from Shike et al. (2002). 
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multifactorial AMP playing a role in many aspects of the vertebrate system 
including innate immunity, immunomodulation and iron regulation. 
 
1.6.4 Cathelicidins 
Cathelicidins are small linear amphipathic α-helical AMPs found in a 
variety of vertebrate species including humans, fish, horses and chickens 
(Kościuczuk, et al., 2012). This family of AMPs was named cathelicidins due to 
the presence of a conserved cathelin domain present in the precursor peptide 
(Masso-Silva & Diamond, 2014). Fish cathelicidins were first identified in 
rainbow trout (Oncorhynchus mykiss) and have since been isolated from 
salmonids (Scocchi et al., 2009), hagfish (Myxine glutinosa) (Uzzell et al., 2003), 
Atlantic cod (Gadus morhua) (Noga, et al., 2011) and ayu (Plecoglossus altivelis) 
(Valero, et al., 2013). Cathelicidin expression has been recorded in a vast array of 
tissues including kidney, spleen, stomach, gonads and brain (Falco, et al., 2012). 
Not all cathelicidins are constitutively expressed in tissues, some are inducible. 
For example, expression of asCATH1 in the skin of healthy Atlantic salmon was 
not detected, but asCATH1 expression was detected in the skin and gills after the 
fish had been exposed to a bacterial challenge (Bridle et al., 2011). The fish 
cathelicidin genes are organised in the same way to mammals (Falco, et al., 2012), 
made up of four exons and three introns encoding a signal peptide, pro-peptide, 
and mature peptide (Figure 13). Even with a similar gene organisation, the mature 
cathelicidin AMPs can vary in size (12 to 100 amino acids long), structure (α-
helical or β-hairpin) and amino acid sequence (Scocchi, et al., 2009; Kościuczuk, 
et al., 2012).  
 
Cathelicidin activity has been recorded against a large range of gram 
positive (Enterococcus facieum, Staphylococcus aureus and Clostridium 
perfringens) and gram negative (Klebsiella pneumonia, Escherichia coli, and 
Pseudomonas aeruginosa) bacteria (Uzzell, et al., 2003). Antifungal activity 
against Candida albicans has also been recorded (Uzzell, et al., 2003). The mode 
of action of fish cathelicidins has not been well explored due to the variable nature 
of the mature peptide sequences and structures between species (Scocchi, et al., 
2009). However, it has been elucidated that the amphipathic structure with net 
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positive charge allows interaction with bacterial membranes highlighting 
cathelicidin bactericidal activity (Kościuczuk, et al., 2012). Mammalian 
cathelicidins have been shown to play various roles throughout the body, both 
immune and non-immune associated, although research into fish cathelicidins is 
so far limited (Masso-Silva & Diamond, 2014). One such study has emerged 
showing that two Atlantic salmon cathelicidins were able to induce IL-8 
expression in blood leukocytes (Bridle, et al., 2011). This suggests fish 
cathelicidins can play an immunomodulatory role as is seen in mammals and may 
be an evolutionarily conserved component of the vertebrate immune system 
(Bridle, et al., 2011). 
 
 
1.6.5 Histone Derived 
Histones are proteins found within eukaryotic cells and are best recognised 
for their role in packaging DNA into structural units called nucleosomes 
(Parseghian & Luhrs, 2006). Histones are known for their rich cationic charge and 
have recently been identified as precursors for a range of histone derived AMPs 
(Chaithanya et al., 2013). The first indication of antimicrobial activity in histones 
was described from calf thymus histone B where bactericidal action was shown 
Figure 13: Gene product of cathelicidins. They are first transcribed as large inactive 
proteins where serine proteases such as proteinase 3 cleave the large product 
activating the cathelin domain and AMP region. Further processing of the AMP 
region leads to multiple active peptides with different activities. Taken from 
Izadpanah and Gallo (2005). 
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against a wide range of bacteria (Hirsch, 1958). Consequently, histone derived 
AMPs have now been identified in a range of organisms including invertebrates, 
amphibians, fish, birds and mammals (Valero, et al., 2013). There are two main 
types of histones, core histones (H2A, H2B, H3, H4) and linker histones (H1), 
where each has been associated as an antimicrobial peptide precursor (Parseghian 
& Luhrs, 2006). Structurally there is a huge diversity in histone derived AMPs, 
from α-helical, to β-sheet, and even random coil domains resulting in an 
amphipathic structure (Valero, et al., 2013). Histones are high in the cationic 
amino acids arginine and/or lysine resulting in a positive charge which is a prime 
feature of AMPs (Chaithanya, et al., 2013). This allows them to bind to the 
anionic surface of a pathogen and causes permeabilisation of the target cell 
membrane (Valero, et al., 2013). It has been shown these peptides destabilise 
bacterial membranes but do not form stable pores. Therefore, it is hypothesised 
they use a carpet method to enter invading cells where they then act intracellularly 
(Noga, et al., 2011). In aquatic environments histone AMP activity has been 
recorded against many microorganisms including, water molds, fish pathogens 
and parasitic dinoflagellates (Masso-Silva & Diamond, 2014). 
 
Histone derived AMPs were first isolated in fish from the skin of channel 
catfish (Ictalurus punctatus), where the isolated proteins showed high sequence 
similarity to histone H2B (Robinette et al., 1998). To date, many other histone 
derived proteins have been discovered in fish, including Oncorhyncin II, SAMP 
H1, histone derived fragment 1 (HSDF-1) and hipposin. Oncorhyncin II was 
initially isolated from the skin of rainbow trout (Oncorhynchus mykiss) and shown 
to be a cleavage product from histone H1 (Fernandes et al., 2004). SAMP H1 was 
isolated from the skin of Atlantic salmon (Salmo salar) and is derived from 
histone H1 (Narvaez et al., 2010). HSDF-1 is also derived from histone H1 and 
has been isolated from the skin of coho salmon (Oncorhynchus kisutch) (Patrzykat 
et al., 2001). Lastly, hipposin is derived from histone H2A and was initially 
isolated from the skin of Atlantic halibut (Hippoglossus hippoglossus) (Birkemo 
et al., 2003). Hipposin is of particular interest because the full primary sequence 
contains the sequences of other histone derived AMPs (Figure 14), such as, 
parasin isolated from the skin mucus of Asian catfish (Parasilurus asotus) (Park 
et al., 1998), and buforin isolated from the stomach of an Asian toad (Bufo bufo 
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garagrizans) (Park et al., 2000). In all fish species studied to date, histone derived 
AMP expression has also been described in the gills, spleen and gut (Masso-Silva 
& Diamond, 2014). These findings highlight histone derived AMPs as a primitive 
form of innate immune defence as they are likely present in many if not all 
teleosts.  Also, the similarity observed in histone H2A sequences between fish, 
amphibians, birds and mammals infers that histone proteins remain relatively 




1.6.6 High Density Lipoproteins 
High density lipoproteins (HDLs) are involved in extracellular transport of 
fats (cholesterol, phospholipids, and triglycerides) around the body, they move fat 
away from cells, tissues and artery walls to organs such as the liver or 
reproductive organs (Concha et al., 2003). HDL fats delivered to the liver are 
converted into bile which is involved in digestion, whereas HDL fats delivered to 
reproductive organs are used in the synthesis of steroid hormones (Johnston et al., 
2008). Other interesting functions have also been attributed to HDL’s including 
their role in immune defence where it has been shown they perform as AMPs 
(Valero, et al., 2013). There are two main types of HDLs within vertebrates 
showing antimicrobial activity, apolipoprotein A-I (apoA-I) and apolipoprotein A-
II (apoA-II). The structure of apolipoproteins vary, apoA-I has an α-helical 
structure whereas, apoA-II has a crystal structure which is organised due to the 
presence of disulphide bonds (Valero, et al., 2013). The primary structure of 
apoA-I shows very little conservation between species, but the secondary and 
Figure 14: Schematic highlighting the primary sequence overlap between the 
naturally occurring histone fragments buforin I, buforin II and parasin to hipposin.  
Taken from Bustillo et al. (2014). 
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tertiary structures are highly similar, therefore, indicating the α-helical structure as 
an important aspect of this peptides antimicrobial activity (Concha et al., 2004). 
The exact mode of action of apolipoprotein functionality is not yet known, 
although it has been hypothesised they form ion channels in bacterial membranes 
(Agawa, et al., 1991), where their antimicrobial activity may solely be due to their 
amphipathic nature and α-helical structure (Johnston, et al., 2008). Other studies 
from human apoA-I have suggested they form pores in lysosomal membranes 
where the pore causes an influx of calcium ions from the cytoplasm, the lysosome 
then swells compromising the physical integrity of the infecting microbe, 
resulting in lysis (Pérez-Morga et al., 2005).  
 
 
 The antimicrobial activity of apoA-I and apoA-II in fish is less well 
understood in comparison to other AMPs, due to limited published studies and 
only recent discovery of the antimicrobial activity of HDLs (Valero, et al., 2013). 
The antimicrobial activity of apoA-I and apoA-II in fish was first analysed in 
common carp (Cyprinus carpio) where these two peptides were isolated from the 
skin and epidermal mucus (Concha, et al., 2003). Studies showed both apoA-I and 
apoA-II isolated from carp skin exhibited antimicrobial activity against gram 
positive (Plancoccus citreus) and gram negative (Yersinia ruckeri, Escherichia 
coli and Pseudomonas sp.) bacteria (Concha, et al., 2004). In addition, 
apolipoproteins have been isolated and their antimicrobial activity studied in 
rainbow trout, (Figure 15) (Villarroel et al., 2007), channel catfish (Pridgeon & 
Klesius, 2013) and striped bass (Johnston, et al., 2008). Further evidence needs to 
Figure 15: Rainbow trout apoA antimicrobial activity against E. coli JM109 in four 
different conditions, LB medium, isolated apoA, the antibiotic tetracycline and 
water. The letters indicated statistically significant (P<0.05) differences between 
treatments. Taken from Dietrich et al. (2015). 
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address the antimicrobial mechanism of apolipoproteins isolated from a range of 




Cytotoxic T lymphocytes and NK cells contain secretory lysozymes that 
contain the lytic proteins granzymes, perforin and granulysin (also known as NK-
lysin) (Andersson et al., 1996; Zhang et al., 2013). In fish granulysins have been 
named NK-lysin which are a part of the saposin-like protein family involved in 
sphingolipid catabolism (Valero, et al., 2013) and has been discovered to play a 
key role in immunity (Pereiro, et al., 2015). The antimicrobial activity of NK-
lysin was first described from the small intestine of pigs (Andersson, et al., 1996), 
but has subsequently been found in various vertebrate species including mice, 
horses, fish and cows. NK-lysin has also been discovered within Entamoeba 
histolytica, a parasitic protozoan, which highlights their role as an ancient but 
evolutionary conserved antimicrobial defence mechanism (Pereiro, et al., 2015). 
In fish the NK-lysin peptide has been isolated from the Japanese flounder 
(Paralichthys olivaceus) (Hirono et al., 2007), tongue fish (Cynoglossus 
semilaevia) (Zhang, et al., 2013), zebrafish (Danio rerio) (Pereiro, et al., 2015) 
and channel catfish (Ictalurus punctatus) (Wang et al., 2006). A comparison of 
genome locations for NK-lysins in selected fish show good conservation and 
synteny (Figure 16), however, no synteny is found between fish and humans 
(Pereiro, et al., 2015). NK-lysin expression has been recorded in a wide range of 
fish tissues, with strong concentrations found in tissues that harbour high numbers 
of lymphocytes (Valero, et al., 2013).  
 
The teleost NK-lysin gene is composed of five exons and four introns with 
a cationic protein composed of 78 residues containing six conserved cysteine 
residues with a predicted three dimensional structure made up of five α-helices 
(Falco, et al., 2012; Zhang, et al., 2013; Zhang et al., 2014). In mammals, the 
AMP activity of NK-lysin plays a significant role in defence against bacteria, 
fungi, viruses, parasites and tumour cells (Pereiro, et al., 2015). In fish, strong 
antibacterial activity of NK-lysin has been shown against Escherichia coli and 
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Bacillus megaterium (Zhang, et al., 2013). The ability of NK-lysin to act on and 
eliminate intracellular pathogens has also been studied (Pereiro, et al., 2015) and 
it has been shown to kill Mycobacterium tuberculosis in combination with 
perforin, another saposin-like family member. Perforin forms pores in the cellular 
membranes of infected cells, allowing NK-lysin to enter and lyse intracellular 
Mycobacterium tuberculosis. The mode of action of NK-lysin against viruses is 
poorly understood, but it has been shown that NK-lysin expression is up regulated 
in fish exposed to viruses, for example, zebrafish exposed to spring viraemia of 
carp virus (SVCV) infection (Pereiro, et al., 2015).  
 
 
Overall fish AMPs are a promising area of investigation where they are 
critical in the first line of immune defence. Additionally, apart from the direct 
antimicrobial activity AMPs show, they also play an important role in innate 
immune modulation, inflammation and adaptive immune responses. 
 
1.7 Molecular Approaches to Understand Immunity 
The transcriptome is defined as the complete set of RNA transcripts (mRNA 
and non-coding RNA) present within an organism (McGettigan, 2013).  The 
transcriptome highlights an important link between encoding DNA and the 
resultant phenotype (Valdés et al., 2013). Transcriptomics, also known as 
expression profiling, examines the expression levels of the transcriptome within a 
Figure 16: Comparative gene location and basic structure of human granulysin and 
NK-lysin from several teleost species. Taken from Pereiro et al. (2015). 
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selected cell population determining the functional components of the genome 
(Valdés, et al., 2013). For example, testing if a particular gene is up-regulated or 
down-regulated in response to a specific external cue (Wang et al., 2009).  
 
Early transcriptomic work was carried out using microarray analysis, where 
oligonucleotides (probes) are bound to a surface which is designed to target 
specific RNA sequences derived from cDNA (target) (Karakach et al., 2010). 
When the cDNA is reverse transcribed it becomes fluorescently labelled, 
consequently allowing detection when probe-target binding occurs (Malone & 
Oliver, 2011). Laser and computer systems are used to recognise and quantify 
fluorescent intensities in order to determine the relative abundance of RNA 
sequences in the target tissue (Karakach, et al., 2010). However, microarray 
methods do have some limitations, one of which is the need for a transcriptome to 
be available before the microarray can be designed (Valdés, et al., 2013). Due to 
these downfalls next generation sequencing (NGS) methods have become 
preferential research techniques (McGettigan, 2013). One such NGS method is 
RNA-seq, where total or mRNA from selected tissues is reverse transcribed into 
cDNA and then sequenced (Valdés, et al., 2013). The result is a transcriptomic 
library made up of short RNA reads (Garber et al., 2011) providing a glimpse of 
the gene expression present within a select tissue at a particular moment in time 
(Wang, et al., 2009). The generated transcriptomic library can also be used for 
gene mapping, however, this is limited to species that have an existing reference 
genome (Zhao et al., 2011). Another useful aspect of RNA-seq transcriptomics is 
the ability to search for genes of interest which can be done by using specific 
genetic attributes to identify candidate genes (Garber, et al., 2011). With the 
emergence of NGS, RNA-seq has become a favourable option to identify immune 
related genes in fish which was previously carried out using techniques such as, 
subtractive hybridisation (Tsoi et al., 2004), homology cloning (Albert, 2001), 
and expressed sequence tags (Altmann et al., 2003), which were difficult to use 
and optimise. Overall, NGS can be used to provide comprehensive information 






AMP’s are an important component of the innate immune response of all 
living organisms that have antimicrobial activity against a range microbes. A 
number of studies have characterised AMP’s within non-mammalian vertebrates 
and started to determine their importance within the immune system. This 
investigation aims to characterise AMP’s in jawed and jawless vertebrate fish 
species, where currently nothing is known. This will be achieved by: 
 
1. Using RNA-seq transcriptome databases to identify AMP genes. 
Transcriptome libraries already exist for selected tissues from S. lalandi 
and G. australis and bioinformatic approaches will be used to aid in 
identifying candidate AMP genes. 
 
2. Using Rapid Amplification of cDNA Ends (RACE)-PCR to obtain the full 
cDNA sequence of selected S. lalandi and G. australis AMP genes. 
Selected amplified products will be cloned and sequenced. 
 
3. Determining the expression of the selected AMP genes within healthy 





Chapter Two: Materials and Methods 
 
All work was carried out in the University of Waikato C.2.03 Molecular 
Biology Laboratory. The work was completed on designated laboratory benches 
cleaned with 70% ethanol (EMSURE®), unless otherwise stated. Waste was 
collected in containers filled with virkon disinfectant (DuPont), followed by a 
sterilisation process where the waste was autoclaved. Animal ethics was also 
considered (see Appendix I) and permission to use genetically modified 




A range of AMP genes in fish species were identified in published literature 
where the entire sequence of each gene was recorded and then aligned using 
ClustalX 2.1 (Jeanmougin et al., 1998). The tree file that was created was 
bootstrapped 1000 times and then opened on Tree View 1.6.6 (Page, 1996), giving 
a phylogenetic tree of all recorded AMP sequences. The tree showed clear 
groupings of AMPs, where two to three representative sequences from each group 
were selected to search the transcriptomic libraries. Geneious v.7.1.7 (Biomatters 
Ltd) software was used to identify AMP genes in the yellowtail kingfish (Seriola 
lalandi) and lamprey (Geotria australis) transcriptomic databases. The 
transcriptomic libraries were established by Dr Steve Bird from S. lalandi spleen, 
ovary, testis and pituitary tissues, and G. australis kidney, liver, skin and gill 
tissues. Construction of the library was carried out using RNA-seq on the Ion 
PGMTM System (Life Technologies) for NGS. Searching the libraries was 
achieved using Geneious by taking a selected sequence from the phylogenetic tree 
and using tblastn, which allows a search of the translated nucleotide 
transcriptomic libraries, using a protein sequence (Gertz et al., 2006). The results 
identified nucleotide sequences that match to a particular AMP in the library, 
these were downloaded and underwent de novo assembly to construct a consensus 
sequence. These consensus sequences were then put into the ExPASy translate 




sequences were then BLAST searched to confirm that they were a match to the 
original AMP used to search the library, corroborating that the correct sequence 
had been identified.  
 
2.2 Primer Design 
Primers to isolate the 5’ and 3’ ends of the S. lalandi and G. australis AMP 
sequences were designed using Primer3 (Untergasser et al., 2012). The sequences 
chosen for further investigation were used and two forward primers for 3’ RACE-
PCR and two reverse primers for 5’ RACE-PCR were designed (Figure 17). 
Primers were designed using a set of parameters (Table 3), however, in some 
instances due to sequence quality not all specifications for primer design were 






Table 3: Parameter levels used in primer design for RACE-PCR 
Parameter Required Level 
Size (bp) 18-30 
Melting Temperature (˚C) 50-60 
GC Content (%) 40-60 
Max Self Complementarity 4 
Max 3’ Self Complementarity 4 
GC Clamp 1 
 
Figure 17: Schematic highlighting the position of forward and reverse primers used 
in 3' and 5' RACE. 
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2.3 RNA Extraction 
RNA extraction was carried out using R&A BLUEᵀᴹ Total RNA Extraction 
Kit (iNtRON Biotechnology). This kit was chosen due to its economical, quick 
and efficient isolation of total RNA from animal tissue. The tissue selected for 
RNA extraction were added to 2.0mL RNase/DNase free conical base screw cap 
tubes (Neptune) containing 1mL of R&A BLUEᵀᴹ solution (iNtRON 
Biotechnology). Also added to the screw cap tube was 0.2mL of 0.1mm 
zirconia/silica beads (BioSpec Productions) and 0.3mL of 0.5mm glass beads 
(BioSpec Productions). The tube was then placed in a bead beater (Alphatech 
Systems Limited) in order to homogenise the tissue at a rate of 4800 oscillations 
per min for 20sec. The tissue was then visually analysed for complete 
homogenisation, and this step was repeated if there was still large aggregates of 
tissue. After homogenisation, 200µL of chloroform (Ajax Finechem) was added 
and the tube was shaken vigorously for 15sec followed by centrifugation 
(Eppendorf Centrifuge 5424R) at 13,000rpm for 10min at 4˚C. Centrifugation 
precipitated out three layers within the tube and was removed carefully from 
centrifuge so as not to disturb the layers. The upper aqueous phase was extracted 
cautiously from the tube using a pipette and transferred to a new labelled 2.0mL 
RNase/DNase free conical base screw cap tube (Neptune). Hyper vigilance was 
used in removing the aqueous phase so as not to disturb any of the subsequent 
layers which could lead to contamination by genomic DNA, proteins, chloroform 
or other organic compounds. Next, 400µL of isopropanol (Ajax Finechem) was 
added to the new tube containing the aqueous phase in order to precipitate out the 
RNA and the tube was inverted five times. Caution was used at this step as rapid 
shaking could sheer the RNA. The tube was then centrifuged at 13,000rpm for 
10min at 4˚C, resulting in a small whitish RNA pellet at the bottom of the tube. 
The supernatant was removed using a pipette, taking care not to disturb the pellet 
and 1mL of 75% ethanol (EMSURE®) was then added and the tube flicked 
several times in order to resuspend the pellet. Ethanol is used to wash the RNA 
pellet removing any salts. The tube was then centrifuged (Heraeus Biofuge Pico) 
at 13,000rpm for 1min at room temperature. The supernatant was then removed so 
as not to disturb the pellet. The ethanol wash step was then repeated and finally 
centrifuged again at 13,000rpm for 1min at room temperature. After completing 
the ethanol wash twice the supernatant was carefully removed using a pipette and 
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the tubes left open for the pellet to dry allowing the remaining ethanol to 
evaporate off, which took approximately 5min. Once the RNA pellet was dry it 
was resuspended in 30µL of diethylpyrocarbonate (DEPC) (Sigma-Aldrich) 
treated water.  
 
Quality and concentration of extracted RNA was then determined using the 
NanoDrop 2000ᵀᴹ (Thermo Scientific). NanoDrop 2000 uses a range of 
absorbance measures to determine the concentration of RNA (260nm), 
contaminants such as phenol (230nm) and proteins (280nm). From these 
absorbance measures RNA quality can be inferred from 230/260 ratio and 
260/280 ratio. To begin 2µL of DEPC water was used to blank the NanoDrop 
2000. The NanoDrop was then wiped clean and 2µL of RNA extract was loaded. 
The machine then gave an output of absorbance levels at 230, 260, 280nm, from 
which the quality and quantity of extracted RNA was determined. A 260/280 ratio 
of 1.8-2.2 and a 260/230 ratio of 2.0-2.2 is generally accepted as a pure sample, 
whereas ratios outside of these indicate the presence of contaminants. While not 
in use RNA samples were kept in -20˚C freezer (Fisher & Paykel). 
 
2.4 Rapid Amplification of cDNA Ends (RACE)-PCR 
The FirstChoice® RLM RACE Kit (Ambion) was used to generate the 3’ 
and 5’ libraries for RACE-PCR. 
 
2.4.1 3’ RACE Library Generation 
3’ RACE is used to amplify the 3’ end of an mRNA sequence. The cDNA is 
generated using a primer sequence complementary to the polyA tail of mRNA, to 
which an adapter sequence is attached. Nested PCR can then be used to amplify 
the 3’ region using primers specific to the adapter sequence (Table 4). To generate 
the 3’ RACE cDNA, 2µL of total RNA isolated from selected tissues were 
transferred to a nuclease free 0.2mL DNase/RNase free PCR tube (Neptune 
Scientific). To this tube the following was added, 4µL of dNTPs, 2µL 3’ RACE 
adapter, 2µL 10X RT buffer, 1µL RNase inhibitor, 1µL M-MLV reverse 
transcriptase and 8µL of nuclease free water. Tubes were mixed gently and pulse 
spun in the centrifuge (Heraeus Biofuge Pico) to bring all liquid to the bottom of 
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the tube. Tubes were then incubated in a thermocycler (Eppendorf) at 42˚C for 
one hour. The generated 3’ RACE libraries were then stored at -20˚C until 
required for nested PCR. 
 
2.4.2 5’ RACE Library Generation 
5’ RACE is more complex than 3’ RACE as an adapter needs to be attached 
to the 5’ end of the mRNA sequence as it does not have a characteristic sequence 
as is seen at the 3’ end which has a polyA tail. Therefore, the 5’ end is treated 
before attachment of the 5’ RACE adapter. Nested PCR can then be used to 
amplify the 5’ region using primers specific to the adapter sequence (Table 4). To 
generate the 5’ RACE cDNA, between 1 - 10µg of RNA isolated from tissues was 
added to a nuclease free 0.2mL DNase/RNase free PCR tube (Neptune Scientific), 
followed by 2µL Calf Intestine Alkaline Phosphotase (CIP), 2µL CIP buffer, and 
nuclease free water to make the volume in the tube up to 20µL. Tubes were mixed 
gently and pulse spun in the centrifuge (Heraeus Biofuge Pico) to bring all liquid 
to the bottom of the tube. Tubes were then incubated in a thermocycler 
(Eppendorf) at 37˚C for one hour to allow CIP treatment to remove the 5 free 
phosphatases from the 5’ end of the RNA. The CIP treated RNA was then purified 
using the Quick-RNAᵀᴹ Mini Prep (Zymo Research). To the CIP treated RNA, 4 
volumes of RNA lysis buffer was added (4:1). Next, 1 volume of 100% ethanol 
(EMSURE®) was added to the sample in RNA lysis buffer at a ratio of 1:1. The 
sample was mixed well and transferred to a Zymo-Spin IIICG Column in a 
collection tube. The tubes were then centrifuged at 13,000rpm for 30sec, this 
allowed the RNA to attach to the column. The precipitate in the bottom of the tube 
was discarded and 400µL of RNA Prep Buffer was added to the column, and the 
tubes centrifuged for another 30sec at 13,000 rpm. The flow through was again 
discarded and 700 µL of RNA wash buffer was added to the column and the tubes 
centrifuged again at 13,000 rpm for 30sec. The flow through was discarded and 
400µL of RNA wash buffer was again added to the column and centrifuged for 
2min at 13,000rpm, to ensure complete removal of wash buffer and any remaining 
contaminants. Next the lid was cut off a 1.5mL RNase/DNase free snap seal 
microfuge tube (Scientific Specialties Inc) and the column placed inside, the old 
collection tube was discarded. Changing the collection tube ensures no 
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contaminants remain. To the column matrix 30µL of nuclease free water (heated 
to 95˚C) was added and the tube centrifuged for 30sec at 13,000rpm to elute the 
purified RNA. The flow through was collected and placed on the matrix again and 
the centrifugation step repeated. Repeating the RNA elution step and heating the 
nuclease free water maximises the RNA yield. Next, the CIP treated purified RNA 
was treated with Tobacco Acid Pyrophosphatase (TAP) which removes the 5’ cap 
structure found at the end of mRNA. In an RNAse free PCR tube (Neptuneᵀᴹ) the 
following components were assembled, 5µL CIP treated purified RNA, 1µL 10x 
TAP buffer, 2µL TAP, and 2µL nuclease free water. The tubes were mixed gently 
and pulse spun and incubated at 37˚C for one hour before being taken on to 5’ 
RACE adapter ligation, which attaches a known adapter sequence to the 5’ end of 
the RNA. In new PCR tubes the following components were assembled 2µL 
CIP/TAP treated RNA, 1µL 5’ RACE adapter, 1µL 10x RNA ligase buffer, 2µL 
T4 RNA ligase, and 4µL nuclease free water. Tubes were gently mixed, pulse 
spun and incubated at 37˚C for one hour. Lastly, the modified RNA was reverse 
transcribed. In new PCR tubes, the following was assembled 2µL ligated RNA, 
4µL dNTP mix, 2µL random decamers, 2µL 10x RT buffer, 1µL RNase inhibitor, 
1µL M-MLV reverse transcriptase, and 8µL nuclease free water (making it up to 
20µL). The tubes were gently mixed, pulse spun and incubated at 42˚C for one 
hour. The generated 5’ RACE libraries were then stored at -20˚C until required for 
nested PCR. 
 
Table 4: Primer and adapter sequences for 5' and 3' RACE 
Primer/Adapter Sequence (5’ – 3’) 
3’ RACE Adapter 
GCGAGCACAGAATTAATACGACTCACTATAGGT12
VN 
3’ RACE Outer Primer GCGAGCACAGAATTAATACGACT 
3’ RACE Inner Primer CGCGGATCCGAATTAATACGACTCACTATAGG 
5’ RACE Adapter 
GCUGAUGGCGAUGAAUGAACACUGCGCGUUUGC
UGGCUUUGAUGAAA 
5’ RACE Outer Primer GCTGATGGCGATGAATGAACACTG 




2.4.3 Nested PCR for 5’ and 3’ RACE 
Nested PCR is a modified traditional PCR method which is used to 
overcome non-specific amplification that may occur due to unanticipated primer 
binding. Nested PCR requires two sets of primers that are used in two sequential 
runs of PCR, with the second set of primers designed to the target inside of the 
product amplified from the first round.  The first primer set F1 or R1 were used in 
the first round of nested PCR and designed to amplify the 3’ or 5’ end of the 
selected sequence. The second set of primers F2 or R2 were designed to anneal 
slightly inside of where the first primer set bound, sometimes with primers 
overlapping. 
 
For 3’ RACE the first set of primers used in round 1 nested PCR are the 
reverse 3’ RACE outer primer which corresponds to part of the adapter sequence 
(Table 4) and a forward primer specific to the gene of interest (F1). The second 
set of primers for 3’ RACE for round 2 nested PCR are the reverse 3’ RACE inner 
primer which also corresponds to part of the adapter sequence (Table 4) and 
another gene specific primer (F2). For 5’ RACE the first set of primers used in 
nested PCR are the forward 5’ RACE outer primer which corresponds to part of 
the adapter sequence (Table 4) and a reverse primer specific to the gene of interest 
(R1). The second set of primers for 5’ RACE for round 2 nested PCR are the 
forward 5’ RACE inner primer which also corresponds to part of the adapter 
sequence (Table 4) and another gene specific reverse primer (R2). Similar to 3’ 
RACE the primers used in round 2 nested PCR select inside the primers used in 
the first round of nested PCR. 
 
For each PCR, ZymoTaqᵀᴹ DNA Polymerase Kit (Zymo Research) was 
used. For the first round of nested PCR a master mix was made up in a 1.5mL 
RNase/DNase free snap seal microfuge tube (Scientific Specialties Inc). The 
master mix contained 12.5µL Reaction Buffer (Zymo Research), 1µL dNTPs 
(Solis BioDyne), 0.2µL ZymoTaq DNA Polymerase, and 7.3µL of DEPC water 
per sample. Each ingredient was multiplied by how many reactions that were 
being run plus an additional sample to ensure enough master mix for each sample. 
For example, if four samples were being synthesised into cDNA, master mix for 
five samples was made up. The master mix solution was pipetted up and down 
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several times to ensure adequate mixing. In a 0.2mL DNase/RNase free PCR tube 
(Neptune Scientific) the following was added, 2µL of template DNA (from 5’ 
RACE), 1µL of forward primer, 1µL of reverse primer and 21µL of master mix, 
which was then mixed thoroughly and pulse spun. The PCR mixes were then 
placed in a thermocycler (Bio-Rad T100) and run using a selection of parameters 
(Table 5). 
 
Table 5: Nested PCR thermocycler parameters 
 Temperature ˚C Time Cycles 
Initial Denaturation 95 10min 1 
Denaturation 95 30sec 
40 Annealing 50-58 30sec 
Elongation 72 30sec 
Final Elongation 72 10min 1 
Holding 4 ∞ 1 
 
The amplified PCR products were run on a 1.5% TAE agarose gel (see 
section 2.5) to confirm the presence of an amplified gene of the right size. For the 
second round of nested PCR all volumes remained the same, the only difference 
being the template DNA was taken from the first round of nested PCR and the 
primers used were F2 and R2 fo 3’ and 5’ RACE respectively. PCR tubes were 
mixed, pulse spun and then placed in the thermocycler on the same programme as 
round 1 (Table 5). Again PCR products were run on a 1.5% TAE agarose gel (see 
section 2.5) to identify if a PCR product of the same size as the gene of interest 
had been amplified, which were then taken on to purification. 
 
2.5 Gel Electrophoresis 
PCR products were run on a 1.5% TAE agarose gel to analyse reaction 
quality and yield. The gel was made by dissolving 0.75g of agarose powder 
(dnature) in 50mL of TAE buffer (Sigma-Aldrich). The solution was mixed in a 
conical flask and microwaved (BRIO) for 2min or until no crystals were visible. 
The solution was left to cool for 3min after which 1µL of 10mg/ml ethidium 
bromide (Sigma-Aldrich) was added and mixed in by swirling the conical flask. 
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The cooled solution was then carefully poured into a gel mould to prevent the 
introduction of any bubbles. A 12 well comb mould was then placed in the gel. 
The gel was left for 20min to set after which the well moulds were removed and 
the gel placed into an electrophoresis mini gel system (OWL Separation System). 
1% TAE buffer was poured into the tank covering the gel and 2µL of gel loading 
buffer (30% glycerol, 0.25% bromophenol blue) was placed onto parafilm 
(Bemis). 10µL of sample was then mixed with each 2µL dot by pipetting up and 
down. The mixed sample was then loaded into a well in the gel, and was repeated 
for each sample, 5µL of 100bp ladder (GenScript) was also loaded into one of the 
wells. Once the gel was loaded the electrodes and cover were connected to the gel 
tank and the voltage was set at 90V and run for 32min. After the set time the 
electrodes were disconnected and the gel removed from the tank and placed onto 
an Omega Lum G imager (Aplegen) in order to visualise the gel. A picture was 
taken using the camera and printed (Mitsubishi). The gel was then discarded and 
the PCR products were stored in a -20˚C freezer until required. 
 
2.6 PCR Product Purification 
In order to maximise the efficiency of downstream applications PCR 
products containing amplified bands of interest were purified using DNA Clean & 
Concentrator Kitᵀᴹ (Zymo Reasearch). In a 1.5mL DNase/RNase free tube 
(Scientific Specialties Inc) 10µL of PCR product was added, along with 50µL of 
DNA binding buffer in, a ratio of 5:1. Tubes were well mixed and pulse spun. The 
entire mixture was then transferred to a labelled Zymo Spin Column in a 
collection tube. The tubes were centrifuged at 13,000rpm for 30sec allowing DNA 
to bind to the columns matrix. The flow through was then discarded and 200µL of 
DNA wash buffer was added directly into the column and the centrifugation step 
was repeated and flow through again discarded. This wash step was repeated to 
guarantee a high purity of DNA. Columns were then transferred to a new 
collection tube to ensure no contamination by wash buffer and 10µL of DEPC 
water was added directly to the column matrix and tubes incubated at room 
temperature for 1min. The tubes were then centrifuged for 30sec at 13,000rpm to 




2.7 Ligation and Bacterial Transformation 
2.7.1 Ligation of PCR product into TA Cloning Vectors 
The pLUG-Prime TA Cloning Vector Kit (iNtRON Biotechnology, Inc) 
was used to ligate PCR products into a TA-Cloning Vector. The TA-Cloning 
Vector is 2728bp in length and includes an ampicillin resistance gene and LacZ 




To a 0.2mL DNase/RNase free PCR tube (Neptune Scientific) the ligation 
reaction was set up (Table 6). The contents of the tubes were vortexed and pulse 
spun. Tubes were then incubated at 4˚C in the fridge overnight in order to 
maximise the efficiency of the T4 DNA ligase. 
Table 6: Reaction reagents and volumes for ligation of purified PCR products into 
TA-Cloning Vectors 
Reagent Volume 
10X Ligation Buffer A 1µL 
10X Ligation Buffer B 1µL 
TA-Cloning Vector 2µL 
T4 DNA Ligase 1µL 
Purified PCR Product 5µL 
Total 10µL 




2.7.2 Lysogeny Broth (LB) Agar Plates 
In order to grow transformed bacteria agar plates containing lysogeny 
broth (LB) + ampicillin + isopropyl β-D-thiogalactopyranoside (IPTG) + 5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside (Xgal) were prepared. To make 
up 250mL of agar, 6.25g LB powder (USB Corporation), 3.75g agar (Coast 
Biologicals Ltd), and 250mL of deionised water were added to a 250mL glass 
Schott bottle (Duran). The bottle was then autoclaved (Astell) on the pre-set 
media cycle. As the autoclave was running, a water bath (Life Technologies) was 
set to 50˚C and once the autoclave was completed, the bottle was put into the pre-
warmed water bath and left for one hour to ensure cooling. This prevented the 
agar from setting and maintained the agar at a temperature that ampicillin could be 
added. After the set time period 125µL of 50µg/mL Ampicillin (Calbiochem), 
250µL of 0.1M IPTG (Biotech), and 500µL of 20mg/mL Xgal (Progen) was 
added and the contents was thoroughly mixed by gently inverting the bottle. Over 
a flame, the agar was poured into 90mm petri dishes (Global Science). The plates 
were then left to set at room temperature, after which they were wrapped in 
aluminium foil (Gilmours) as light degrades ampicillin and Xgal. Plates were then 
stored in the fridge (FRIGOREX) at 4˚C up to a maximum of 4 weeks. 
 
2.7.3 Transforming E. cloni 10G Chemically Competent Cells 
Before beginning the transformation, the ligation reaction had to be 
terminated by placing the PCR tube containing the ligation mix in the 
thermocycler (Bio-Rad T100) at 70˚C for 15min. As the thermocycler was 
running tubes containing 40µL of E. cloni subcloning grade cells (Lucigen) were 
removed from long term storage in the -80˚C freezer (Thermo Electron 
Corporation) and placed on ice to thaw for 10min. Once cells had thawed, 4µL of 
heat inactivated ligation reaction was added to the 40µL of E. cloni cells and tubes 
were given a gentle mix, and incubated on ice for 30min. This incubation allowed 
the ligation vector to attach to the cell wall of the E. cloni cells. After incubation, 
cells were then heat shocked by placing tubes at 42˚C for 45sec. The heat shock 
causes the E. cloni cell membrane to increase in fluidity allowing uptake of the 
plasmids. Cells were then returned to ice for 2min after which 160µL of room 
temperature recovery media (Lucigen) was added to the cells. Tubes were then 
51 
 
placed in a shaking incubator (Alphatech) at 300rpm for 2 hours at 37˚C, this 
incubation allowed for expression of the ampicillin resistant gene. Pre-made LB + 
ampicillin+ IPTG + Xgal plates were placed in a 37˚C incubator for at least 20min 
to allow the plates to dry. Once incubation of the plates and transformed cells was 
completed 50µL of the transformed cells was pipetted onto plates and spread over 
the surface of the plate using a glass hockey stick spreader. Before and between 
samples the hockey stick was decontaminated by being dipped into 100% ethanol 
and waved over a flaming Bunsen burner. Plates were then incubated upside down 
at 37˚C (Sanyo) overnight. 
 
2.7.4 Screening Transformed Bacterium 
The TA-Cloning vector allows for two different methods of screening, 
firstly, the use of ampicillin and secondly, the blue and white colony screen. The 
incorporation of the vector into the E. cloni cells gave the bacteria ampicillin 
resistance as the vector contains a β-lactamase gene thus allowing the growth of 
these cells on LB + ampicillin plates. The second level of screening is the blue-
white colony screen, which is informative as to whether the vector within the 
E.cloni cell contains the amplified PCR product. The site where the product is 
inserted disrupts the LacZ gene in the vector causing it to not be expressed. In a 
vector that contains no genetic insert the LacZ gene is able to be expressed, 
leading to the production of the β-galactosidase. β-galactosidase is able to 
hydrolyse Xgal a sugar included in the agar and this hydrolysis in turn results in 
the colony becoming a distinct blue colour. Therefore, interruption of the lacZ 
gene via a ligated PCR product inhibits β-galactosidase expression, preventing 
hydrolysis of Xgal, thus causing the colonies to stay a characteristic white colour. 
IPTG is a molecular reagent also incorporated into the LB agar plates which aids 
in triggering the expression of the LacZ gene. Therefore, from this screen it can be 
concluded that white cells contain the PCR product whereas blue colonies do not. 
To further validate this the blue-white colony screen, white colonies were selected 
from the plates and a PCR was run targeting the region of the ligated PCR 
product. On the bottom (underside) of each plate, ten white colonies were chosen 
and marked with a label from 1 to 10. 2µL of DEPC water was added to ten 
0.2mL PCR tubes (Neptune Scientific). Each tube was then labelled and 
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inoculated with one of the selected colonies on the plate which was done by 
touching the colony with a sterile 10µL pipette tip (Denville Scientific Inc) and 
transferring a small portion of the colony into the DEPC water by pipetting up and 
down. Caution was taken not to contaminate the tubes with agar as inclusion of 
this in the mixture could inhibit the following PCR reaction. The primers used in 
the PCR mix were M13 forward (5’-GTAAAACGACGGCCAGT-3’) and M13 
reverse (5’-AGTGTGTCCTTTGTCGATACTG-3’) which specifically targeted 
the ligated product inside the plasmid. To each tube containing the bacterial 
colony and 2µL of DEPC water (template DNA), the following was added: 1µL 
of M13 forward primer, 1µL M13 reverse primer giving a total volume of 4µL. A 
master mix was then made up in the same way as nested PCR (see section 2.4.3) 
with 12.5µL 10x reaction buffer (Zymo Research), 1µL dNTPs (Solis BioDyne), 
0.2µL ZymoTaq DNA Polymerase, and 7.3µL of DEPC water per sample. Tubes 
were pulse spun then placed in the thermocycler (Bio-Rad T100) and run using 
selected cycles parameters (Table 5). The PCR products were subsequently run on 
a 1.5% agarose gel (see section 2.5) to visualise and confirm the presence of the 
ligated PCR product. 
 
2.7.5 Culturing Transformed Bacteria 
Colonies found to contain the ligated PCR product, as confirmed by the 
PCR screen were grown in LB + Ampicillin medium overnight. LB medium was 
made up in a 500mL glass Schott bottle (Duran) by dissolving 12.5g of LB 
powdered medium (USB Corporation) in 500mL of deionised water. The bottle 
was then autoclaved (Astell) on the pre-set media cycle to ensure sterility. Once 
cooled, in a sterile 50mL falcon tube (Greiner) 5mL of sterile LB medium and 
5µL of 50mg/mL Ampicillin (Calbiochem) was added. A disposable sterile 
transfer loop was used to transfer the colony containing the correct PCR insert 
from the agar plate to the culture tube. The tubes were then incubated at 37˚C 
overnight in a shaking incubator (Alphatech). 
 
2.7.6 Plasmid Extraction 
Following successful bacterial growth (LB medium was cloudy), the 
plasmid was extracted. The DNA-spinᵀᴹ Plasmid DNA Purification Kit (iNtRON 
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Biotechnology) was used to effectively isolate and remove the plasmids from the 
bacterial cells. 3mL of bacterial suspension was centrifuged at 13,000rpm for 
1min which caused the bacteria to form a pellet in the bottom of the tube and the 
supernatant was discarded. Cells were resuspended in 250µL of resuspension 
buffer and vortexed (Chiltern) thoroughly. 250µL of lysis buffer was added to the 
tube and inverted gently ten times. This step allows the plasmid DNA to be 
released from the bacterial cell. Gentle mixing is needed as any vigorous action 
may cause shearing of the plasmids. Tubes were then incubated at room 
temperature for 3min, after which 350µL of neutralisation buffer was added to the 
tube, and the tube inverted ten times, followed by a 5min incubation on ice. After 
the incubation time tubes were centrifuged (Eppendorf) at 13,000rpm for 10min at 
4˚C. Supernatant was collected and transferred to a DNA-spin column and 
collection tube, with care taken not to disturb the precipitate as it contained 
unwanted cell debris, proteins, and genomic DNA. The column was centrifuged 
for 1min at 13,000rpm. The flow through was discarded and 500µL of Washing 
Buffer A (removes trace nuclease activity) was added to the DNA-spin column 
and then centrifuged for 1min at 13,0000rpm. The flow through was discarded 
and 700µL of Washing Buffer B (removes any unwanted salts) was added to the 
column and again centrifuged for 1min at 13,000rpm. The flow through was 
discarded and columns were centrifuged once again for 1min at 13,000rpm to 
completely remove any residual ethanol and to completely dry the membrane. The 
DNA-spin column was then transferred into a new clean collection tube to prevent 
the addition of washing buffer contaminants and 50µL of DEPC water was added 
directly onto the matrix of the column. The tube was incubated for 1min at room 
temperature and then centrifuged a final time for 1min at 13,000rpm, which 
allowed the eluted DNA to be collected in the bottom of the tube. The column was 
then discarded and using the 2000 nanodrop (Thermo Scientific) the quality and 
quantity of the collected plasmid DNA was determined in the same way as 
described for RNA (see section 2.3).  
 
2.7.7 Restriction Enzyme Digest 
Prior to sending the isolated plasmids for sequencing, a final screening 
method was used to ensure the presence of the correct PCR product in the 
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plasmid. This was carried out through a restriction digest of the plasmid. Within 
the PLUG-Prime TA Cloning Vector there are restriction sites located on either 
side of where the PCR product is inserted (Figure 18). Therefore, two restriction 
enzymes can be used to exploit these sites cutting the PCR product from the 
plasmid. For this reaction, EcoR1 and Pst1 restriction enzymes (Roche 
Diagnostics) were used. In a 1.5mL RNase/DNase free snap seal microfuge tube 
(Scientific Specialties Inc) the plasmid was added to the restriction digest reagents 
(Table 7). 
Table 7: Reagents and volumes used for the restriction digest of the plasmids 
Reagent Volume 
Plasmid 2µL 
10X SuRE Cut Buffer 2µL 
EcoR1 10U/µL 2µL 
Pst1 10U/µL 2µL 
DEPC Water 12µL 
Total 20µL 
 
The contents of the tubes was briefly mixed by inverting the tube several 
times, followed by a pulse spin for 5sec. Tubes were then incubated overnight at 
37˚C (Sanyo). Once incubation was complete samples were run on a 1.5% agarose 
gel (see section 2.5). A successful digest contained two bands, the first band with 
a size of around 2700bp representing the plasmid, and the second band of 
approximately the same size as the ligated PCR product size. The presence of this 
second band indicated a successful ligation. 
2.8 Sequencing 
Upon conformation of the correct ligated PCR product after restriction 
digests the extracted plasmids (section 2.7.6) were prepared for sequencing. 15µL 
of plasmid at a DNA concentration of 100ng/µL was required for the sequencing 
reaction. Using the determined plasmid concentrations through the nanodrop 
results the correct amount of plasmid needed at the correct concentration was 




The calculated plasmid volume was then added to a labelled 0.2mL DNase/RNase 
free PCR tube (Neptune Scientific), followed by DEPC water to make the final 
volume up to 15µL. The tubes were then sent to the DNA Sequencing Facility 
located at the University of Waikato. The plasmid was sequenced using Applied 
Biosystems BigDye® Terminator v3.1 Cycle Sequencing Kit, where the sequence 
was then run on a 3130xl Genetic Analyser System (Applied Biosystems). 
Plasmid sequencing was carried out using the M13 forward primer and the M13 
reverse primer (sequences previously outlined in section 2.7.4). At least three 
plasmids for each amplified product were sequenced. 
 
2.8.1 Sequence Analysis 
Once the nucleotide sequence was obtained for either the 3’ or the 5’ 
RACE, analysis of the results could be carried out. Firstly, any vector sequence 
was identified and removed from the sequenced products. Secondly, the primer 
sequences that had been used to amplify the initial PCR product were located. 
Multiple alignments of sequenced products obtained from the same initial PCR 
were carried out using ClustalX 2.1 (Jeanmougin, et al., 1998) to allow the 
generation of a consensus sequence. This is required to provide quality control to 
the sequences obtained as errors can occur during the sequencing process at a rate 
of approximately every 10^6 nucleotides. Each consensus sequence obtained for 
the 3’ and the 5’ RACE was then compared to the initial sequence found in the 
transcriptomic database to determine it was the correct sequence. Once the 
identity of the sequenced products had been confirmed, the sequenced 3’ and 5’ 
RACE products for the same gene were joined together, to give the full length 
cDNA sequence which were then translated using ExPASy translate tool 
(http://web.expasy.org/translate/) to determine the amino acid sequence of the 
AMP of interest. BLAST analysis was used to confirm the identity of the protein 
and ClustalX 2.1 was used to align the protein with already characterised fish 
AMP’s. SignalP ver4.0 (Petersen et al., 2011) was used to predict the presence of 
any signal peptides within the predicted proteins and using the alignments 




2.9 Real-Time PCR 
Real-time PCR (RT-PCR) is used to monitor the amplification of a targeted 
gene during a PCR reaction. This method can be used to quantitatively or semi 
quantitatively show amplification of genes relative to each other.  
 
2.9.1  Primer Design 
Using Primer3 an online program (http://primer3.sourceforge.net/) forward 
and reverse primers were designed for the genes of interest and the selected 
housekeeping genes. As with RACE primer design the following characteristics 
were followed as much as possible. Primers had a GC content of 40-60% in order 
to ensure stability of the product. The melting temperature of the primers was 
between 54 and 60°C with the forward and reverse primers used in the same 
reaction within 1°C of each other. Primers also ended with a GC clamp as T and 
A residues more easily bind to DNA non-specifically. The number of possible 
interactions within a primer and between primers were kept to a minimum to 
prevent hairpin loops or primer dimers, respectively. Lastly, the primers and 
amplicons were BLAST searched against the transcriptome and public database to 
confirm that the primers targeted the correct gene of interest. 
 
2.9.2 RNA Extraction and cDNA Synthesis 
Total RNA was prepared from gill, liver and spleen tissues from three 
different S. lalandi individuals, for use in determination of primer efficiency and 
specificity. Preparation of high purity RNA, with no gDNA contamination was 
crucial for achieving the best results from RT-PCR. To achieve this, the Quick-
RNA™ MiniPrep kit (Zymo) was used, which reliably and rapidly isolates DNA-
free RNA from tissue. The RNA isolation and extraction protocol consisted of 
three steps; sample lysis, sample clearing (gDNA removal) and RNA purification. 
Selected tissues were added to a 2.0mL RNase/DNase free conical base screw cap 
tubes (Neptune) containing 600 µL of RNA Lysis Buffer. 0.2mL of 0.1mm 
zirconia/silica beads (BioSpec Productions) and 0.3mL of 0.5mm glass beads 
(BioSpec Productions) were added and the tubes and placed into a bead beater 
(Alphatech Systems Limited). The tissues were homogenised at 4800 oscillations 
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per minute for 10sec, which was repeated if the tissue did not break down 
completely. Homogenisation caused the lysis buffer to foam, which was cleared 
by centrifuge at 13,000rpm for 1min. The supernatant was then transferred into a 
yellow Spin-Away™ Filter, which was placed into a collection tube. The sample 
was centrifuged at 13,000rpm for 1min allowing DNA to bind to the columns 
matrix and therefore removing the contaminating gDNA from the mix. The flow-
through in the collection tube was collected and used for RNA purification. To the 
flow-through, 1 volume of ethanol (95-100%) was added at a ratio of 1:1 and 
mixed well. The mixture was then transferred to a green RNA Zymo-Spin™ 
IIICG column in a collection tube and centrifuged 13,000rpm for 30sec. 
Centrifugation allowed the total RNA to bind to the columns matrix, the flow-
through was discarded. To ensure complete removal of any trace gDNA, the 
isolated total RNA underwent DNase I treatment. 400 µl of RNA Wash Buffer 
was added to the column, which was then centrifuged at 13,000rpm for 30sec. The 
flow through discarded. For each sample to be treated, a DNase I Reaction Mix 
was prepared in a 2.0mL RNase/DNase free tube, which contained 5µL of DNase 
I DNA and 75μL of Digestion Buffer. The 80μL DNase I Reaction Mix was 
added directly to the column matrix and incubated at room temperature for 15min. 
The column was then centrifuged at 13,000rpm for 30sec and flow through 
discarded. 400µL of RNA Prep Buffer was added to the column and again 
centrifuged at 13,000rpm for 30sec. The flow-through was discarded ensuring 
complete removal of gDNA and the DNase I Reaction Mix. 700µl of RNA Wash 
Buffer was added to the column in order to wash the RNA contained in the 
matrix. The column was centrifuged at 13,000rpm for 30sec and the flow-through 
discarded. The RNA wash step was repeated where another 400µl RNA Wash 
Buffer was added to the column. The tube was then centrifuged 13,000rpm for 
2min to ensure complete removal of the wash buffer. The RNA-spin column was 
then transferred into a new clean collection tube to prevent any addition of 
washing buffer contaminants. 30µL of DEPC water was added directly onto the 
matrix of the column, and incubated for 1min at room temperature to elute the 
RNA. The tube was then centrifuged a final time for 30sec at 13,000rpm, which 
allowed eluted RNA to be collected in the bottom of the tube. The column was 
then discarded, and a nanodrop reading carried out to establish the quality and 
quantity of the RNA (see section 2.3). 
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The RNA was immediately used for cDNA synthesis to minimise RNA 
degradation. To synthesise cDNA the HiSenScript™ RH(-) cDNA Synthesis Kit 
(iNtRON) was used. This kit is designed for the sensitive, reproducible detection 
and analysis of full-length cDNA copies from total RNA. For each sample the 
following mixture was made up in a 0.2mL DNase/RNase free PCR tube 
(Neptune); 1µg of total RNA, 10μL of 2X RT Reaction Solution, 1μL of Enzyme 
Mix Solution and DNase/RNase Free Water up to a total volume of 20μL. Tubes 
were then vortexed to ensure thorough mixing, pulse spun and finally incubated in 
a Biorad T100 thermal cycler at 42°C for 1 hour. Incubation allowed for reverse 
transcription of the RNA into cDNA. Following reverse transcription the reaction 
was inactivated by incubation at 85°C for 5min. Tubes were then stored at 4°C 
until being used in RT-PCR for testing primer efficiencies.  
 
2.9.3 Real-Time PCR 
RT-PCR was performed using the Rotor-Gene 6000 (Corbett). The 
RealMODᵀᴹ GH Green q PCR Master Mix Kit (iNtRON) was used following the 
manufacturer's instructions. Briefly, into a 0.2mL RNase/DNase free, thin walled, 
clear PCR tube (Axygen), 10µL of 2x RealMODTM GH Green qPCR Master 
Mix, 1µL of forward primer (10 µM), 1µL of reverse primer (10µM) and 8µL of 
previously synthesised cDNA was added. Amplification was carried out using the 
following program; Initial denature at 94°C for 5min, followed by 40-50 cycles of 
denaturation at 94°C for 20sec and annealing/extension at 60°C for 30sec. 
Fluorescent outputs were then measured and recorded at 80°C. A melt curve for 
each sample was performed between 72°C and 94°C to ensure only a single 
product had been amplified. Using the graphs generated, a threshold line was set 
on the amplification curves to generate the threshold cycle (Ct) value for each 
reaction, which is where a detectable amount of amplicon product had been 
generated during the early exponential phase of the reaction. 
 
2.9.4 Primer Testing and Efficiencies 
Prior to determination of gene expression, the primer efficiencies were 
tested to establish amplification efficiencies. The previously prepared cDNA from 
selected tissues underwent either a 2-fold or a 4-fold serial dilution. The produced 
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cDNA was used at multiple concentrations, undiluted, 1:4, 1:16 and 1:64 for the 
housekeeping genes and undiluted, 1:2, 1:4, and 1:16 for the genes of interest. For 
each cDNA dilution, primer pairs were run in duplicate as well as a negative 
control. The determination of primer efficiencies were run in duplicate to ensure 
accurate results. The negative control contained DNase/RNase free water in lieu 
of cDNA template in order to check for contamination. At each dilution, Ct values 
were obtained from each amplification curve. The Ct values were plotted against 
the initial amounts of template on a semi-log10 plot. A line of best fit was applied 
to the points and the gradient of the line and the R2 value was calculated. This 
determined how close the points were to the line of best fit. Efficiencies (E) of the 
primers were calculated using the equation E=10(-1/s)-1, where “s” is the slope of 
the line. In addition, real-time products were run on a 1.5% agarose gel, using the 
same protocol that was previously described (section 2.5) to confirm amplification 
of a single product. 
 
2.9.5 Measuring Gene Expression 
The housekeeping genes were used to normalise the expression of selected 
genes, with expression analysis being achieved using the geometric means of 
these genes (Vandesompele et al., 2002). Using the comparative ΔCq method 
(Silver et al., 2006), relative expression levels were determined. This method was 
a variation of the Livak method (Livak & Schmittgen, 2001) which is used to 




Chapter Three: Results 
 
3.1 Bioinformatics 
Known AMP genes and their corresponding amino acid sequence were 
compiled from several fish species (Figure 19). Cathelicidins, piscidins, 
hepcidins, defensins, and other groups of AMPs were identified from searches of 
public databases or from published literature. Several of these sequences were 
then used to search the available yellowtail kingfish (Seriola lalandi) and pouched 
lamprey (Geotria australis) transcriptomic library to identify genetic fragments 
similar to the input sequence. The transcriptomic library used for S. lalandi in this 
research was derived from spleen tissue of an adult individual. Whereas, the 
transcriptomic libraries generated for G. australis were derived from liver, kidney, 
skin and gill tissue of adult individuals. Candidate gene sequences were then 
generated using de novo assembly in Geneious from identified fragments. Within 
these libraries sequences were then aligned with known AMP sequences from fish 
to confirm that the correct genetic product had been identified.  
 
From the S. lalandi transcriptomic library ten different AMPs were 
identified (see Appendix IV), hepcidin, moronecidin, two high density 
lipoproteins (apoA-I and apoA-II), piscidin, epinecidin, two histone derived 
AMPs (H2A and H2B), haemoglobin derived, and NK-lysin. Each identified 
sequence was aligned with a known AMP gene of the same type to determine 
sequence homology (see Appendix V). Whereas, from the G. australis 
transcriptomic library only five AMPs were identified (see Appendix VI), 
defensin-like, haemoglobin derived, NK-lysin, and two histone derived AMPs, 
H2A and H2B. Each identified sequence was aligned with a known AMP gene of 
the same type to determine sequence homology (see Appendix VII). From this 
two potential S. lalandi AMP genes (moronecidin and hepcidin) and one G. 
australis AMP gene (defensin-like) were chosen for further analysis. All other 
significant hits from the transcriptomic library were saved as potential candidate 






Figure 19: Range of AMP sequences identified in fish and available in public 
databases. Identification for each sequence is listed in appendix III. 
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3.1.1 Yellowtail Kingfish (S. lalandi) 
Hepcidin and moronecidin were two AMP genes identified from the S. 
lalandi transcriptomic library and showed good homology when aligned with 
other known fish AMP sequences. A potential moronecidin gene was identified 
and aligned against duskytail grouper (Epinephelus bleekeri) nucleotide sequence 
(Figure 20). The potential S. lalandi moronecidin gene was then translated and the 
protein sequence aligned against the duskytail grouper moronecidin protein 
(Figure 21). 
 
Potential S. lalandi moronecidin   GGCCAAGGGCCAAGGCGAGACACGGRCCTCWSAGCGGCCAAGGCGCAGTC 
Duskytail grouper moronecidin      -------------------------------------------------- 
                                                                                      
 
Potential S. lalandi moronecidin   ATCAGGAAGGATGAAGTTCATCGCCCTGTTTCTTGTGTTGTCACTGGTCG 
Duskytail grouper moronecidin      ----------ATGAGGTGCATCGCCCTCTTTTTTGTGTTGTCGCTGGTGG 
                                             **** ** ********* *** ********** ***** * 
 
Potential S. lalandi moronecidin   TCCTCATGGCTGAACCTGGGGAAGGTTTTTTTCACCACATTCTCTCGGGA 
Duskytail grouper moronecidin      TCCTCATGGCTGAACCCGGGGAGGGGTTCTTTTTCCACATCATCAAAGGA 
                                   **************** ***** ** ** ***  ******  **   *** 
 
Potential S. lalandi moronecidin   ATTTTTCACGTTGGCAAAATGATCCACGGCGCGATCCAAAGGAGGAGACA 
Duskytail grouper moronecidin      CTCTTTCACGCTGGCAAGATGATCCATGGACTTATCCACAGGAGACGACA 
                                    * ******* ****** ******** **    ***** *****  **** 
 
Potential S. lalandi moronecidin   T-GGCATGACAGAGCTAGAGCGATGCGGGTGGAGCGGTCGT--CTCTGGA 
Duskytail grouper moronecidin      TCGACATGGGATGGA-AGAGCTGCAAGACCTGGACCAACGTGCCTTTGAA 
                                   * * ****  *  *  *****     *    *  *   ***  ** ** * 
 
Potential S. lalandi moronecidin   TCAGG--------------------------------------------- 
Duskytail grouper moronecidin      CGAGAGAAAGCTTTTGCCTGAGTCTACAATAGCCCAGTGAAGGAGCTACT 
                                     **                                               
 
Potential S. lalandi moronecidin   -------------------------------------------------- 
Duskytail grouper moronecidin      CATTGTTAACACAAAAACGAAAAGATTTTTGTTTTTGAGTATAGGAAGTA 
                                                                                      
 
Potential S. lalandi moronecidin   -------------------------------------------------- 
Duskytail grouper moronecidin      TTGGCTCAATTGGGTAACCAAAATATTTTACATTGATCTAATCGATTTTG 
                                                                                      
 
Potential S. lalandi moronecidin   ------------------------------------------------ 
Duskytail grouper moronecidin      AAAAAAACGTTATTCGAAATAAATCTGGAATCTGTGTTACGCAAAAGC  
Figure 20: Moronecidin nucleotide sequence obtained from the S. lalandi 
transcriptomic library aligned against a duskytail grouper moronecidin gene 
(Accession number, HQ437912.1). 
 
 
Potential S. lalandi moronecidin    GQGPRRDTXLXAAKAQSSGRMKFIALFLVLSLVVLMAEPGEGFFHHILSG 
Duskytail grouper moronecidin       --------------------MRCIALFFVLSLVVLMAEPGEGFFFHIIKG 
                                                        *: ****:****************.**:.* 
 
Potential S. lalandi moronecidin    IFHVGKMIHGAIQRR--RHGMTELERCGWSGRLWIR----- 
Duskytail grouper moronecidin       LFHAGKMIHGLIHRRRHRHGMEELQ--DLDQRAFEREKAFA 
                                    :**.****** *:**  **** **:  . . * : *       
Figure 21: S. lalandi potential moronecidin protein sequence aligned against a 




The potential hepcidin gene identified from the S. lalandi transcriptomic 
database was aligned against the large yellow spotted croaker (Larimichthys 
crocea) nucleotide sequence (Figure 22). The potential S. lalandi hepcidin gene 
was then translated and the protein sequence aligned against the large yellow 
croaker hepcidin protein (Figure 23). 
 
 
Potential S. lalandi hepcidin     -------------------------------------------------- 
Large yellow croaker hepcidin     ATGAAGGCATTCAGCATTGCAGTTGCAGTGACACTCGTGCTCGCCTTTAT 
                                                                                     
 
Potential S. lalandi hepcidin     -GGCCAAGGCGAGAGCTCTGCTGTCCCATTCCACGGGGTGCGAGAGCTGG 
Large yellow croaker hepcidin     TTGCATTCTGGAGAGCTCTGCTGTCCCATTCACCGGGGTGCAAGAGCTGG 
                                    **      *********************  ******** ******** 
 
Potential S. lalandi hepcidin     AAGAGGCAGGAAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGTCA 
Large yellow croaker hepcidin     AGGAGGCAGGGAGCAATGACACTCCAGTTGCGGCACATCAAGAAATGTCA 
                                  * ******** ******************* ***** ****** ****** 
 
Potential S. lalandi hepcidin     ATGGCATCGTGGATGATGCCGAATCCCGTCAGGCAGAAGCGCCAGAGCCA 
Large yellow croaker hepcidin     ATGGAATCGTGGATGATGCCCAATCACATCAGGCAGAAGCGTCAGAGCCA 
                                  **** *************** **** * ************* ******** 
 
Potential S. lalandi hepcidin     CCTCTCCATGTGCCGCTGGTGCTGCAACTGCTGCACGGCCAACAAGGGCT 
Large yellow croaker hepcidin     CCTCTCCTTGTGCCGCTGGTGCTGCAACTGCTGCAAGAGCAACAAGGGCT 
                                  ******* *************************** *  *********** 
 
Potential S. lalandi hepcidin     GCGGTTTCTGCTGCAGGTTCTGAGGATTCCCGCCACAGCCTCGAAATATT 
Large yellow croaker hepcidin     GCGGTTTCTGCTGCAGGTTC------------------------------ 
                                  ********************                               
 
Potential S. lalandi hepcidin     AATTTATTTTACTTCTTTTTGCTTTACCCCAGGAAATGACCCTCTTTC 
Large yellow croaker hepcidin     ------------------------------------------------  
Figure 22: Hepcidin nucleotide sequence obtained from the S. lalandi transcriptomic 




Potential S. lalandi hepcidin      -----------------GQGESSAVPFHGVRELEEAGSNDTPVVARQEMS 
Large yellow croaker hepcidin      MKAFSIAVAVTLVLAFICILESSAVPFTGVQELEEAGSNDTPVAAHQEMS 
                                                       ******* **:************.*:**** 
 
Potential S. lalandi hepcidin      MASWMMPNPVRQKRQSHLSMCRWCCNCCTANKGCGFCCRF-GFPPQPRNI 
Large yellow croaker hepcidin      MESWMMPNHIRQKRQSHLSLCRWCCNCCKSNKGCGFCCRF---------- 
                                   * ****** :*********:********.:**********           
 
Potential S. lalandi hepcidin      NLFYFFLLYPRK-PSF 
Large yellow croaker hepcidin      ----------------  
Figure 23: S. lalandi potential hepcidin protein sequence aligned against a large 






A defensin-like peptide was identified from the G. australis transcriptomic 
library using an already characterised protein sequence from sea lamprey 
(Petromyzon marinus; Accession number, Q10996.1). There is no nucleotide 
sequence available for this protein, so an alignment comparing four different 
sequences identified from the lamprey transcriptomic library was generated 
(Figure 24). However, the protein sequence translated from the identified 
nucleotide sequences shows good homology when aligned with the sea lamprey 
defensin-like protein (Figure 25). Other AMP sequences were also identified in 
the lamprey transcriptomic library and aligned (Appendix VII). 
 
 
G. australis 1  ------------------AATGTTAAAGGTTTGCTGTAATGCACAGTGGTTATCTTAAAT 
G. australis 2  ------------------AATGTTAAAGGTTTGCTGTAATGCACAGTGGTTATCTTAAAT 
G. australis 3  AGATGAAGATGGGCGGCCGGGAGGAGAAGGTCGCYGKRKY-YGTCGKSAYGWYCMCTCAT 
G. australis 4  ----------------------------------AGAATT-CACCAGRCKGATC----AT 
                                                   *                 *    ** 
 
G. australis 1  G--TTTGAACAATAAACCAGTTATAGTATGAATAGTG--TGKACWYTMSTCAGCTTGTCC 
G. australis 2  G--TTTGAACAATAAACCAGTTATAGTATGAATAGTG--TGKACWYTMSTCAGCTTGTCC 
G. australis 3  GGCTCTTCTTCGTGCGCTGTTGCTGCTGGTGGTGGTGACTGGGCTCTCGTCAGCTTGTCC 
G. australis 4  GGCTCTTCTTCGTGCGCTGTTGCTGCTGGTGGTGGTGACTGGGCTCTCGTCAGCTTGTCC 
                *  * *      *   *   *  *  *     * ***  **  *  *  *********** 
 
G. australis 1  CTGCGGCAAAAGAAGATGCTGCGTTCGAGGCTTGACGGTTTACTGCTGCTT-GCAGACAG 
G. australis 2  CTGCGGCAAAAGAAGATGCTGCGTTCGAGGCTTGACGGTTTACTGCTGCTT-GCAGACAG 
G. australis 3  CTGCGGCAAAAGAAGATGCTGCGTTCGAGGCTTGACGGTTTACTGCTGCTTTGCAGACAG 
G. australis 4  CTGCGGCAAAAGAAGATGCTGCGTTCGAGGCTTGACGGTTTACTGCTGCTTTGCAGACAG 
                *************************************************** ******** 
 
G. australis 1  GGAGGAAA-CGGAGTGATGCAAGGAAGCAGAATTCACCAAGCGTTGGATTGTTCACCCAC 
G. australis 2  GGAGGAAA-CGGAGTGATGCAAGGAAGCAGAATTCACCAAGCGTTGGATTGTTCACCCAC 
G. australis 3  GGAGGAAAACGGAGTGATGCAAGTGACCATGGTGCCGGCACAGGCTGTTT-CTC-CCTAC 
G. australis 4  GGAAGAAAACGGAGTGATGCAAGTGACCATGGTGCCGGCACAGGCTGNTTTCTC-CCTAC 
                *** **** **************  * **   * *    *  *   * **  ** ** ** 
 
G. australis 1  TAATAGGGAACGTGAGCTGGGTTAGACCGTCGTGAGACAGGTTAGTTTACCC-------- 
G. australis 2  TAATAGGGAACGTGAGCTGGGTTAGACCGTCGTGAGACAGGTTAGTTTACCC-------- 
G. australis 3  AACGCCCACGCCCGCTCCTGCTCAGGC-GCTGTCTGCTCGGCCAATGGAGAATCTCGCTG 
G. australis 4  AACGCCCACGCCCGCTCCTGCTCAGGC-GCTGTCTGCTCGGCC----------------- 
                 *        *  *  *  * * ** * *  **  *   **                    
 
G. australis 1  --------------- 
G. australis 2  --------------- 
G. australis 3  CCTGCCCCATGTCTG 
G. australis 4  ---------------  
Figure 24: Defensin-like nucleotide alignment comparing four different sequences 





Potential G. australis defensin-like    R-RWAAGRRRSXXXSXXXLMALLRALLLLVVVTGLSSACPCGKRRCCVRG 
Petromyzon marinus defensin-like        --------------------------------------CPCGRRRCCVRG 
                                                                              ****:******* 
 
Potential G. australis defensin-like    LTVYCCFADREENGVMQVTMVPAQAVSPYNAHARSCSGAVCSANGESRCL 
Petromyzon marinus defensin-like        LNVYCCF------------------------------------------- 
                                        *.*****                                            
 
Potential G. australis defensin-like    PHV 
Petromyzon marinus defensin-like        ---  
Figure 25: G. australis defensin-like protein sequence translated from the identified 
nucleotide sequence aligned against the sea lamprey defensin-like protein (Accession 
number, Q10996.1).  
 
 
To compare the homology of the identified G. australis defensin-like 
protein to a known mammalian defensin, it was aligned to human alpha defensin-
1 (Figure 26). Overall there is low sequence homology, although conserved 
cysteine and arginine residues between the proteins can be seen. 
 
 
G. australis transcriptome -------------------------------------------------- 
Human alpha defensin-1     MRTLAILAAILLVALQAQAEPLQARADEVAAAPEQIAADIPEVVVSLAWD 
                                                                              
 
G. australis transcriptome ---------------CPC-------GKRR---CCVRG-LTVYCCL 
Human alpha defensin-1     ESLAPKHPGSRKNMACYCRIPACIAGERRYGTCIYQGRLWAFCC- 
                                          * *       *:**   *  :* * .:**  
Figure 26: Sequence alignment of the G. australis defensin-like protein identified 
from the transcriptomic library aligned with human alpha defensin-1 (Accession 
number, NP_004075.1). Highlighted are the cysteine and arginine residues. 
 
 
3.2 Rapid Amplification of cDNA Ends (RACE)-PCR 
3.2.1 RNA Extraction 
3’ and 5’ RACE was carried out on RNA from adult S. lalandi and G. 
australis tissues. Four S. lalandi tissue types (spleen, gills, liver, and kidney) were 
used, whereas, only kidney tissue was used in G. auatralis. Total RNA was 
extracted from these tissues and quantified using the Nanodrop 2000 (Table 8). 
The nanodrop showed the RNA purity of each tissue to be 1.7 or above. In 
addition, the concentration for each sample was used to calculate the volume of 




Table 8: Nanodrop results from RNA extraction of various S. lalandi tissues and one 
G. australis tissue. 
 
 
3.2.2 Yellowtail Kingfish 3’ RACE 
3.2.2.1 Primer Design 
The partial hepcidin and moronecidin sequences identified from the S. 
lalandi transcriptomic library were used to design 3’ RACE primers. Two forward 
primers were designed close to the start of the sequences. The first forward primer 
(F1) and second forward primer (F2) are outlined for moronecidin (Figure 27) and 
hepcidin (Figure 28) 
 
 
Figure 27: Candidate S. lalandi moronecidin sequence with F1 primer outlined by a 




Figure 28: Candidate S. lalandi hepcidin sequence with F1 primer outlined by a box 






S. lalandi Kidney 1164.6 2.01 2.10 
S. lalandi Liver 179731 1.80 1.90 
S. lalandi Gill 1721.5 2.07 2.18 
S. lalandi Spleen 6393.9 1.72 1.82 
G. australis Kidney 597 2.06 2.25 
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3.2.2.2 Nested PCR 
The two primers designed for each S. lalandi AMP sequence were used in 
nested 3’ RACE-PCR in an effort to isolate the 3’ ends of the moronecidin and 
hepcidin genes. The first round of nested PCR was carried out on the 3’ RACE 
cDNA, using either the forward primers F1 or F2 for each gene along with the 
outer 3’ RACE reverse primer. PCR products were run on a 1.5% agarose gel 
(Figure 29). Gel imaging showed the presence of multiple bands when using the 
F1 and F2 moronecidin primers (lane 1 and 2 consecutively). The presence of 
multiple bands was also noted for the F1 hepcidin primer (lane 3). In contrast, 





PCR products obtained from round one nested PCR using the F1 and 3’ 
RACE outer primer for both moronecidin and hepcidin were subsequently used as 
the template for the second round. The forward primer F1 or F2 for each gene 
were used alongside the 3’ RACE inner primer. PCR products were run on an 
agarose gel (Figure 30). Multiple faint bands could be seen using the F1 primer 
for moronecidin (lane 1) and hepcidin (lane 3), whereas, a single strong band was 
amplified when using F2 for each gene (lane 2 and lane 4). The single isolated 
bands for moronecidin and hepcidin show product sizes of approximately 400bp 
for moronecidin and 500bp for hepcidin.  
Figure 29: Gel image showing the first round of nested PCR. Products obtained 
were using the F1 and F2 primers for moronecidin and hepcidin alongside the 3' 
RACE outer reverse primer. The template DNA used was a combination of all S. 
lalandi tissues from which RNA was previously isolated. Lane numbering is as 
follows; lane 1 moronecidin F1, lane 2 moronecidin F2, lane 3 hepcidin F1, and 










In each case the first round of nested PCR using the F1 forward primer and 
reverse 3’ RACE outer primer first isolated a number of fragments, however, the 
second round of nested PCR using the F2 forward primer and reverse 3’ RACE 
inner primer increased specificity allowing the isolation of a single major product 
band. Following the successful amplification of these products using nested PCR, 
fresh products were taken on to be cloned for sequencing. 
 
3.2.2.3 Ligation and Bacterial Transformation 
Each PCR product obtained after the second round of nested PCR were 
ligated into a cloning vector followed by transformation into chemically 
competent E. cloni cells (Appendix XVII). Transformed bacterial cells were 
grown up on LB + AMP + Xgal + IPTG plates, and underwent a blue and white 
colony screen. Transformed cells for both moronecidin (Plate 1, Figure 31) and 
hepcidin (Plate 2, Figure 31) were grown up on these selective plates.  
 
 
Figure 30: Gel image showing the second round of nested PCR. Products obtained 
were using the reverse 3' RACE inner primer alongside the F1 or F2 S. lalandi 
moronecidin or hepcidin primers. Lane numbering is as follows; lane 1 
moronecidin F1, lane 2 moronecidin F2, lane 3 hepcidin F1, and lane 4 hepcidin 






White colonies indicated cells that contained the cloning vector with a 
successfully ligated PCR product. However, blue colonies contained a cloning 
vector but no ligated PCR product. Six white colonies from each plate were 
selected and screened using conventional PCR to determine if they contained PCR 
products of the correct size. M13 forward and M13 reverse primers were used to 
select for the ligated gene, the expected product sizes for each gene included part 
of the cloning vector where the M13 primers bound. PCR products were run on an 
agarose gel for moronecidin (Figure 32) and hepcidin (Figure 33), where products 




Figure 32: Gel image showing PCR products obtained from six colonies screened 
from the moronecidin plate. Refer to appendix VIII for ladder band sizing. 
 





Figure 33: Gel image showing PCR products obtained from six colonies screened 
from the hepcidin plate. Refer to appendix VIII for ladder band sizing. 
 
From the moronecidin colonies analysed using PCR, three colonies were 
successful in showing gene products of the correct size, colonies 1.1, 1.3 and 1.5. 
Whereas, the PCR screening of hepcidin indicated all colonies contained the 
correct PCR product. All screened colonies of the correct size were selected to be 




Figure 34: Example of transformed E. cloni cells grown up in LB + Ampicillin 
medium for 24 hours. 
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3.2.2.4 Plasmid Extraction and Restriction Digest 
Following colony growth in LB + ampicillin medium, plasmids were 
extracted from the bacteria. A restriction digest was carried out on the extracted 
plasmids to confirm the ligated moronecidin (Figure 35) and hepcidin (Figure 36) 
PCR product was still present. Each restriction digest was run on an agarose gel.  
 
 
Figure 35: Moronecidin restriction digest. Outlined by the black box shows an insert 
that matches the size of the moronecidin PCR product. Refer to appendix VIII for 
ladder band sizing. 
 
 
Figure 36: Hepcidin restriction digest. Outlined by the black box shows an insert 
that matches the size of the hepcidin PCR product. Refer to appendix VIII for 
ladder band sizing. 
 
The restriction digest carried out on the moronecidin products (Figure 35) 
showed large bands at the top of the gel (>1500bp) which are the plasmids, 
whereas the smaller fainter bands are the ligated products. Lanes 2 to 4 showed 
moronecidin products of the correct size ~400bp. The restriction digest carried out 
on the hepcidin products (Figure 36) showed large plasmid bands, whereas, the 
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small faint bands are the ligated product. Lanes 1 to 3 show a genetic insert of the 
correct size ~500bp for hepcidin, outlined by the black box. Each plasmid that 
showed an insert of the expected size for moronecidin and hepcidin were sent for 
sequencing and the results analysed. 
 
3.2.2.5 Sequencing Results 
Three samples for each cloned product were sent for sequencing to the 
DNA Sequencing Facility located at the University of Waikato. Once sequencing 
was completed the inserted product had to be identified from the vector sequence. 
First the polyA tail was identified as this is characteristic of all mRNA sequences 
in eukaryotes. Following the polyA tail was the 3’ RACE inner primer, with 
anything after the primer sequence being part of the vector and therefore could be 
removed. Next the F2 forward primer sequence could be identified so the vector 
sequence appearing before this could also be removed, leaving the actual 
amplified moronecidin (Figure 37) and hepcidin (Figure 38) 3’ RACE sequenced 
products. 























Figure 37: S. lalandi moronecidin gene sequences amplified using 3’ RACE. The F2 
primer is highlighted in red, the polyadenylation sequence is highlighted in green, 
the polyA tail is highlighted in yellow and the reverse 3' RACE inner primer 

































Figure 38: S. lalandi hepcidin gene sequences amplified using 3’ RACE. The F2 
primer is highlighted in red, the polyadenylation sequence is highlighted in green, 
the polyA tail is highlighted in yellow and the reverse 3' RACE inner primer 
highlighted in blue. 
 
 
All moronecidin sequences (Figure 39) and hepcidin sequences (Figure 
41) were aligned using ClustalX 2.1 to produce a consensus sequence for each 
gene. The consensus sequence for moronecidin (Figure 40) and hepcidin (Figure 
42) does not contain the 3’ RACE reverse primer sequence or the gene specific 










Monorecidin Colony 1.1      ATCAGGAGGAGA-GTTCATCGCCCTGTTTCTTGTGTTGTCACTGGTCGTC 
Monorecidin Colony 1.5      ATCAGGAGGAGAAGTTCATCGCCCTGTTTCTTGTGTTGTCACTGGTCGTC 
Monorecidin Colony 1.3      ATCAGGAAGGAGAGTTCATCGGCCTGTTTCTTGTGTTGTCACTGGTCGTC 
                            ******* *    ******** **************************** 
 
Monorecidin Colony 1.1      CTCATGGTTGAACCTGGGGAAGGTTTTTTTCACCACATTCTCTCGGGAAT 
Monorecidin Colony 1.5      CTCATGGCTGAACCTGGGGAAGGTTTTTTTCACCACATTCTCTCGGGAAT 
Monorecidin Colony 1.3      CTCATGGCTGAACCTGGGGAAGGTTTTTTTCACCACATTCTCTCGGGAAT 
                            ******* ****************************************** 
 
Monorecidin Colony 1.1      TTTTCACGTTGGCAAAATGATCCACGGCGCGATCCAAAGGAGGAGACATG 
Monorecidin Colony 1.5      TTTTCACGTTGGCAAAATGATCCACGGCGCGATCCAAAGGAGGAGACATG 
Monorecidin Colony 1.3      TTTTCACGTTGGCAAAATGATCCACGGCGCGATCCAAAGGAGGAGACATG 
                            ************************************************** 
 
Monorecidin Colony 1.1      GCATGACAGAGCTAGAGCAGGGGTAGTTTGACCGAGATCGGGCTGATTTT 
Monorecidin Colony 1.5      GCATGACAGAGCTAGAGCAGGGGCAGTTTGACCGAGATCGGGCTGATTTT 
Monorecidin Colony 1.3      GCATGACAGAGCTAGAGCAGGAGCAGTTTGACCGAGATCGGGCTGATTTT 
                            ********************* * ************************** 
 
Monorecidin Colony 1.1      GCCTAGACCTCCTATGACCTATAATGTTTCACCTGAAGGAGTCACTGTGA 
Monorecidin Colony 1.5      GCCTAGACCTCCTATGACCTATAATGTTTCACCTGAAGGAGTCACTGTGA 
Monorecidin Colony 1.3      GCCTAGACCTCCTATGACCTATAATGTTTCACCTGAAGGAGTCACTGTGA 
                            ************************************************** 
 
Monorecidin Colony 1.1      AGCAATTCACACACAATTGTCTAATGGTGTTATTCTTGGGTTCTTTGGAA 
Monorecidin Colony 1.5      AGCAATTCACACACAATTGTCTAATGGTGTTATTCTTGGGTTCTTTGGAA 
Monorecidin Colony 1.3      AGCAATTCACACACAATTGTCTAATGGTGTTATTCTTGGGTTCTTTGGAA 
                            ************************************************** 
 
Monorecidin Colony 1.1      AAATATGATTCATCAATTCAAATAAAATTGCATTTTAAAGAGTTAAAAAA 
Monorecidin Colony 1.5      AAATATGATTCATCAATTCAAATAAAATTGCATTTTAAAGAGTTAAAAAA 
Monorecidin Colony 1.3      AAATATGATTCATCAATTCAAATAAAATTGCATTTTAAAGAGT-AAAAAA 
                            ******************************************* ****** 
 
Monorecidin Colony 1.1      AAAAACCTATAGTGAGTCGTATTAATTCGGATCCGCG 
Monorecidin Colony 1.5      AAAAACCTATAGTGAGTCGTATTAATTCGGATCCGCG 
Monorecidin Colony 1.3      AAAAACCTATAGTGAGTCGTATTAATTCGGATCCGCG 
                            *************************************  
Figure 39: Alignment of the three products sequenced for the S. lalandi moronecidin 



















Hepcidin Colony 1.2      AGCTGGAGAGGCAGGAAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGTCAATGGT 
Hepcidin Colony 1.4      AGCTGGAGAGGCAGGAAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGTCAATGGT 
Hepcidin Colony 2.3      AGCTGGAGAGGCAGGAAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGTCAATGGC 
                         ***********************************************************  
 
Hepcidin Colony 1.2      ATCGTGGATGATGCCGAATCCCGTCAGGCAGAAGCGCCAGAGTCACCTCTCCGTGTGCCG 
Hepcidin Colony 1.4      -TCGTGGATGATGCCGAATCCCGTCAGGCAGAAGCGCCAGAGCCACCTCTCCATGTGCCG 
Hepcidin Colony 2.3      ATCGTGGATGATGCCGAATCCCGTCAGGCAGAAGCGCCAGAGCCACCTCTCCATGTGCCG 
                          ***************************************** ********* ******* 
 
Hepcidin Colony 1.2      CTGGTGCTGCAACTGCTGCACGGCCAACAAGGGCTGCGGTTTCTGCTGCAGGTTTTGAGG 
Hepcidin Colony 1.4      CTGGTGCTGCAACTGCTGCACGGCCAACAAGGGCTGCGGTTTCTGCTGCAGGTTTTGAGG 
Hepcidin Colony 2.3      CTGGTGCTGCAACTGCTGCACGGCCAACAAGGGCTGCGGTTTCTGCTGCAGGTTCTGAGG 
                         ****************************************************** ***** 
 
Hepcidin Colony 1.2      ATTCCCGCCACAGCCTCGAAATATTAATTTATTTTACTTCTTTTTGCTTTACCCCAGGAA 
Hepcidin Colony 1.4      ATTCCCGCCACAGCCTCGAAATATTAATTTATTTTACTTCTTTTTGCTTTACCCCAGGAA 
Hepcidin Colony 2.3      ATTCCCGCCACAGCCTCGAAATATTAATTTATTTTACTTCTTTTTGCTTTACCCCAGGAA 
                         ************************************************************ 
 
Hepcidin Colony 1.2      ATGACCCTCTTTCTTGACTTCTTTCTCCAATGCATTGCCTGTGATATTCACTTTTTTTTG 
Hepcidin Colony 1.4      ATGACCCTCTTTCTTGACTTCTTTCTCCAATGCATTGCCTGTGATATTCACTTTTTTTTG 
Hepcidin Colony 2.3      ATGACCCTCTTTCTTGACTTCTTTCTCCAATGCATTGCCTGTGATATTCACTTTTTTTTG 
                         ************************************************************ 
 
Hepcidin Colony 1.2      TATCATTTTTGATGGTATGATTCATAGAAGAGCACTGGAAACAAATGAGAAGCTATTCTG 
Hepcidin Colony 1.4      TATCATTTTTGATGGTATGATTCATAGAAGAGCACTGGAAACAAATGAGAAGCTATTCTG 
Hepcidin Colony 2.3      TATCCTTTTTGATGGTATGATTCATAGAAGAGCACTGGAAACAAATGAGAAGCTATTCTG 
                         **** ******************************************************* 
 
Hepcidin Colony 1.2      TGTATTTATTTTGTATGTTTGTAATACTTTCACCCTGGAACTCTTTTTGTAAACTCAATG 
Hepcidin Colony 1.4      TGTATTTATTTTGTATGTTTGTAATACTTTCACCCTGGAACTCTTTTTGTAAACTCAATG 
Hepcidin Colony 2.3      TGTATTTATTTTGTATGTTTGTAATACTTTCACCCTGGAACTCTTTTTGTAAACTCAATG 
                         ************************************************************ 
 
Hepcidin Colony 1.2      GCATGTCAAGACTGTTTCTTTTTATCTAAATTAAATCTGTAATAAATAATGAACATTTGA 
Hepcidin Colony 1.4      GCATGTCAAGACTGTTTCTTTTTATCTAAATTAAATCTGTAATAAATAATGAACATTTGA 
Hepcidin Colony 2.3      GCATGTCAAGACTGTTTCTTTTTATCTAAATTAGATCTGTAATAAATAATGAACATTTGA 
                         ********************************* ************************** 
 
Hepcidin Colony 1.2      AGCAAAAAAAAAAAAACCTATAGTGAGTCGTATTAATTCGGATCCGCG 
Hepcidin Colony 1.4      AGCAAAAAAAAAA--ACCTATAGTGAGTCGTATTAATTCGGATCCGCG 
Hepcidin Colony 2.3      AGCAAAAAAAAAGAAACCTATAGTGAGTCGTATTAATTCGGATCCGCG 
                         ************   *********************************  
Figure 41: Alignment of the three products sequenced for the S. lalandi hepcidin 3’ 

















3.2.3 Lamprey 3’ RACE 
3.2.3.1 Primer Design 
The partial defensin-like sequence identified from the G. australis 
alignment (Figure 24) where a consensus was found between all the sequences 
was used to design 3’ RACE primers. As there was limited sequence data, two 
sets of forward primers were designed, the first set F1A and F2A (Figure 43) and 
the second set F1B and F2B (Figure 44).  
 
 
Figure 43: Candidate defensin-like sequence with the first set of primers shown, 




Figure 44: Candidate defensin-like sequence with the second set of primers shown, 
F1B outlined in a box and F2B highlighted in blue. 
 
3.2.3.2 Nested PCR 
The two primer sets designed for the defensin-like gene were used in 
nested 3’ RACE-PCR in an effort to isolate the 3’ ends of the gene. The first 
round of nested PCR was carried out using either the forward primer F1A or F1B 
with the reverse 3’ RACE outer primer. PCR products were run on an agarose gel 
where multiple bands can be seen using both the F1A and F1B defensin-like 
primers (Figure 45).  
 
PCR products obtained from round one nested PCR using the F1A and 
F1B primers were used as the template for the second round. The second round 
primers used were F2A with the PCR mixture produced by F1A in round 1 and 
F2B with the PCR mixture produced by F1B in the first round. In each case the 
reverse 3’ RACE inner primer was used (Figure 46). Much like the first round of 
nested PCR multiple bands could be seen using F2A and F2B primers. Further 
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optimisation will be required to improve gene product specificity before being 












Figure 45: Gel image showing the first round of nested PCR. Products obtained 
when using the F1A (Lane 1) and F1B (Lane 2) primers for the defensin-like 
peptide with the reverse 3' RACE outer primer. The template DNA used was 
kidney tissue from G. australis. Refer to appendix VIII for ladder band sizing. 
Figure 46: Gel image showing the second round of nested PCR. Products obtained 
were using the reverse 3' RACE inner primer alongside the F2A (Lane 1) or F2B 




3.2.4 Yellowtail Kingfish 5’ RACE 
3.2.4.1 Primer Design 
The partial hepcidin and moronecidin sequences confirmed using 3’ 
RACE were used to design 5’ RACE primers. Two reverse primers were designed 
close to the end of the sequences. The first reverse primer (R1) and second reverse 
primer (R2) can be seen outlined for moronecidin (Figure 47) and hepcidin 
(Figure 48). 
 
Figure 47: Moronecidin 5' RACE reverse primers designed from 3' RACE 




Figure 48: Hepcidin 5' RACE reverse primers designed from 3' RACE consensus 
sequence. R2 primer is outlined by a box and R1 primer is highlighted in blue. 
 
3.2.4.2 Nested PCR 
The two primers designed for each S. lalandi AMP gene were used in 
nested 5’ RACE-PCR in an effort to isolate the 5’ ends of the moronecidin and 
hepcidin genes. There were two mixtures of tissues used for construction of the 5’ 
RACE cDNA, a mixture of kidney and spleen (KS) tissue and a mixture of liver 
and gill (LG) tissue. The first round of nested PCR was carried out using the 
reverse primers R1 or R2 for each gene along with the outer 5’ RACE reverse 






Figure 49: Gel image showing the first round of nested PCR. Products obtained 
when using the R1 primers for moronecidin and hepcidin alongside the forward 5' 
RACE outer primer. In lane 1 the R1 hepcidin primer was used on KS tissues. In 
lane 2 the R1 moronecidin primer was used on KS tissues. In lane 3 the R1 hepcidin 
primer was used on LG tissues. In lane 4 moronecidin R1 primer was used on LG 
tissues. Refer to appendix VIII for ladder band sizing. 
 
Multiple bands can be seen using the R1 moronecidin and hepcidin 
primers in the LG tissues (lanes 3 and 4). However, there was only one band seen 
for the R1 hepcidin primer in KS tissue (lane 1), and no bands were amplified 
when using the R1 moronecidin primer in KS tissue (lane 2). All PCR products 
obtained from round one nested PCR using the R1 and 5’ RACE outer primer for 
both moronecidin and hepcidin were used as the template for the second round. 
The moronecidin or the hepcidin reverse R2 primers alongside the forward 5’ 




















Moronecidin showed good amplification (lanes 2 and 4) with the R2 
primer giving a product from the KS tissue of approximately 400bp, whereas, two 
moronecidin products were amplified from LG tissue of approximately 250bp and 
400bp. For moronecidin the larger amplified product was used for sequencing. 
For hepcidin in lane 1 an amplified product could be seen but it is not very 
specific, therefore, round 2 nested PCR was repeated for hepcidin in both tissue 
types using different PCR conditions. The PCR products were run on an agarose 
gel (Figure 51). Lane 1 clearly shows the R2 hepcidin primer in KS tissue 
amplified a single prominent product at ~500bp. However, no bands appeared in 
lane 2 with the LG tissue. Following the successful amplification of products for 
moronecidin and hepcidin using nested PCR, fresh products were taken and 
ligated into the cloning vector for sequencing. 
 
 
Figure 50: Gel image showing the second round of nested PCR. Products 
obtained when using the R2 primers for moronecidin and hepcidin alongside the 
forward 5' RACE inner primer. In lane 1 and 3 the R2 hepcidin primer was used 
on the corresponding lane template from round 1. In lane 2 and 4 the R2 
moronecidin primer was used on the corresponding lane template from round 1. 









3.2.4.3 Ligation and Bacterial Transformation 
The PCR products obtained after the second round of nested PCR were 
ligated into a cloning vector followed by transformation into chemically 
competent E. cloni cells. Cloned and transformed cells were grown up on LB + 
AMP + Xgal + IPTG plates with one plate for each PCR product. Colonies for 
both moronecidin (Plate 1, Figure 52) and hepcidin (Plate 2, Figure 52) grew on 
the selective plates. 
 
 
Figure 52: Blue and white colony screen for moronecidin (plate 1) and hepcidin 
(plate 2). 
 
Figure 51: Gel image showing the repeated second round of nested PCR. Products 
obtained when using the R2 primers for hepcidin alongside the forward 5' RACE 
inner primer. In lane 1 the R2 hepcidin primer was used with template based on 
KS tissue from round 1. In lane 2 the R2 hepcidin primer was used with template 
based on LG tissue from round 1. Refer to appendix for ladder band sizing. 
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Ten white colonies indicating that cells contained the cloning vector with a 
successfully ligated PCR product, were selected from each plate and screened 
using PCR to determine if they contained ligated products of the correct size. M13 
forward and M13 reverse primers were used to screen the colonies. When 
products were run on an agarose gel expected product sizes for moronecidin 




Figure 53: Gel image showing PCR products obtained from ten colonies on the 
moronecidin plate. The black box highlights ligated products of the correct size for 




Figure 54: Gel image showing PCR products obtained from ten colonies on the 
hepcidin plate. The black box highlights ligated products of the correct size for 
hepcidin (~650bp). Refer to appendix VIII for ladder band sizing. 
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From the moronecidin colonies screened, four colonies showed products 
of the correct size, colonies 1.5, 1.6, 1.7 and 1.8. However, the screening of the 
hepcidin colonies indicated nine colonies contained the correct PCR product, with 
colony 1.1 which contained a smaller genetic insert. All successfully screened 
colonies were grown in LB + AMP medium for 24 hours (Figure 34) in order to 
increase colony concentration. 
 
3.2.4.4 Plasmid Extraction and Restriction Digest 
Following colony growth in LB + Ampicillin medium, plasmids were 
extracted from the bacteria and a restriction digest was carried out on the plasmids 
to confirm the ligated PCR product was still present. Restriction digests for 







The restriction digest carried out on the moronecidin plasmids shows a 
large band at the top of the gel (>1500bp) which indicates the presence of the 
plasmid. Whereas, the smaller fainter bands show the product inserts. All lanes 
showed a product insert of the expected size of ~400bp indicating it is likely the 
moronecidin product initially amplified. 
Figure 55: Moronecidin restriction digest. Outlined by the black box shows a 
band that matches the size of the moronecidin product. Refer to appendix VIII 








The restriction digest carried out on the hepcidin plasmid also showed a 
larger plasmid band with lanes 1, 3, 4 and 5 showing a product insert of the 
expected size ~500bp for hepcidin, outlined by the black box. Plasmids that 
contained the correct size product for moronecidin and hepcidin were sent for 
sequencing. 
 
3.2.4.5 Sequencing Results 
Samples for each gene were sent for sequencing to the DNA Sequencing 
Facility located at the University of Waikato. Once sequencing was completed the 
ligated product had to be identified from the plasmid. First the 5’ RACE inner 
primer was identified, followed by the R2 gene specific primers used to amplify 
the moronecidin (Figure 57) and hepcidin (Figure 58) products.  
 
All moronecidin sequences (Figure 59) and hepcidin sequences (Figure 
61) were aligned using ClustalX 2.1 to produce a consensus sequence for each 
gene. The consensus sequence for moronecidin (Figure 60) and hepcidin (Figure 
62) does not contain the 5’ RACE forward primer sequence or the gene specific 
primer sequences for moronecidin and hepcidin.  
 
 
Figure 56: Hepcidin restriction digest. Outlined by the black box shows a band that 
























Figure 57: S. lalandi 5' RACE moronecidin product sequences. The forward 5’ 
RACE inner primer is highlighted in blue and the F2 primer is highlighted in red. 
 



































Figure 58: S. lalandi 5' RACE hepcidin product sequences. The forward 5’ RACE 




Moronecidin_1.5      CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAAAGGCATCTATCCACTCAGAGAT 
Moronecidin_1.6      CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAAAGGCATCTATCCACTCAGAGAT 
Moronecidin_1.8      CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAATAGGCATCTATCCACTCAGAGAT 
                     ************************************* ********************** 
 
Moronecidin_1.5      TTGTCTTGTCTTTGACATCAGTTTTTTGACTCTTGACTCAGTCATCAGGAAGGATGAAGT 
Moronecidin_1.6      TTGTCTTGTCTTTGACATCAGTTTTTTGACTCTTGACTCAGTCATCAGGAAGGATGAAGT 
Moronecidin_1.8      TTGTCTTGTCTTTGACATCAGTTTTTTGACTCTTGACTCAGTCATCAGGAAGGATGAAGT 
                     ************************************************************ 
 
Moronecidin_1.5      TCATCGGCCTGTTTCTTGTGTTGTCACTGGTCGTCCTCATGGCTGAACCTGGGGAAGGTT 
Moronecidin_1.6      TCATCGGCCTGTTTCTTGTGTTGTCACTGGTCGTCCTCATGGCTGAACCTGGGGAAGGTT 
Moronecidin_1.8      TCATCGGCCTGTTTCTTGTGTTGTCAGTGGTCGTCCTCATGGCTGAACCTGGGGAAGGTT 
                     ************************** ********************************* 
 
Moronecidin_1.5      TTTTTCACCACATTCTCTCGGGAATTTTTCACGTTGGCAAAATGATCCACGGCGCGATCC 
Moronecidin_1.6      TTTTTCACCACATTCTCTCGGGAATTTTTCACGTTGGCAAAATGATCCACGGCGCGATCC 
Moronecidin_1.8      TTTTTCACCACATTCTCTCGGGAATTTTTCACGTTGGCAAAATGATCCACGGCGCGATCC 
                     ************************************************************ 
 
Moronecidin_1.5      AAAGGAGGAGACATGGCATGACAGAGCTAGAGCAGGAGCAGTTTGACCGAGATCGGGCTG 
Moronecidin_1.6      AAAGGAGGAGACATGGCATGACAGAGCTAGAGCAGGAGCAGTTTGACCGAGATCGGGCTG 
Moronecidin_1.8      AAAGGAGGAGACATGGCATGACAGAGCTAGAGCAGGAGCAGTTTGACCGAGATCGGGCTG 
                     ************************************************************ 
 
Moronecidin_1.5      ATTTTGC 
Moronecidin_1.6      ATTTTGC 
Moronecidin_1.8      ATTTTGC 
                     *******  
Figure 59: Alignment of the three sequenced samples for the S. lalandi moronecidin 













Hepcidin_1.3      CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAAGACGGCGGAAAGAGTCGAGAAG 
Hepcidin_1.5      CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAAGACGGCGGAAAGAGTCGAGAAG 
Hepcidin_1.2      CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAAGACGGCGGAAAGAGTCGAGAAG 
Hepcidin_1.4      CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATGAAAGACGGCGGAAAGAGTCGAGAAG 
                  ************************************************************ 
 
Hepcidin_1.3      GAGCCGACAGGGGTCACAGAAAAGATCTGACGAAATCCACTTGCCCAGACAATCACCATC 
Hepcidin_1.5      GAGCCGACAGGGGTCACAGAAAAGATCTGACGAAATCCACTTGCCCAGACAATCACCATC 
Hepcidin_1.2      GAGCCGACAGGGGTCACAGAAAAGATCTGACGAAATCCACTTGCCCAGACAATCACCATC 
Hepcidin_1.4      GAGCCGACAGGGGTCACAGAAAAGATCTGACGAAATCCACTTGCCCAGACAATCACCATC 
                  ************************************************************ 
 
Hepcidin_1.3      CATCACTGGAGCTGAAGAACAAAGACACAGTCGTCCTCTTCGGTGGCCTGACACCCATGA 
Hepcidin_1.5      CATCACTGGAGCTGAAGAACAAAGACACAGTCGTCCCCTTCGGTGGCCTGACACCCATGA 
Hepcidin_1.2      CATCACTGGAGCTGAAGAACAAAGACACAGTCGTGCTCTTCGGTGGCCTGACACCCATGA 
Hepcidin_1.4      CATCACTGGAGCTGAAGAACAAAGACACAGCCGTGCTCTTCGGTGGCCTGACACCCATGA 
                  ****************************** *** * *********************** 
 
Hepcidin_1.3      GAAAGAGGAACCCTCAACTCTAATCTTCTCAGGATTTAATCACTAAATCATTTAAAACAT 
Hepcidin_1.5      GAAAGAGGAACCCTCAACTCTAATCTTCTCAGGATTTAATCACTAAATCATTTAAAACAT 
Hepcidin_1.2      GAAAGAGGAACCCTCAACTCTAATCTTCTCAGGATTTAATCACTAAATCATTTAAAACAT 
Hepcidin_1.4      GAAAGAGGAACCCTCAACTCTAATCTTCTCAGGATTTAATCACTAAATCATTTAAAACAT 
                  ************************************************************ 
 
Hepcidin_1.3      CCCATAAAATGAAGGCATTCAGCATTGCAGTTGCAGT-GACACTCG-TGCTCGCCTTTAT 
Hepcidin_1.5      CCCATAAAATGAAGGCATTCAGCATTGCAGTTGCAGT-GACACTCG-TGCTCGCCTTTAT 
Hepcidin_1.2      CCCATAAAATGAAGGCATTCAGCATTGCAGTTGCAGT-GACACTCG-TGCTCGCCTTTAT 
Hepcidin_1.4      CCCATAAAATGAAGGCATTCAGCATTGCAGTTTTTTTTGGCAGAGGGTGCTCGCCTTTAT 
                  ********************************    * * **   * ************* 
 
Hepcidin_1.3      TTGCATTCTGGAGAGCTCTGCTGTCCCATTCCACGGGGTGCGAGAGCTGGAAGAGGCAGG 
Hepcidin_1.5      TTGCATTCTGGAGAGCTCTGCTGTCCCATTCCACGGGGTGCGAGAGCTGGAAGAGGCAGG 
Hepcidin_1.2      TTGCATTCTGGAGAGCTCTGCTGTCCCATTCCACGGGGTGCGAGAGCTGGAAGAGGCAGG 
Hepcidin_1.4      TTGCATTCTGGAGAGCTCTGCTGTCCCATTCCACGGGGTGCGAGAGCTGGAAGAGCCAA- 
                  ******************************************************* **   
 
Hepcidin_1.3      AAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGTCAATGGCATCGTGGATGATGCC 
Hepcidin_1.5      AAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGTCAATGGCATCGTGGATGATGCC 
Hepcidin_1.2      AAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGTCAATGGCATCGTGGATGATGCC 
Hepcidin_1.4      AAGCAATGACACTCCAGTTGTGGCACGTCAAGAGATGCCAATG-CATCGTGGATGATGCC 
                  ************************************* ***** **************** 
 
Hepcidin_1.3      GAATCCCGTCAGGCAGAA 
Hepcidin_1.5      GAATCCCGTCAGGCAGAA 
Hepcidin_1.2      GAATCCCGTCAGGCAGAA 
Hepcidin_1.4      GAATCCCGTCAGGCAGAA 
                  ******************  
Figure 61: Alignment of the three sequenced samples for the S. lalandi hepcidin 5’ 














3.2.5 Lamprey 5’ RACE 
3.2.5.1 Primer Design 
The partial defensin-like sequence identified from the G. australis 
alignment (Figure 24) where a consensus was found between all sequences and 
used to design 5’ RACE primers. As there was limited sequence data, two sets of 
reverse primers were designed, the first set R1A and R2A (Figure 63) and the 
second set R1B and R2B (Figure 64).  
 
 
Figure 63: Candidate defensin-like sequence with the first set of primers shown, 
R1A outlined in a box and R2A highlighted in blue. 
 
 
Figure 64: Candidate defensin-like sequence with the second set of primers shown, 




3.2.5.2 Nested PCR 
The two reverse primer sets designed for the defensin-like gene were used 
in nested 5’ RACE-PCR in an effort to isolate the 5’ ends of the gene. The first 
round of nested PCR was carried out using either the reverse primer R1A or R1B 
with the forward 5’ RACE outer primer. PCR products were run on an agarose gel 









The isolation of a single major product band was seen when using either 
the R1A or R1B defensin-like primers. PCR products obtained from round one 
nested PCR using the R1A and R1B primers were used as a template for the 
second round. The second round primers used were R2A with the PCR mixture 
produced by R1A in round 1 and R2B with the PCR mixture produced by R1B in 
the first round. In each case the forward 5’ RACE inner primer was used. PCR 





Much like the first round of nested PCR only single bands could be seen 
using R2A and R2B primers (150bp and 200bp) but these appear too small for the 
actual 5’ end. Further optimisation is requires to improve gene product specificity 
and size before being taken on to be ligated, cloned and sequenced.  
Figure 65: Gel image showing the first round of nested PCR. Products obtained 
when using the R1A (Lane 1) and R1B (Lane 2) primers for the defensin-like 
peptide with the forward 5' RACE outer primer. The template DNA used was 
from kidney of G. australis. Refer to appendix VIII for ladder band sizing. 
Figure 66: Gel image showing the second round of nested PCR. Products obtained 
when using the R2A (Lane 1) or R2B (Lane 2) primers for the defensin-like peptide 




3.3 Sequencing Results   
The 3’ RACE and 5’ RACE consensus sequences for moronecidin and 
hepcidin were aligned to determine the site of overlap. Once the overlap site was 
identified they were joined together resulting in the full sequenced moronecidin 
























Figure 68: Full hepcidin cDNA sequence obtained from 3’ and 5’ RACE. 
 
To determine the correct genes had been identified, sequences were 
translated using ExPasy for moronecidin (Figure 69) and hepcidin (Figure 70). 
Both showed good homology when aligned with other known fish AMP protein 
sequences. For moronecidin the S. lalandi protein sequence was aligned against a 
striped sea bass (Morone saxatilis) moronecidin protein sequence (Figure 71). 
Whereas, for S. lalandi hepcidin the obtained protein sequence was aligned 
against a turbot (Scophthalmus maximus) hepcidin protein sequence (Figure 72). 
Based on these alignments the positioning of the signal peptide, mature peptide 






Figure 69: S. lalandi moronecidin protein sequence, translated from the full 
hepcidin gene using ExPASy Translate tool. The 5’ UTR is highlighted in red and 




Figure 70: S. lalandi hepcidin protein sequence, translated from the full hepcidin 
gene using ExPASy Translate tool. The 5’ UTR is highlighted in red and the 3’ UTR 
is highlighted in blue 
92 
 
S. lalandi          MKFIGLFLVLSLVVLMAEPGEGFFHHILSGIFHVGKMIH----G--AIQRRRHGMTELEQ 
M. saxatilis        MKCATLFLVLSMVVLMAEPGDAFFHHIFRGIVHVGKTIHRLVTGGKAEQDQQDQQYQQEQ 
                    **   ******:********:.*****: **.**** **    *  * * ::.   : ** 
 
S. lalandi          -EQ-------FDRDRADFA 
M. saxatilis        QEQQAQQYQRFNRERAAFD 
                     **       *:*:** *  
Figure 71: S. lalandi moronecidin protein sequence aligned against a striped sea bass 
moronecidin protein (Accession number, Q8UUG0.1). The signal peptide is outlined 
in blue, the mature peptide in red and the pro-domain in yellow. 
 
 
S. lalandi       MKAFSIAVAVTLVLAFICILESSAVPFHGVRELEEAGSNDTPVVARQEMSMASWMMPNPV 
S. maximus       MKAFSIAVAVTLVLAFVCILESSAVPFPGVQELEEAGSNDTPAAAHQETSMEPWTVPSHI 
                 ****************:********** **:***********..*:** ** .* :*. : 
 
S. lalandi       RQKRQSHLSMCRWCCNCCTANKGCGFCCRF 
S. maximus       RQKRQSHISLCRWCCNCCKANKGCGFCCKF 
                 *******:*:********.*********:*  
Figure 72: S. lalandi hepcidin protein sequence aligned against a turbot moronecidin 
protein (Accession number, AAX92670.1). The signal peptide is outlined in blue, the 
pro-domain in yellow and the mature peptide in red. 
 
 
Comparison of the identified S. lalandi moronecidin protein sequence 
against several other known fish protein sequences showed high sequence 
homology (Figure 73). The S. lalandi moronecidin protein sequence was aligned 
against Chinese perch (Siniperca chuatsi; Accession number, AAV65044.1), sand 
bass (Morone chrysops; Accession number, AAL57318.1), striped beakfish 
(Oplegnathus fasciatus; Accession number, BAM99885.1), and duskytail grouper 
(Epinephelus bleekeri; Accession number, ADY86110.1) moronecidin proteins. 
Comparison of known fish hepcidin protein sequences including that identified in 
S. lalandi shows some sequence homology when aligned against a known human 
(Homo sapien) hepcidin (Figure 74). S. lalandi hepcidin protein sequence was 
aligned against human (Accession number, NP066998), large yellow croaker 
(Larimichthys crocea; Accession number, ABC18307.1) and gilthead seabream 
(Sparus aurata; Accession number, ABV01929.1) moronecidin proteins. 
Particular conservation is noted in the functionally important cysteine residues of 
the mature peptide. 
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Chinese Perch ID:AAV65044.1         MKCTALFLVLSLVVLMAEPGDAIFHHIFKGIVHVGKTIHRLVTGG----- 
Sand Bass ID:AAL57318.1             MKCATLSLVLSMVVLMAEPGDAFFHHIFRGIVHVGKTIHKLVTGGKAEQD 
Striped Beakfish ID:BAM99885.1      MKCITLFLVLSMVVLMAEPGEAFFHHIFNGLVGVGKTIHRLITGG----- 
Yellowtail Kingfish S. lalandi      MKFIGLFLVLSLVVLMAEPGEGFFHHILSGIFHVGKMIHGAIQRR----- 
Duskytail Fish ID:ADY86110.1        MRCIALFFVLSLVVLMAEPGEGFFFHIIKGLFHAGKMIHGLIHRRR---- 
                                    *:   * :***:********:.:*.**: *:. .** **  :         
 
Chinese Perch ID:AAV65044.1         -------QNMKDQQKLEQRSFDQERAAFD 
Sand Bass ID:AAL57318.1             QQDQQYQQDQQDQQAQQYQRFNRERAAFD 
Striped Beakfish ID:BAM99885.1      -------RNQQDQKELDKRFLNQQQAAFN 
Yellowtail Kingfish S. lalandi      ------RHGMTELE---QEQFDRDRADFA 
Duskytail Fish ID:ADY86110.1        -----HRHGMEELQDLDQRAFEREKA-FA 
                                           :.  : :    . :::::* *  
Figure 73: S. lalandi moronecidin protein sequence alignment with other known fish 
moronecidin proteins. 
 
Yellowtail Kingfish S. lalandi      -MKAFSIAVAVTLVLAFICILESSAVPFHGVRELEEAGSNDTPVVARQEM 
Yellow Croaker ID:ABC18307.1        -MKAFSIAVAVTLVLAFICILESSAVPFTGVQELEEAGSNDTPVAAHQEM 
Striped Bass ID:P82951.1            -MKTFSVAVAVAVVLAFICLQESSAVPVTEVQELEEPMSN-----EYQEM 
Gilthead Seabream ID:ABV07929.1     -MKTFSVAVAVAIVLTFICLQESSAVSFTEVQDLEEPMSSDGAVAAYKEM 
Homo Sapiens ID:NP066998            MALSSQIWAACLLLLLLLASLTSGSVFPQQTGQLAELQPQD------RAG 
                                       : .: .*  ::* ::.   *.:*    . :* *  ..       :   
 
Yellowtail Kingfish S. lalandi      SMASWMMPNPVRQKRQSHLSMCRWCCNCCTANKGCGFCCRF 
Yellow Croaker ID:ABC18307.1        SMESWMMPNHIRQKRQSHLSLCRWCCNCCKSNKGCGFCCRF 
Striped Bass ID:P82951.1            PVESWKMPYNNRHKRHSSPGGCRFCCNCCPNMSGCGVCCRF 
Gilthead Seabream ID:ABV07929.1     PEESWKMGYGSRRWK------CRFCCRCCPRMRGCGLCCRF 
Homo Sapiens ID:NP066998            ARASWMPMFQRRRRRDTHFPICIFCCGCCHRSK-CGMCCKT 
                                    .  **      *: :      * :** **     **.**:  
Figure 74: S. lalandi hepcidin protein sequence alignment with other known fish 
hepcidin proteins. Note the conservation of cysteines between all sequences in the 
mature peptide. Also highlighted in the S. lalandi hepcidin are the conserved 
residues in the mature peptide, histidine at position 3, glycine at position 20, glycine 
at position 22 and a phenylalanine at position 27. 
 
3.4 Real-Time PCR 
The efficiency of each pair of primers designed (Table 9) for RT-PCR first 
had to be determined. At 100% efficiency primers would be doubling the amount 
of template DNA after each PCR cycle; however, primer pairs often deviate from 
this ideal scenario. Therefore, calculating exact efficiencies was used to determine 
if the designed primers could successfully be used. Determination of primer 
efficiency for the housekeeping genes (GAPDH and β-actin) and the genes of 
interest (moronecidin and hepcidin) was achieved by producing a calibration 
curve where serially diluted template of known concentrations was used. An 
example of how this was done is shown using GAPDH. Using cDNA at different 
dilutions (Figure 75) Ct values were calculated by placing a threshold line on the 
Y-axis of the amplification plot. The dilution series for the housekeeping genes 
were: undiluted, 1:4, 1:16 and 1:64, whereas, the dilutions for the genes of interest 
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(moronecidin and hepcidin) were, undiluted, 1:2, 1:4, and 1:8. The position of the 
line was determined by finding a region of the graph where a detectable amount of 
product could be seen at the early exponential phase. Following the calibration 
curve, a melt curve was performed (Figure 76) and the products were run on an 
agarose gel (Figure 77) showing the presence of only one product. 
 













Figure 75: Calibration curve for RT-PCR obtained from GAPDH primers. Different 
dilutions of template cDNA were used and the threshold was set to obtain the 





Figure 76: Melt curve obtained using GAPDH primers. The presence of one peak 




Figure 77: Gel image showing the GAPDH RT-PCR products. Dilutions of undiluted, 
1:4, 1:16 and 1:64 were performed in duplicate and run on a 1.5% agarose gel. 
Refer to appendix VIII for ladder band sizing 
 
The GAPDH Ct values were plotted on a graph against the log of the 
initial amount of template cDNA (Figure 78). A line of best fit was drawn through 
these points which produced a line equation and R2 value. The line equation for 
GAPDH was y = -3.1749x + 28.046 and the R2 value was 0.99. The closer the line 
gradient is to -3.33, the closer the amplification efficiency is to the 100%. The 
gradient for the GAPDH primers was -3.17, using the equation E= 10(-1/s)-1, to 


























Figure 78: Standard curve for GAPDH with Ct values plotted against the log of the 
template concentration. The equation of the line and the R2 value is shown. 
 
Subsequently, a number of primer efficiencies were then carried out on the 
other housekeeping gene (β-actin) and the primers for the genes of interest. The 
efficiency plots for β-actin (Figure 79), moronecidin (Figure 81) and hepcidin 
(Figure 83) were determined, followed by their corresponding melt curves, for β-
actin (Figure 80), moronecidin (Figure 82) and hepcidin (Figure 84). The 
efficiency plots for β-actin, moronecidin and hepcidin primers gave efficiencies of 
98%, 82% and 84% respectively and each melt curve showed that only one 































Figure 79: Standard curve for β-actin with Ct values plotted against the log of the 





Figure 80: The melt curve obtained using β-actin primers. The presence of one peak 























Figure 81: Standard curve for moronecidin with Ct values plotted against the log of 




Figure 82: The melt curve obtained using moronecidin primers. The presence of one 




























Figure 83: Standard curve for hepcidin with Ct values plotted against the log of the 




Figure 84:The melt curve obtained using hepcidin primers. The presence of one 




3.5 Expression of the Genes of Interest 
The relative expression of the genes of interest was determined. The data 
was obtained by taking the geometric mean of three replicate RT-PCR runs (see 
Appendix IX and X). Moronecidin expression is highest in the spleen, followed 
closely by the gill and lowest expression was seen in the liver (Figure 85). 
Whereas hepcidin showed highest expression in the liver with significantly lower 
expression levels in the gill and spleen (Figure 86). In comparison to each other 
moronecidin is overall more highly expressed in all tissue types. 
 
Figure 85: Relative expression of S. lalandi moronecidin (n=3). 
 
 
Figure 86: Relative expression of S. lalandi hepcidin (n=3). 
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Chapter Four: Discussion 
 
Currently, very little is known about the immune systems of yellowtail 
kingfish (Seriola lalandi) and pouched lamprey (Geotria australis). The aim of 
this investigation was to identify and characterise AMPs, an important component 
of the innate immune system, from a jawed (S. lalandi) and jawless (G. australis) 
vertebrate. Initially, bioinformatic approaches were used to identify various AMPs 
in transcriptomic libraries created from S. lalandi spleen tissue, and G. australis, 
liver, gill, skin and kidney tissue. A range of molecular techniques were used to 
confirm the predicted sequences, followed by RT-PCR in order to examine 
expression levels in selected S. lalandi tissues. 
 
4.1 Transcriptomic Database Searching 
The S. lalandi and G. australis genomes have not yet been sequenced, but 
transcriptomic libraries have been produced in order to search for immune genes 
of interest. Several fish species do have sequenced genomes including the 
zebrafish (D. rerio) (Howe et al., 2013), Atlantic salmon (S. salar) (Davidson et 
al., 2010) and rainbow trout (O. mykiss) (Berthelot et al., 2014). Due to the 
availability a lot has been learnt about the components of fish immune systems 
and gene identification in species without an available genome has become 
significantly easier as specific sequence characteristics of immune genes can be 
used to search available transcriptomic libraries. Whilst having a complete 
genome is useful for a species of interest, transcriptomic libraries provide a much 
quicker and cheaper alternative to genome sequencing (Tachibana, 2015). A 
transcriptomic library is essentially a database of expressed genes and they can be 
produced at specific points in an organisms development, at different stages of 
disease progression and within different tissues, depending on the genes of 
interest being studied or the research focus (Storvall, 2016). RNA-seq is a high 
throughput sequencing technology which is free of many limitations found with 
other transcriptomic approaches such as, microarray and tag-based sequencing 
methods (Wang, et al., 2009). RNA-seq has been used for various practical 




example, RNA-seq has led to the finding of more than 550 distinct non-coding 
RNAs in a zebrafish embryo (Ulitsky et al., 2011). Non-coding RNAs play an 
essential role in many cellular processes where these newly discovered transcripts 
will promote genome annotation and lead the way for future functional studies. 2) 
Identification of gene associated single nucleotide polymorphisms (SNPs) 
(Qian, et al., 2014). For example, 342,104 intra-specific SNPs have been 
identified in channel catfish using RNA-seq explaining 90% of differences 
between individuals (Liu et al., 2011). 3) Quantification of transcript levels 
(Qian, et al., 2014). This can be essential in understanding gene up/down 
regulation in response to changing environment and/or intrinsic programs. 
 
Transcriptomics has also begun to play a major role in the understanding 
of the immune system of fish through the identification of immune related genes 
(Storvall, 2016). Comparison of fish transcriptomic expression before and after an 
immune challenge can give insight into, host immune responses and specific 
pathways involved in immunity, therefore, aiding in the development of immune 
based therapies for fish diseases. In turbot (Scophathalamus maximus) immune 
gene expression has been analysed in individuals infected by Enteromyxum leei, 
which causes emaciation of the fish as it inhabits the gut (Robledo et al., 2014). 
Using transcriptomics, upregulation of chemokines and cytokines was noted in 
infected individuals. Another example in channel catfish (I. punctatus) looked at 
transcriptome expression after exposure to Flavobacterium columnare. This is a 
gram negative bacterium which plays a role in infectious outbreaks in fish, as a 
response to this microbe I. punctatus interferon gene expression was significantly 
upregulated (Sun et al., 2012). Understanding how F. columnare affects the 
immune system of fish lays the foundation for therapeutic insights. 
 
The transcriptomic library used for S. lalandi in this research was derived 
from spleen tissue of a healthy adult individual (greater than 75cm in length). The 
spleen was selected due to its immunological properties as it contains immune 
related cells such as erythrocytes, neutrophils, and granulocytes (Moore & 
Hawke, 2004). The spleen also contains genetically expressed immune transcripts, 
involved in antigen processing, haematopoiesis and antibody production (Moore 
& Hawke, 2004). The transcriptomic libraries generated for G. australis were 
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derived from liver, kidney, skin, and gill tissue of healthy and diseased adult 
individuals. The diseased individuals were affected by lamprey reddening 
syndrome (LRS), a fatal infection, currently with unknown origins. LRS is 
characterised by red patchy skin and gills resulting in extensive haemorrhaging 
and ultimately death (Mitland et al., 2014). Therefore, due to the effects of LRS 
on the skin and the gills and a need to understand this disease in lamprey, these 
tissues were chosen to create a transcriptomic library. The liver and kidney tissues 
were also chosen due to the role they play in immunological responses. The liver 
facilitates local immune responses in fish while also producing immunoregulatory 
peptides and proteins (Uribe, et al., 2011; Secombes & Wang, 2012). Whereas, 
the kidney is considered to be analogous to mammalian bone marrow producing 
vital immune cells such as granulocytes (Tort, et al., 2003). For the sake of this 
research the transcriptomic libraries from healthy and diseased G. australis 
individuals were combined to search for AMP sequences. 
 
Amino acid sequences of AMPs already identified and characterised in 
other fish species were used to perform a search within the S. lalandi and G. 
australis generated transcriptomic libraries. They were searched using tblastn, 
where a selected protein sequence is aligned to a nucleotide database which has 
been translated into all six reading frames (Gertz, et al., 2006). Genetic fragments 
obtained from tblastn searches then underwent de novo assembly generating a 
larger consensus sequence. The consensus sequence was then translated using the 
ExPASy translate tool (Gasteiger et al., 2003) and the resultant protein sequences 
used in an online BLAST search to confirm the preliminary genetic sequence.  
 
Transcriptomic library searches for candidate AMP genes produced many 
results for S. lalandi, including piscidins, high density lipoproteins and NK-lysin 
(see Appendix V). A large range of AMPs were able to be identified using tblastn 
searching due to the number of AMP sequences available in public databases for 
closely related fish species. As AMPs have highly conserved domains, a 
significant number of hits were made in order to generate consensus sequences. 
For this investigation the genes moronecidin and hepcidin were chosen for further 
study as they were easily identified from the transcriptomic library and showed 
good homology when aligned with multiple genes from various species. In 
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contrast, when searching the G. australis transcriptomic library only a small 
selection of likely AMP sequences could be identified (see Appendix VI). The 
consensus sequences generated from the tblastn searches found, an NK-lysin, a 
defensin-like sequence, a haemoglobin derived AMP and two histone derived 
AMPs (see Appendix VII). The limited number of AMP consensus sequences 
identified within the G. australis transcriptomic library is likely due to the 
primitive nature of the organism. The closest living relative to lamprey are 
hagfish, which are significantly different therefore limiting the amount of AMP 
sequences that could be identified using a homology approach. To further identify 
AMPs in lamprey, the transcriptome would need to be searched manually using 
specific characteristics of AMPs, such as patterns of conserved cysteine residues 
and highly cationic sequences. Out of the limited number of AMPs identified the 
defensin-like G. australis sequence was chosen for further study in this 
investigation due to its primitive nature, as it is also found in plants, and could 
provide insights into evolution. 
 
Sequences resulting from the transcriptome were used as the backbone to 
design primers for the amplification and confirmation of the targeted sequences 
(moronecidin, hepcidin, and defensin-like AMPs). Primers were designed for the 
three selected gene sequences in an attempt to amplify the full cDNA sequence 
using 3’ and 5’ RACE-PCR. Regions within the consensus sequences with the 
highest quality were used to design primers, with quality determined by 
overlapping regions with an already confirmed AMP nucleotide sequence. For 
hepcidin and moronecidin overlapping areas were defined by comparison to other 
known AMPs of the same kind. The identified hepcidin was aligned with the 
known large yellow croaker (L. crocea) hepcidin (Accession number, 
DQ307050.1) which showed high sequence homology particularly at the 
beginning of the sequence. Therefore, as close to this part of the sequence is 
where the primers were designed. The identified moronecidin was aligned with a 
known duskytail grouper (E. bleekeri) moronecidin (Accession number, 
HQ437912.1) which showed high sequence homology towards the middle of the 




In comparison, the defensin-like protein identified in the G. australis 
transcriptome had no nucleotide sequences for comparison, as the Petromyzon 
marinus sequence (Accession number, Q10996.1) within the public database was 
submitted as a protein sequence (Conlon & Sower, 1996). Therefore, the multiple 
consensus sequences that had been identified in the transcriptome search were 
aligned and primers designed in the area of highest homology. Designing primers 
in these areas increased the chance for specific amplification and reduced the 
likelihood of mismatching. Standard primer design recommendations were used 
(Dieffenbach et al., 1993) which included: 1) Having a GC content between 40-
60%, which is important as too many runs of GC bases may stabilise non-specific 
primer annealing. 2) Having a GC clamp at the end of the primer, which assists in 
the primer binding to the template. Overall, meeting primer design features such 
as these, aids in increasing amplification efficiency. However, due to the low 
amount of sequence available and low sequence quality which occurred during 
transcriptome generation, primers could not always be designed to meet all 
specifications. Therefore, primers as close to these specifications as possible were 
designed, which is not uncommon practice. 
 
4.2 Conformation of AMP cDNA Sequence 
Following bioinformatics and primer design, RNA extraction was carried 
out on S. lalandi kidney, spleen, liver and gill tissue, and a mixture of G. australis 
kidney tissues from healthy and diseased individuals. Similar to the tissues chosen 
for transcriptomic library generation, the tissues selected for gene sequence 
conformation are known to be important in fish immunity and were the tissues 
that the potential AMP sequences had originally been identified in the RNA-seq 
transcriptomes.  
 
Rapid amplification of cDNA ends (RACE) is a PCR technique which aids 
in cloning of full length cDNA when only a part of the cDNA sequence is 
available. Traditionally cDNA sequences were obtained from clones isolated from 
a plasmid or phage library (Okayama & Berg, 1982). Isolating a full length clone 
of cDNA provided certainty that the entire mRNA protein coding sequence had 
been identified, however, partial clones were frequently obtained that lacked the 
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5’ end of the mRNA transcript. To combat this issue multiple and repeated 
screens of the cDNA library were carried out in the hope of obtaining a full length 
clone. In the 1980s a better solution was developed where a general PCR was 
used to amplify the 5’ end of cDNA (Frohman et al., 1988). This more modern 
RACE methods varied in design to traditional methods. Here total RNA is first 
reverse transcribed into cDNA (Yeku & Frohman, 2011) and at this point a 5’ 
RACE adapter is added to the cDNA creating a 5’ RACE library. Amplification 
between the adapter and gene specific primer can then be carried out using nested 
PCR. However, the major limitation here is there is no specific selection for 
mRNA, all RNA is an acceptable template. In this study, RNA Ligase Mediated 
(RLM) RACE was used, which is a major improvement on the more modern 
approach. The FirstChoice RLM-RACE kit was used which specifically selects 
for the 5’ end of mRNA through the targeting of the 5’ cap structure, favouring 
the selection of full length mRNA products. Here the 5’ cap structure is removed 
and a specific adapter sequence is attached creating the 5’ RACE library. From 
this the target sequence can be selected for by using complementary adapter 
primers and gene sequence specific primers during nested PCR. 3’ RACE has 
always been relatively straight forward as it uses the naturally occurring polyA 
tail that exists at the 3’ end of vertebrate mRNA transcripts where an adapter is 
added during the generation of cDNA. Therefore, 3’ RACE is typically easier 
generating results faster. 
 
Nested PCR is used after generation of the 5’ RACE and 3’ RACE 
libraries in order to reduce non-specific amplification, as only one primer specific 
to the gene of interest is used in each PCR. In nested PCR two sets of primers are 
used in the two successive runs of PCR with the second set targeting a sequence 
within the first amplified product (Yeku & Frohman, 2011). This type of PCR is 
used as it is highly unlikely non-specific products would contain binding sites for 
both sets of primers, providing more confidence in the amplified PCR product.  
 
4.2.1 S. lalandi Moronecidin 
Four moronecidin primers were designed, two forward primers for 3’ 
RACE nested PCR and two reverse primers for 5’ RACE nested PCR. The first 
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round of 3’ RACE nested PCR resulted in multiple sized bands being amplified 
when using both the F1 and F2 forward primers. However, in the second round of 
nested PCR that used the template generated using the F1 primer and using the F2 
primer, only a single band was isolated. After cloning and sequencing this resulted 
in a product of 338bp, which clearly contained the 3’ end of the S. lalandi 
moronecidin. A clear polyA and polyadenylation site could be seen which 
indicated this. Similar to 3’ RACE the first round of nested PCR for 5’ RACE 
resulted in multiple bands. After the second round of nested PCR two bands were 
present within the liver and gill tissue, with no defined bands in the kidney and 
spleen tissue. The two bands that were produced from liver and spleen tissue were 
of significantly different sizes, one at 250bp and the other 400bp. Both were sent 
for sequencing, the smaller band resulted in a product of 198bp, which upon 
analysis had no similarity to other known moronecidin sequences. However the 
larger moronecidin band resulted in a product of 249bp where similarity to other 
known moronecidin sequences could be seen and significant overlap was found 
with the 3’ RACE product. Upon generation of the consensus sequences and the 
combining of the 3’ RACE and 5’ RACE products, the final moronecidin cDNA 
sequence was 425bp. This was translated and the sequence analysed for features 
common to moronecidin proteins. 
 
Moronecidin is an alpha helical, positively charged AMP which acts via 
membrane disruption forming transmembrane channels in bacteria (Sun, et al., 
2007). This creates severe permeability problems killing or inhibiting growth of 
the bacterial cells. Analysis of the moronecidin 425bp product generated from S. 
lalandi RACE-PCR resulted in a protein sequence of 69aa, which contained a 
signal peptide of 22aa, a mature peptide of 18aa and a pro-domain of 25aa. When 
compared to other fish, similar protein configurations can be found, such as in the 
hybrid striped bass (M. saxatalis) which has a predicted pre-pro-peptide of 79aa 
consisting of a 22aa signal peptide, a 22aa mature peptide, and a 35aa pro domain 
(Lauth, et al., 2002). Since the discovery of moronecidin in hybrid striped bass it 
has consequently been discovered in Atlantic cod (Gadus morhua), European bass 
(Dicentarachus labrax), rainbow trout (O. mykiss), winter flounder (Sun, et al., 
2007) and now yellowtail kingfish (S. lalandi). However, there is a lot of 
difficulty in defining which species moronecidin has been identified in due to the 
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confusion associated with piscidin family members and the nomenclature that has 
been used in different fish species. 
 
Comparison of the protein sequence with other moronecidins showed high 
sequence homology in the signal peptide region, especially between S. lalandi and 
M. saxatalis with 73% similarity. There is slightly less conservation in the mature 
peptide with 64% similarity, with a poorly conserved C terminus, which was seen 
in the alignment between S. lalandi and M. saxatilis. However, the N-terminus of 
moronecidin mature peptides have been shown to be highly conserved and are 
specifically rich in histidine and phenylalanine (Bae et al., 2014) and these mature 
peptide characteristics can also be seen in the moronecidin found in S. lalandi. 
Compared to the signal and mature peptide sequences, the pro-domain shows very 
little sequence conservation with only 31% similarity between S. lalandi and M. 
saxatilis, which is typical of the pro-domain in many AMPs that have been 
characterised in fish. However, the pro-domain of piscidin AMPs are shown to 
contain a repeating XQQ motifs (where X represents Asp, Tyr, Glu or Ala) (Sun, 
et al., 2012). The S. lalandi moronecidin does not contain this XQQ motif in the 
pro-domain, which suggests it is much more similar to moronecidin and 
pleurocidin. Interestingly, the pro-domain of the M. saxatilis moronecidin does 
contain six repeated XQQ motifs, which does raise the question about the actual 
identity of this protein. The piscidin family contains several different members 
which include moronecidin, pleurocidin, piscidin, epinecidin and gaduscidin. 
Currently, with each of these family members there is no overall definition, which, 
results in significant overlap in sequence and name differentiation leading to the 
confusion that exists. An example of this overlap is where moronecidin and 
piscidin proteins were isolated from sea bass but have since been discovered to be 
the same gene (Silphaduang & Noga, 2001). In future, a general consensus needs 
to be developed to distinguish the differences between piscidin family members 
which could ultimately be achieved through functional studies. However, due to 
the overlap of all piscidin family members it may make more sense that piscidin is 




4.2.2 S. lalandi Hepcidin 
Four hepcidin primers were designed, two forward primers for 3’ RACE 
nested PCR and two reverse primers for 5’ RACE nested PCR. The first round of 
3’ RACE nested PCR resulted in multiple sized band being amplified when using 
the F1 primer and using just the F2 primer in round one of nested PCR resulted in 
no bands being present. However, using the F2 primer in the second round of 
nested PCR resulted in a single strong band, which after cloning and sequencing 
resulted in a 3’ RACE cDNA product of 428bp in length which clearly contained 
the 3’ end of the S. lalandi hepcidin. Clear polyA tail and polyadenylation 
(Proudfoot, 2011) sites could be seen which indicated this. In the first round of 5’ 
RACE nested PCR only a single band was amplified using R1. The same band 
was isolated again in the second round of nested PCR using R2. Cloning and 
sequencing of the 5’ RACE nested PCR amplicons resulted in a product of 383bp 
in length where similarity to other known moronecidin sequences could be seen 
and significant overlap with the 3’ RACE product was found. Upon generation of 
the consensus sequences and the combining of the 3’ RACE and 5’ RACE 
products, the final hepcidin cDNA sequence was 804bp.  
 
Analysis of the hepcidin 804bp product resulted in a protein sequence of 
90aa with a signal peptide of 24aa, a pro-domain of 40aa and a mature peptide of 
26aa. This configuration is identical to the hepcidin found in S. maximus (Chen, et 
al., 2007). The similarity found between the S. lalandi and S. maximus hepcidin is 
extremely high with the signal peptide sharing 96% similarity, the pro-domain 
sharing 68% similarity, and the mature peptide sharing 85% similarity. Overall, 
the signal peptide and mature peptide show the highest sequence conservation, 
whereas the pro-domain is less well maintained. This hepcidin sequence 
conservation between species potentially indicates conserved functionality 
between fish (Ke et al., 2015). 
 
Hepcidin is a β-sheet hairpin AMP with eight conserved cysteine residues 
that form four disulphide bridges (Masso-Silva & Diamond, 2014). Hepcidin has 
been identified in a wide range of organisms including amphibians, fish and 
mammals (Falco, et al., 2012). The defining characteristic between the hepcidin 
found in such a wide array of organisms is the cysteine saturation in the mature 
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peptide (Douglas, et al., 2003). For example, little sequence similarity was 
detected between human and fish hepcidin in this study, however, the 
characteristic cysteine residues are very well conserved in the same location 
between all these species. Due to the preservation of these cysteine residues it can 
be assumed that the hepcidin disulphide bridge formation must be functionally 
important.  
 
Similar to pleurocidin the protein sequence of fish hepcidin is highly 
similar between species (Douglas, et al., 2003). Up to seven hepcidin gene 
isoforms have been identified in Japenese black porgy (Acanthopargus schlegelii) 
(Yang et al., 2007), therefore, indicating several duplication and diversification 
events (Masso-Silva & Diamond, 2014). In comparison, mammals contain only a 
single hepcidin gene which functions both as an AMP and as an iron regulator. As 
fish contain several hepcidin genes the suggestion is, different hepcidins may 
carry out different functions (Neves et al., 2015). Further analysis of hepcidin 
variants found in fish has also determined they can be clustered into two groups, 
hamp-1 and hamp-2 (Masso-Silva & Diamond, 2014). Under experimental 
conditions it has been shown that hamp-1 expression was up-regulated in response 
to elevated iron levels and infection, whereas hamp-2 expression was highly 
upregulated in response to infection where changing iron levels had no effect 
(Neves, et al., 2015). This study concluded hamp-1 may play more of a role in 
iron regulation and hamp-2 in infections. Apart from the conserved cysteine 
residues teleost hamp-1 contains four conserved amino acids in the mature 
peptide, a histidine at position 3, a glycine at position 20, another glycine at 
position 22, and a phenylalanine at position 27 (Lee et al., 2011). Based on these 
characteristics it can be concluded that the hepcidin isolated from S. lalandi is 
more similar to hamp-1, as the mature peptide contains all of these conserved 
residues. In comparison to hamp-1, hamp-2 has high variability in protein length 
and sequence, with heterogenous structure and charge. Due to the high 
microbicidal activity that is characteristic of hamp-2, it would be ideal to go back 
and specifically search the S. lalandi transcriptome, to determine if hamp-2 can be 
found. Some antimicrobial activity has been detected in fish hamp-1, therefore, 
the isolated S. lalandi hepcidin would still be of interest in bioactivity studies. For 
example, hamp-1 in spotted scat (Scatophagus argus) showed antibacterial 
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activity against gram positive and gram negative bacteria, in some cases more 
effective than hamp-2. However, no microbicidal activity was detected for hamp-
1 against viruses, where hamp-2 showed strong antiviral activity. Therefore, the 
antimicrobial activity of hamp-1 may be slightly more limited in the breadth of 
micro-organisms it is effective against in comparison to hamp-2. 
 
4.2.3 Defenisn-Like 
Two sets of defensin-like forward primers were designed for 3’ RACE, the 
first set F1A and F2A and the second set F1B and F2B. For 5’ RACE two sets of 
reverse primers were also designed, the first set R1A and R2A and the second set 
R1B and R2B. This was because the size of the consensus sequence obtained from 
the transcriptome was short and features important for good primer design had to 
be compromised. The first round of 3’ RACE nested PCR using F1A and F1B 
primers resulted in multiple sized bands being amplified. A similar result was 
seen in round 2 of nested PCR using F2A and F2B with the presence of multiple 
bands. There were two bands that were specifically distinct, one at 100bp which is 
likely primer dimer, and a second at 350bp. Ideally PCR parameters would need 
to be optimised to maximise the efficiency of the primers in order to more 
specifically select for the 350bp product. Another method that could have been 
utilised is to cut the 350bp band out of the agarose gel from which the DNA could 
be purified. In the first round of 5’ RACE nested PCR only a single band was 
amplified using R1A and R1B reverse primers. The same band was isolated again 
in the second round of nested PCR using R2A and R2B primers. Using set A 
primers a band of approximately 150bp was amplified, whereas, using set B 
primers amplified a slightly larger product of around 200bp. Further optimisation 
of these primers again is needed to determine if these small sized isolates are from 
the gene of interest. Due to time constraints this work was not taken further but 
does open up work for a future project. 
 
Defensins (α-defensins, β-defensins, and θ-defensins) are a family of 
AMPs that are characteristically arginine rich with six conserved cysteine residues 
forming three intramolecular disulphide bonds (Bateman et al., 1996). 
Corticostatin was proposed as an alternative name for α-defensins as it was found 
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that rabbit α-defensin bound to the adrenocorticotrophic hormone (ACTH) 
receptor which are located on the surface of adrenal cells (Lehrer & Lu, 2012). 
This activity of α-defensins as antagonists for ACTH receptors has led to their 
classification as corticostatin-defensins (Raj & Dentino, 2002). Research looking 
at protein expressed in pacific lamprey skin found a cysteine and arginine rich 
peptide termed lamprey corticostatin related peptide (LCRP) with some structural 
similarity to mammalian corticostatin-defensins (Conlon & Sower, 1996). Using 
the LCRP protein a similar sequence in the G. australis transcriptome was 
identified, this corticostatin-defensin like protein was then aligned against human 
α-defensin-1. Overall, there was low sequence similarity between human α-
defensin-1 and the identified G. australis defensin-like sequence from the 
transcriptome, although conserved cysteine and arginine residues were present, 
indicating the identified protein as being functionally similar. The ability to verify 
the presence of the corticostatin-defensin like peptide and its mRNA sequence 
would provide significant evolutionary insights, as lamprey are the most primitive 
living vertebrate (Raj & Dentino, 2002). 
 
Unfortunately, in the Pacific lamprey, there is no nucleotide sequences 
currently available for LCRP, therefore, the expected size for the full G. australis 
defensin-like sequence from RACE-PCR is unknown. Cryptdin a corticostatin-
defensin-like precursor in mice has an mRNA sequence length of 450 to 480 
nucleotides (Ouellette et al., 1989), and this could give an indication of size, 
although further analysis is required to confirm this. Having only a small region of 
the protein currently makes exact identification impossible. 
 
4.3 Real-Time PCR 
Primers were designed for the characterised S. lalandi moronecidin and 
hepcidin genes, as well as the housekeeping genes GAPDH and β-actin which 
were used as reference genes. The expression of each of the genes were targeted 
in three available S. lalandi tissues spleen, liver and gill from three individual 
adult fish. To begin with each set of reference AMP and reference gene primers 
had their amplification efficiency established. As the amplification efficiencies of 
each primer set was high it was found appropriate to use the ΔCq = 2Cq(ref) - 
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Cq(target). RT-PCR was then carried out on each tissue sample and the relative 
expression of each gene was determined using the comparative ∆Cq test (Bird et 
al., 2005).  
 
In S. lalandi tissues moronecidin showed highest expression levels in the 
spleen followed closely by the gill and significantly lower expression in the liver. 
In comparison, moronecidin expression is similar in the hybrid striped bass which 
has been shown to have relatively high expression in the gill and spleen and 
relatively undetectable levels in the liver (Lauth, et al., 2002). Expression of 
moronecidin in healthy rock sea bream showed ubiquitous detection in all tissues 
tested, where highest expression was noted in the gill with decreasing expression 
in liver and spleen. These results do show some variability to S. lalandi 
moronecidin expression levels as expression in the liver was higher than the 
spleen (Bae, et al., 2014). However, there does appear to be a general consensus 
with high ubiquitous expression levels of moronecidin in all tissues. It has been 
proposed that the high level of moronecidin expression in the tissues of healthy 
fish may be due to the presence of moronecidin in circulating immune cells such 
as peripheral blood lymphocytes (PBLs) and red blood cells (RBCs) (Bae, et al., 
2014). 
 
Further to moronecidin expression in healthy fish, expression levels have 
also been analysed in fish exposed to bacterial and viral challenges. Hybrid 
striped bass exposed to Streptococcus iniae showed increased expression of 
moronecidin in all tissues although the differences were not shown to be 
statistically significant (Lauth, et al., 2002). Another study in rock sea bream 
analysing moronecidin expression in response to bacterial and viral infection was 
analysed in the spleen and gill (Bae, et al., 2014). In the spleen inducible 
moronecidin expression was noted with increasing levels over a 7 day period in 
response to Edwardsiella tarda, S. iniae, and red sea bream iridovirus (RSIV). In 
the gill increasing expression of moronecidin over 7 days was also noted in 
response to E. tarda, S, iniae although no detectable induction was found in 
response to RSIV (Bae, et al., 2014). Overall, there appears to be differing 
opinions on the inducible expression of moronecidin, therefore it needs to be 
explored in more depth. It is possible moronecidin is only induced in response to 
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particular pathogens. Further investigation of moronecidin expression should be 
analysed in more tissues from healthy S. lalandi and in tissues from immune 
compromised S. lalandi. 
 
In comparison to moronecidin, hepcidin showed highest expression in S. 
lalandi liver tissue with significantly lower expression levels in the gill and 
spleen. Although, relative to each other moronecidin showed much higher 
constitutive expression in all tissue types in comparison to hepcidin. It may be that 
hepcidin is a more inducible AMP in comparison to moronecidin which shows 
more constitutive expression as has been shown in other studies (Douglas, et al., 
2003; Valero, et al., 2013; Bae, et al., 2014). As previously mentioned, fish have 
been shown to contain two hepcidins, hamp-1 and hamp-2, expression has been 
characterised in a wide range of fish species. In turbot hamp-1 was detected 
mostly in the liver, with moderate expression in the spleen and lowest detection 
levels in the gills, and hamp-2 is also predominantly detected in the liver. As the 
isolated hepcidin from S. lalandi is also predominantly in the liver and limited 
tissues were studied it is not entirely clear from which of the two hepcidins S. 
lalandi is related to. However, the tissue specific pattern of hepcidin expression in 
the liver is characteristic of hepcidin (Douglas, et al., 2003). 
 
Expression levels have also been explored in immune challenged fish. Upon 
bacterial infection expression of hepcidin increases in the liver spleen and gills or 
most adult fish (Douglas, et al., 2003; Chen, et al., 2007; Huang et al., 2007). 
Turbot hepcidin showed high inducible expression after bacterial challenge with 
Aeromonas salmonidica (Douglas, et al., 2003). This is also in line with Atlantic 
salmon infected with Aeromonas salmonidica showing increased expression in 
most tissues tested, whereas healthy individuals had barely detectable levels. The 
time-course of hepcidin expression is highest after 3-6 hours post infection with 
decreasing levels thereafter, putting it in line with other immune proteins such as 
IL-1β (Yang, et al., 2007; Li et al., 2013). In addition, in mammals tumour cells 
lines (SAF-1 and L-1210) and fungi (Saccharomyces cerevisiae) have shown to 
induce hepcidin expression (Cuesta, et al., 2011; Masso-Silva & Diamond, 2014). 




4.4 Problems and Limitations 
There were a number of problems encountered throughout the course of this 
research, limiting all aims being completed. The initial step of this research 
involved bioinformatics, where the literature was searched for known fish AMPs. 
The difficulty surrounding this is the multitude of information available when 
defining AMPs. There is significant overlap in the naming of AMPs where some 
are characterised by structure and others by sequence homology. Therefore, a 
substantial amount of time was spent reading a broad range of literature in order 
to gain an understanding of fish AMPs and their organisation. Another restriction 
is that a significant amount of the work carried out on fish AMPs is limited to 
functional mature peptides and not the whole sequence. In order to search the 
transcriptomic library the entire pre-pro-peptide sequence was required, meaning 
that many AMPs that have an available mature peptide sequence were not able to 
be used as the sequence was too short, limiting the search of the transcriptome. A 
major short coming with the G. australis transcriptomic database mining was that 
they are such an evolutionary distinct animal where their genome is significantly 
different to bony fish, limiting the amount of transcriptome hits possible. A way 
to overcome this issue is by manually searching the transcriptome looking for 
characteristic features of known AMPs. This can include features such as, high 
cysteine residue content. Another method that could be used to search the G. 
australis transcriptome is sequences from other organisms, not limited to fish 
AMPs, thus, increasing the likelihood of matches. Unfortunately, these 
approaches are time consuming and were outside the scope of this project. 
However, the work presented in this thesis has provided an in depth study of 
AMPs available in the two species that were investigated. 
 
Primer design was another issue as not all primers were able to amplify a 
product. A significant amount of amplification protocols were trialled in an 
attempt to optimise primers. In some instances, very blurry products were 
amplified and in this instance increasing the annealing temperature from 54˚C to 
58˚C resulted in a more defined band. Also generation of new RACE libraries 
aided in the generation of more specific results. Once amplification of genes by 
PCR generated consistent results, experimental research was also delayed due to 
issues with bacterial cloning and transformation. The pLUG-Prime TA-cloning 
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vectors used for ligation of PCR products, were left overnight at 4˚C to ensure 
maximum ligation efficiency. The ligated plasmids were then transformed into 
chemically competent E. cloni cells and grown up on LB + ampicillin agar plates. 
Several attempts at this resulted in agar plates densely populated with white 
colonies, in contrast to the desired effect being a combination of blue and white 
colony growth. Initially it was thought the white colony growth was due to 
degraded IPTG and Xgal, therefore new stocks of this were acquired. When this 
made no difference, new plates were then made and the Xgal and IPTG were 
incorporated into the agar itself. This made a small difference where some blue 
colonies were then visible, however, a PCR screen was carried out on ten of the 
white colonies but none of them contained the correct product inserts (see 
Appendix XI). Even though some blue colonies were present the overall growth 
on the plate was still extremely dense. Therefore the ampicillin concentration was 
increased to 100µg/mL which eventually gave an agar plate with the expected 
combination of blue and white colonies. A PCR screen showed positive results 
with colonies containing PCR product inserts of the correct size. 
 
The final procedure that also caused some delay was the restriction digest 
which is used to confirm the presence of a PCR product insert within a plasmid 
before it is sent for sequencing. In some instances when running a restriction 
digest on a gel zero bands were present, including the band where the plasmid 
should be. It was concluded that between the PCR screen to determine the 
presence of a PCR product insert and the restriction digest, DNase became 
introduced. Prior to the restriction digest plasmid isolates were run on a gel 
resulting in extremely blurry bands, suggesting DNase may have already been 
introduced before the restriction digest and had become introduced during the 
plasmid extraction step. A new plasmid extraction kit was used and seemed to 
resolve this problem. 
 
Although these issues prevented all work being completed in the set 
timeframe this investigation has paved the way for future AMP studies in S. 
lalandi and G. australis. Two genes have been fully sequenced from S. lalandi, 




4.5 Future Recommendations 
4.5.1 Characterisation of AMPs 
A wider range of AMPs in the immune systems of S. lalandi and G. 
australis could be further characterised using the same approaches adopted in this 
research. The transcriptomes available for S. lalandi and G. australis could be 
used to identify other AMPs using a variety of different techniques such as 
manual database searching, particularly when it comes to the G. australis 
transcriptome. The AMPs already identified in each transcriptome also need to be 
further characterised to determine their specific sequence using RACE-PCR. 
Greater transcriptomic work could also focus on characterising the expression of 
various AMPs and a range of studies have shown the use of RNA-seq for 
comparing gene expression during infection, vaccination and throughout 
development (Qian, et al., 2014).  
 
Sequencing the genomes of these species is a possibility with the cost 
being more affordable in eukaryotic organisms. Understanding how these genes 
are organised in the genome may provide insights into their exact identity. Also 
information gained from having a genome may increase the assortment of AMPs 
found as the transcriptomes used relied on the AMPs showing constitutive 
expression and some may be inducible. An example is β-defensin found in mice 
which has been shown to be induced in the epithelia of organs following 
Pseudomonas aeruginosa infection in the airway (Bals et al., 1999). Therefore, 
this inducible expression may explain why no β-defensin sequences were able to 
be isolated from the S. lalandi and G. australis transcriptome. 
 
From the scope of information this research has reached, there is a 
significant amount of work that can be further compiled. The work characterising 
the G. australis defensin-like peptide needs to be refined through alterations of 
PCR parameters in order to increase primer specificity. The next step for hepcidin 
and moronecidin would be recombinant protein production which can be carried 
out using protein expression vectors. A specific gene can be introduced into a 
vector that is placed into a target cell which is stimulated to synthesise proteins. 
The protein can then be isolated and purified in order for functional studies to be 
118 
 
carried out. Bioactivity studies to see what organisms the S. lalandi hepcidin and 
moronecidin show microbicidal activity against could then be analysed. 
Bioactivity of these proteins may be limited as folding of the proteins can be 
functionally important and some AMPs are known to stay in a linear formation 
until contact with a pathogen associated membrane protein (PAMP), at which 
time they fold into their active structure (Lai & Gallo, 2009). Other AMPs may 
need to have their activation analysed as they may need folding into a certain 
structure before bioactivity assays can occur (Aoki & Ueda, 2013). However, 
bioactivity studies could focus on looking at activity against pathogens affecting 
aquaculture success and antibiotic resistant bacteria such as methicillin resistant 
Pseudomonas aeruginosa (MRSA) and vancomycin resistant Enterococcus 
faecalis (VRE). Other areas for future research include looking at how particular 
AMPs could be used as therapeutic agents. For example, carrying out a red blood 
cell screen looking at haemolytic activity and attraction to zwittertonic cells. 
These types of assays are important as AMPs that show haemolytic activity may 
need chemical modification before use in therapeutics (Bragadeeswaran et al., 
2011). Overall, the possibility of future works from this research are extensive and 
have crucial and important applications. 
 
4.5.2 Application of AMPs 
The aim of this work was to characterise AMP genes in jawed (S. lalandi) 
and jawless (G. australis) vertebrates in order to gain insight into the immune 
systems of these species. Understanding the AMPs that are present and their 
expression in fish is important for this and with future bioactivity studies have 




It is estimated that routine operations will become deadly within 20 years 
as the ability to fight conventional infections is lost due to the rise in antibiotic 
resistant microbes (Mazel & Davies, 1999; Buonocore, 2011). Therefore, much 
research has been focused on discovery and isolation of alternative compounds to 
supersede traditional antibiotics (Marshall & Arenas, 2003). AMPs have been 
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identified as promising candidates for biomedical uses in order to combat the 
issue of antimicrobial resistance (Wiesner & Vilcinskas, 2010; Buonocore, 2011). 
As fish live in a microbe dense environment and are exposed to many organisms 
that terrestrial animals are not, the identification and characterisation of fish 
AMPs may provide a unique contribution to this area of biomedicine (Masso-
Silva & Diamond, 2014). Moronecidin and piscidins are of significant interest as 
they are a fish specific family of AMPs and could be very effective against 
terrestrial microbes. A study looking at the antimicrobial activity of moronecidin 
has shown antibacterial action against methicillin resistant MRSA and VRE 
(Lauth, et al., 2002). Thus highlighting AMPs can be used as a natural antibiotic 
to combat the issue of antibiotic resistance. Other actions of fish AMPs has also 
been investigated, one such example is the use of tilipa hepcidin in mice. 
Hepcidin was shown to have a bacteriostatic effect acting as an antimicrobial and 
immunomodulatory agent against the bacterial pathogen Vibrio vulnificus (Pan et 
al., 2012). Overall, understanding AMPs and their function in non-mammalian 
species will be of vital importance in biomedicine where they have the potential 
as a therapeutic replacement option for traditional antibiotics.  
 
4.5.2.2 Aquaculture 
Aquaculture is becoming increasingly necessary in the developed world 
because of both increasing population size and decreasing wild fish stocks from 
recreational and commercial fishing (Tidwell & Allan, 2001; Noga, et al., 2011). 
Current obstacles in aquaculture are the high mortality rate in young fish and the 
continued disease and abnormalities that can occur during development (Gjedrem 
et al., 2012). Fishes rely heavily on their innate immune system to fight pathogen 
invasion during the first stages of life as their adaptive immune system is inactive 
until they are completely developed (Buonocore, 2011). AMPs are a major 
component of the fishes innate immune defence system protecting them from 
pathogenic infections (Falco, et al., 2012). Therefore, due to the impact on fish 
immune systems AMP levels could be useful to determine, maintain, or improve 




S. lalandi are found mainly in waters surrounding New Zealand (Aotearoa) 
and Australia, preferring temperate and sub-tropical waters, 18-24°C (Stewart 
Fielder, 2013). S. lalandi are excellent candidates for introduction into New 
Zealand aquaculture due to their fast growth rates, large size (reaching 2.5m long 
and a maximum weight of 96.8kg), and high value in cuisine as a traditional food 
source for Māori (Miller, et al., 2011). Japan currently has the largest aquaculture 
industry for various Seriola spp. where they make up to 57% of all farmed 
aquaculture (139000 tonnes per annum) (Stewart Fielder, 2013). S. lalandi 
aquaculture in Australia began in 2001 and has grown consistently with 
aquaculture of S. lalandi in New Zealand presently under development (Miller, et 
al., 2011). Australia currently produces 3000-4000 tonnes of S. lalandi per annum 
(Miller, et al., 2011). The growth of aquaculture systems in Australia has been 
constrained by high mortality rates, disease and growth deformities in farmed S. 
lalandi (Moran et al., 2007). There is no large scale production of S. lalandi in 
New Zealand aquaculture due to the large costs required for infrastructure and the 
current limitations with disease prevalence in farmed fish (Miller, et al., 2011). 
Within New Zealand and Australia, S. lalandi are not included in any quota 
management system and as such have no conservation status, therefore, to ensure 
sustainable aquaculture of S. lalandi hatchery production in New Zealand and 
Australia is used (Stewart Fielder, 2013). Overall, aquaculture is a promising field 
for global food production but growth in this industry has been constrained by 
high mortality rate in juvenile fishes and adult disease and deformities (Miller, et 
al., 2011). Therefore, it is vital to develop tools that will increase survival and 
quality of hatchlings (Stewart Fielder, 2013). Greater success of species in 
aquaculture is understanding fish physiology which will provide insights into 
development, health, growth, and reproduction. Due to the impact AMPs have on 
the fish immune system, they have been proposed as a therapeutic target for up-
regulation, they have possible uses in vaccine development and could be used as a 
measure of overall fish health. AMP use has experimentally been shown to protect 
fish, where in coho salmon following infection with Vibrio anguillarum fish 
began receiving cecropin, an AMP isolated from insects. Mortality rates in 
infected coho salmon decreased from 58% to 13% (Jia et al., 2000). Therefore, 
these results highlight the potential for AMPs to protect fish against infections and 
using what is naturally found in fish needs to be investigated. Stress in 
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aquaculture is another major issue contributing to fish mortality and can lead to 
down regulation of AMP expression, therefore, being able to measure AMP levels 
in farmed fish could be a good measure of health status (Buonocore, 2011). Also 
targeting AMPs for over expression in farmed fish could lead to enhanced disease 
resistance improving the efficiency of traditional treatments against pathogens 
(Noga, et al., 2011) and immunostimulants such as bacterial peptidoglycan have 
been added to fish diets in order to increase AMP expression (Falco, et al., 2012). 
Overall, understanding aspects of S. lalandi immunity is vital for successful 
introduction of this species into New Zealand aquaculture. 
 
4.5.2.3 Disease 
Much like farmed fish, wild fish stocks can also be detrimentally affected 
by disease and can be a significant issue in the wild especially when disease or 
parasites from an introduced species start to negatively affect native species 
(Masso-Silva & Diamond, 2014). Disease in the wild can be due to parasites, 
bacteria, viruses, fungi and water molds. In some cases disease in wild fish stocks 
can be a major cause of mass die offs (Poulin et al., 2011). A recent example is G. 
australis lamprey or piharau an ancient primitive fish with a single species 
inhabiting Aotearoa (New Zealand). Since October 2011 significantly high 
numbers of piharau have been found dead in Aotearoa rivers and research into this 
has shown individuals that are dying are exhibiting red skin markings. Due to this 
the disease is now referred to as lamprey reddening syndrome (LRS) (Mitland, et 
al., 2014). The cause of LRS is not yet known but it thought to be associated with 
a bacterial or viral infection. Piharau are an important taonga species for Māori 
communities and due to this syndrome are drastically declining in numbers in the 
wild (Mitland, et al., 2014). Therefore, it is of significant importance to find a 
way to treat and mitigate this disease. Little is known about piharau and their 
immune systems. Isolating and characterising AMPs in these organisms will 
provide a greater understanding of their immune system and possible mechanisms 





Overall, understanding aspects of fish immunity is vital for economical and 
successful fish farming, while also providing possible therapeutic benefits 
associated with AMP research in biomedicine and disease in wild fish stocks. The 
aim of this work was to identify yellowtail S. lalandi and G. australis AMPs 
involved in innate immunity and to use molecular techniques to fully sequence 
and quantify their expression in adult individuals. Using RNA-Seq transcriptomic 
libraries several S. lalandi and G. australis potential AMP genes were found. 
Using molecular approaches hepcidin and moronecidin were successfully isolated 
and sequenced from S. lalandi tissues. Expression of moronecidin and hepcidin 
was also analysed where hepcidin showed strong expression in liver tissues and 
moronecidin showed high expression in the spleen and gill tissues. In conclusion, 
this study provides preliminary data on AMP genes found in S. lalandi and G. 
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The University of Waikato received Hazardous Substances and New 
Organisms (HSNO) approval (GMD101146) from the New Zealand 
Environmental Protection Authority (EPA) in 2011 to develop a range of 
genetically modified non-pathogenic microorganisms, cell lines and zebrafish 
carrying genes coding for proteins involved in causation of disease, in the 
evolution of protein stability and cellular functions. The research in this thesis 
meets these requirements by developing a genetically modified organism (GMO) 
containing the antimicrobial peptide genes, hepcidin and moronecidin for work 
towards characterising the expression of these genes in Seriola lalandi. The 
location and nature of the development and the disposal of the approved 
genetically modified E. cloni were in accordance with the APP201152 application 
submitted to the EPA, and controls listed in the GMD101146 approval. Details of 






Appendix III - Accession Numbers 
Sequences used in the generation of the phylogenetic tree in the section 3.1. 
apoA-1 Common Carp Cyprinus carpio (Accession number, CAC34942.1) 
apoA-2 Rainbow Trout Oncorhynchus mykiss (Accession number, NP_001154920.1) 
AsCath-1 Atlantic Salmon Salmo salar (Accession number, NP_001117045.1) 
AsCath-2 Atlantic Salmon Salmo salar (Accession number, NP_001117058.1) 
acCATH Arctic Char Salvelinus alpines (Accession number, ACE96052.1) 
codCATH-1 Atlantic Cod Gadus morhua (Accession number, ACE96051.1) 
CATH1-SALTR Brown Trout Salmo truttafario (Accession number, ABW16872.1) 
CATH-THYTH Grayling Thymallus thymallus (Accession number, CAQ60112.1) 
Dicentracin European Bass Dicentrarchus labrax (Accession number, P59906.1) 
Epinecidin-1 Grouper Epinephelus coioides (Accession number, AAQ57624.1) 
fuBD1 Fugu Takifugu rubripes (Accession number, CAJ57646.1) 
Gramminstin (Pp1) Soapfish Pogonoperca punctata (Accession number, BAF37109.1) 
HbβP-1 Channel Catfish Ictalurus punctatus (Accession number, NP_001187115.1) 
HbβP-2 Channel Catfish Ictalurus Punctatus (Accession number, AHA82590.1) 
HbβP-3 Channel Catfish Ictalurus punctatus (Accession number, AHA82591.1) 
Hepcidin Turbot Scophthalmus maximus (Accession number, AAX92670.1) 
Hepcidin Red Sea Bream Chrysophrys major (Accession number, AAR28076.1) 
Hepcidin Zebrafish Danio rerio (Accession number, P61516.1) 
Hepcidin Striped Bass Morone saxatilis x Morone chrysops (Accession number, P82951.1) 
OM-hep1 Medaka Oryzias latipes (Accession number, ADM83600.1) 
OM-hep2 Medaka Oryzias latipes (Accession number, ADM23869.1) 
HFIAP-1 Hagfish Myxine glutinous (Accession number, AAQ04687.1) 
HFIAP-3 Hagfish Myxine glutinous (Accession number, AAQ04688.1) 
Hipposin Zebrafish Daino rerio (Accession number, NP_001083033.1) 
HLP1 Zebrafish Daino rerio (Accession number, XP_001923636.1) 
JF-1 Japenese Flounder Paralichthys olivaceus (Accession number, AAT01564.1) 
JF-2 Japanese Flounder Paralichthys olivaceus (Accession number, AAT01563.1) 
LEAP2 Grass Carp Ctenopharyngodon idella (Accession number, ACR54299.1) 
LEAP2 Winter Flounder Paralichthys olivaceus (Accession number, ACB97648.1) 
LEAP2 Medaka Oryzias latipes (Accession number, XP_004080006.1) 
LEAP2 Channel Catfish Ictalurus punctatus (Accession number, AAX45792.1) 
LEAP-2A Rainbow Trout Oncorhynchus mykiss (Accession number, AAS49157.1) 
LEAP-2A Carp Cyprinus carpio (Accession number, AGK89728.1) 
LEAP-2A Zebrafish Danio rerio (Accession number, NP_001122249.1) 
LEAP-2B Rainbow Trout Oncorhynchus mykiss (Accession number, NP_001117937.1) 
LEAP-2B Carp Cyprinus carpio (Accession number, AGK89729.1) 
LEAP-2B Zebrafish Danio rerio (Accession number, XP_003200926.1) 
MgCATH29 Atlantic Hagfish Myxine glutinosa (Accession number, AAQ04688.1) 
MgCATH37 Atlantic Hagfish Myxine glutinosa (Accession number, AAQ04687.1) 
NK-lysin Channel Catfish Ictalurus punctatus (Accession number, NP_001187137.1) 
OgBD1 Orange Spotted Grouper Epinephelus coioides (Accession number, AFA41485.1) 
OmBD1 Rainbow Trout Oncorhynchus mykiss (Accession number, ABR68250.1) 
OncorhyncinII Rainbow Trout Oncorhynchus mykiss (Accession number, P06350.2) 
Piscidin-1 Striped Bass Morone saxatilis (Accession number, Q8UUG0.1) 
Piscidin-4 Striped Bass Morone saxatilis (Accession number, ADP37959.1) 
PleurocidinWinter Flounder Peluronectes americanus ID, AAK52842.1) 
rtCATH-1 Rainbow Trout Oncorhynchus mykiss (Accession number, AAT67998.1) 
rtCATH-2 Rainbow Trout Oncorhynchus mykiss (Accession number, AAT44539.1) 
Sal-1 Atlantic Salmon Salmo salar (Accession number, Q801Y3.1) 
Sal-2 Atlantic Salmon Salmo salar (Accession number, NP_001134321.1) 
SAMPH1 Atlantic Salmon Salmo salar (Accession number, P84408.3) 
TH1-5 Tilapia Oreochromis mossambicus (Accession number, XP_003453514.1) 
TH2-3 Tilapia Oreochromis mossambicus (Accession number, XP_003450578.1) 
tnBD1 Pufferfish Tetraodon migroviridis (Accession number, CAJ57644.1) 
tnBD2 Pufferfish Tetraodon migroviridis (Accession number, CAG00590.1) 




ZFDB2 Zebrafish Danio rerio (Accession number, NP_001075023.1) 
ZFDB3 Zebrafish Danio rerio (Accession number, NP_001075024.1) 
Piscidin-1 Atlantic Cod Gadus morhua (Accession number, ACS91329.1) 
Moronecidin Chinese Perch Siniperca chuatsi (Accession number, AAV65044.1) 
Dicentracine European Sea Bass Dicentrarchus labrax (Accession number, AAP58960.1) 
Moronecidin Sand Bass Morone chrysops (Accession number, AAL57318.1) 
Moronecidin Stripped Bass Morone saxatilis (Accession number, AAL57319.1) 
Piscidin-Like Hong Kong Grouper Epinephelus akaara (Accession number, ACE78290.1) 
Piscidin-Like Orange Spotted Grouper Epinephelus coioides (Accession number, ACE78291.1) 
Piscidin-Like Yellow Croaker Larimichthys crocea (Accession number, ACE78289.1) 
Graduscidin-1 Atlantic Cod Gadus morhua (Accession number, ADK63423) 
Graduscidin-2 Atlantic Cod Gadus morhua (Accession number, ADK63424) 
Piscidin-2 Atlantic Cod Gadus morhua (Accession number, ADU34222) 
Piscidin-2β Atlantic Cod Gadus morhua (Accession number, ADU34223) 
Moronecidin Black Cod Anoplopoma fimbria (Accession number, C3KH06-1) 
Moronecidin Mandarin Fish Siniperca chuatsi (Accession number, Q2VWH5-1) 
CATH1_SALFO Brook Trout Salvelinus fontinalis (Accession number, B8ZHC5-1) 
CATH2_SALFO Brook Trout Salvelinus fontinalis (Accession number, B8ZHC6-1) 
aCATH Ayu Olecoglossus altivelis (Accession number, CBV36822.1) 
omDB-2 Rainbow Trout Oncorhynchus mykiss (Accession number, NP_001182097.1) 
omBD-3 Rainbow Trout Oncorhynchus mykiss (Accession number, CBB12548.1) 
omBD-4 Rainbow Trout Oncorhynchus mykiss (Accession number, NP_001182098.1) 
saBD Gilthead Seabream Sparus aurata (Accession number, FM158209) 
ScBD Mandarin Fish Siniperca chuatsi (Accession number, ACO88907.1) 
Defensin Medaka Oryzias latipes (Accession number, NP_001153910.1) 
Hepcidin1 Gilthead Seabream Sparus aurata (Accession number, ABV07929.1) 
Gramminstin-like Rainbow Trout Oncorhynchus mykiss (Accession number, CDQ73614.1) 
apoA-1 Silver Carp Hypophthalmichthys molitrix (Accession number, ADF97611.1) 
apoA-1 Mud Carp Cirrhinus molitorella (Accession number, ACY82518.1) 
apoA-1 Spotted Barbel Hemibarbus mylodon (Accession number, ACI15889.1) 
apoA-2 Ayu Plecoglossus altivelis (Accession number, CBD77421.1) 
apoA-2 Yellow Perch Perca flavescens (Accession number, ABW06868.1) 
apoa-2 Barramundi Lates calcarifer (Accession number, ABV66070.1) 
Cathelicidin Rainbow Trout Oncorhynchus mykiss (Accession number, NP_001117952.1) 
H1 Tetra Astyanax altiparanae (Accession number, AHW46398.1) 
H1 Zebrafish Danio rerio (Accession number, XP_009301186.1) 
H1 Brown Trout Salmo trutta (Accession number, P02254.1) 
NK-Lysin Tetra Astyanax mexicanus (Accession number, XP_007253844.1) 
NK-Lysin Zebrafish Danio rerio (Accession number, XP_009291114.1) 
NK-Lysin Guppy Poecilia reticulate (Accession number, XP_008398114.1) 
NK-Lysin Pufferfish Takifugu rubripes (Accession number, XP_003962755.1) 
H2A Tounge Fish Cynoglossus semilaevis (Accession number, XP_008308956.1) 
H2A Southern Platyfish Xiphophorus maculatus (Accession number, XP_005812306.1) 
H2A Guppy Poecilia reticulate (Accession number, XP_008401837.1) 
H2B RainbowTrout Oncorhynchus mykiss (Accession number, P69069.2) 
H2B Tetra Astyanax mexicanus (Accession number, XP_007238182.1) 
Hbß Catfish Silurus asotus (Accession number, O13163.2) 
Hbß Loach Paramisgurnus dabryanus (Accession number, AAM93251.1) 



































Supplementary Figure 1: Phylogenetic tree showing all identified S. lalandi 




Appendix V - S. lalandi Alignments 
High Density Lipoprotein apoA-1 Alignment 
apoA-1 Snakehead Murrel         MKFVALAVALLLAVGCQAASLQADAPSQLAHIKAAIDVYANQVKDSFKNA 
apoA-1 Cobia                    MKFVALALALLLAVGSQAASLQSDAPSQLAHIRAAMDVYLNQVKDSANRA 
Potential apoA-I S. lalandi     -------------------------------------------------- 
                                                                                   
 
apoA-1 Snakehead Murrel         LNSLDDTEHQELKQRLSQRVDEFHAQLKALQGSVSPITDSVVSTLADATA 
apoA-1 Cobia                    LDQLDDTEYRQLKQSLSQRLDIMYNQIKAMQGAVSPITDNVVSTIADATA 
Potential apoA-I S. lalandi     ------------------------------------QTD----------- 
                                                                     **            
 
apoA-1 Snakehead Murrel         DFRASLTKDIETLKADLEPKRAKLREVINEHLQEYRIQLEPIVKKYYDKH 
apoA-1 Cobia                    DLRASLITDIETLKLELEPKRIALRDVVNKHIEEYRELMQPIFNEYYTKH 
Potential apoA-I S. lalandi     ---AWLVX---------EX-------VINKHIDEYRTQMQPIISEYYSKH 
                                   * *           *        *:*:*::***  ::**..:** ** 
 
apoA-1 Snakehead Murrel         TADMEALKVRLEPVVEELRAKVATNVEETKAALMPILEAIRTKVHARLEN 
apoA-1 Cobia                    TSEMEALRLKLEPVLEDLRQKVAVNLEETKAAVTPIVEQVRSKLSERLEA 
Potential apoA-I S. lalandi     TADMEALRVKLEPVVEELRQKVATNLDETKTALMPIVEAVRNKLSERLET 
                                *::****:::****:*:** ***.*::***:*: **:* :*.*:  ***  
 
apoA-1 Snakehead Murrel         LKELVSPYVEEYKDQLKQAYSQVRSIDSQEVNARSIDSQEVNALREKIAP 
apoA-1 Cobia                    LKELASPYVEEYKDQMKQVYSQAQNIN----------TEDLTNMKEKILP 
Potential apoA-I S. lalandi     LKDMASPYVEEYKDQLKQAYSQAQXXX----------XX----------- 
                                **::.**********:**.***.:                           
 
apoA-1 Snakehead Murrel         LVEDIKVKLHEIFEAVAATVTKS 
apoA-1 Cobia                    LAEEIKVKLQSIFEIIAAAVTKN 
Potential apoA-I S. lalandi     -----------------------  
Supplementary Figure 2: Potential apoA-I protein sequence obtained from the S. 
lalandi transcriptomic library aligned against a cobia (Rachycentron canadum; 
Accession number, ACV50420.1) and snakehead murrel (Channa striata; Accession 
number, AIL82447.1) apoA-I protein. 
 
 
High Desnity Lipoprotein apoA-II Alignment 
apoA-II Rainbow Trout            MNGKLALALVLALQVSVCLCQ--VPEPDKELVEKYEAMKSVFYKRLMNAY 
apoA-II Ayu                      MSGKYLLAVFLALQVSMSLCQLEIPQPDQELVDKYENMKSIFYKRLLNAY 
Potential apoA-II S. lalandi     --------------TLLARCS----KP-----------------LLLSCX 
                                               . :. *.    :*                  *:..  
 
apoA-II Rainbow Trout            SKVQAAVGPMTENLGQG-HGQAAKDYIEELQGNPKFLSAVKIGTGLAQEA 
apoA-II Ayu                      NKMQAAVAPVADSLGEG-RSQAAKDYIEDLQTKPQFQAAVKVATGLAGEA 
Potential apoA-II S. lalandi     ------------KIGESERGQTARTYLEELQGKPELQAAVKVASGLGEEA 
                                             .:*:. :.*:*: *:*:** :*:: :***:.:**. ** 
 
apoA-II Rainbow Trout            APLVDKARMAGLGLYGHYVRPHVGTYLDEAITSIKVYLDKVLPAEE 
apoA-II Ayu                      APLVDKARMAGLGLYGKYLRPHVGTYLDDAINNIKVYLDQYMPAE- 
Potential apoA-II S. lalandi     APPVGQGPYSSSGSVRTLPAPPCWR-LPERRHRPRQGLPGQIPAR- 
                                 ** *.:.  :. *       *     * :     :  *   :**.  
Supplementary Figure 3: Potential apoA-II protein sequence obtained from the S. 
lalandi transcriptomic library aligned against a rainbow trout (Oncorhynchus 
mykiss; Accession number, NP_001154920.1) and ayu (Plecoglossus altivelis; 







Piscidin Striped Bass               MKCVMIFLVLTLVVLMAEPGEGFFRHL---FRGAKAIFRGARQGWRAHK- 
Piscidin Orange Spotted Grouper     MKFVMVFLVLSLVVLMAEPGEGFLRHIKSFWKGAKAIFRGARQGWREHR- 
Potential Piscidin 2 S. lalandi     MKFVMIFLVLSLVVLMAEPGECFFKHLKTIWSGAKAIFRGARAGWRGHRN 
Potential Piscidin 1 S. lalandi     -----SFSCCRWSSSWLNXGECFFKHLKTIWSGAKAIFRGARAGWRGHRK 
                                          *          : ** *::*:   : ********** *** *:  
 
Piscidin Striped Bass               ----VVSRYRNR-------DVPETDN--------------NQEEPYNQR- 
Piscidin Orange Spotted Grouper     ----ALSKQRKM-------DQGGGGNEVD-----------NGTPPYWQK- 
Potential Piscidin 2 S. lalandi     SRRMAAIRYRNAXAN-CMRYQQGGYNRLAGTACNLPMHFCTLSQPFCVSF 
Potential Piscidin 1 S. lalandi     LTQNGCDKVQKWXWANCMRYQQGGYNQKS--------AALMGSEPVHFKE 
                                           : ::              *                  *      
 
Piscidin Striped Bass               --------------- 
Piscidin Orange Spotted Grouper     --------------- 
Potential Piscidin 2 S. lalandi     CVLSIPPWHL----- 
Potential Piscidin 1 S. lalandi     FELQLSALQFCLSPP  
Supplementary Figure 4: Potential piscidin protein sequence obtained from the S. 
lalandi transcriptomic library aligned against a orange spotted grouper 
(Epinephelus coioides; Accession number, AKA60777.1) and striped bass (Morone 
saxatilis; Accession number, ADP37959.1) piscidin protein. 
 
Epinecidin Alignment 
Potential Epinecidin S. lalandi     AKAXAKAQSSGRMKFIALFLVLSLVVLMAEPGEGFFHHILSGIFHVGKMI 
Epinecidin Orange Spotted Grouper   ------------MRCIALFLVLSLVVLMAEPGEGFIFHIIKGLFHAGKMI 
                                                *: ********************:.**:.*:**.**** 
 
Potential Epinecidin S. lalandi     HGAIQRRRHGMTELE---QEQFDRDRADFAVLLWPQL 
Epinecidin Orange Spotted Grouper   HGLVTRRRHGVEELQDLDQRAFEREKA-FA------- 
                                    ** : *****: **:   *. *:*::* **         
Supplementary Figure 5: Potential epinecidin protein sequence obtained from the S. 
lalandi transcriptomic library aligned against a orange spotted grouper 
(Epineohelus coioides; Accession number, AAQ57624.1) epinecidin protein. 
 
Histone Derived H2A Alignment 
H2A Guppy                       --MSGRGKTGGKAR---AKAKTR--SSRAGLQFPVGRVHRLLR-KGNYAE 
H2A Tounguefish                 --MSGRGKTGGKAR---AKAKTR--SSRAGLQFPVGRVHRLLR-KGNYAQ 
Potential H2A 1 S. lalandi      LKMSGRGKKAVPKP---KSSVSR--SSRAGVTFPVGRIHRLLR-RGQYAK 
Potential H2A 2 S. lalandi      AKAKTKVCVGGPRRXXVAKAVSXXXSQRAGLQFPVGRIHRHLKTRTTSHG 
                                   . :   .        .: :   *.***: *****:** *: :      
 
H2A Guppy                       RVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDE 
H2A Tounguefish                 RVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDE 
Potential H2A 1 S. lalandi      RVGSGSAVYLSAVLEYLCAEILELAGNASRDNKKHRIAPRHILLAVKNDE 
Potential H2A 2 S. lalandi      RVGATAAVYSAAILEYLTAEVLELAGNASKDLKVKRITPX---------- 
                                ***: :.** :*:**** **:*******::* *  ** *            
 
H2A Guppy                       ELNKLLGGVTIAQGGVLPNIQAVLLPKKTEKAAKTK 
H2A Tounguefish                 ELNKLLGGVTIAQGGVLPNIQAVLLPKKTEKAAKTK 
Potential H2A 1 S. lalandi      ELNKLLAGVTISEGGVIXXXXXXLLPQK-------- 
Potential H2A 2 S. lalandi      ---------SLAAG----------HPW--------- 
                                         ::: *           *            
Supplementary Figure 6: Potential H2A protein sequence obtained from the S. 
lalandi transcriptomic library aligned against a guppy (Poecilia reticulate; Accession 
number, XP_008401837.1) and toungefish (Cynoglossus semilaevis; Accession 




Histone Derived H2B Alignment 
H2B Tetra                    ---------------------------MPEPAKAAP--KKGSKKAVTKTA 
H2B Zebrafish                ---------------------------MPEPAKAAP--KKGSKKAVTKTA 
H2B Rainbow Trout            ---------------------------MPEPAKSAP--KKGSKKAVTKTA 
Potential H2B S. lalandi     GQGGXXXRXXXXXLXSSCSTXXXTEEKMPDPAKSAPAPKKGSKKAVTKTQ 
                                                        **:***:**  ***********  
 
H2B Tetra                    GKGGKKRRKTRK-ESYAIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFE 
H2B Zebrafish                GKGGKKRKRTRK-ESYAIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFE 
H2B Rainbow Trout            GKGGKKRKRSRK-ESYAIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFE 
Potential H2B S. lalandi     XXARQEAPQEQEXESYAIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFE 
                               . ::  : :: ************************************* 
 
H2B Tetra                    RIAGESSRLAHYNKRSTITSREIQTAVRLLLPGELAKHA-VSEGTKAVTK 
H2B Zebrafish                RIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHA-VSEGTKAVTK 
H2B Rainbow Trout            RIAGESSRLAHYNKRSTITSREIQTAVRLLLPGELAKHA-VSEGTKAVTK 
Potential H2B S. lalandi     RIX-RGSVTAGALQQEIHHHLQGDPDRRPPAAARRAGRARRVRGHQGLTK 
                             **  ..*  *   ::.     : :.  *   ... * :*   .* :.:** 
 
H2B Tetra                    YTSSK 
H2B Zebrafish                YTSSK 
H2B Rainbow Trout            YTSSK 
Potential H2B S. lalandi     YTSSK 
                             *****  
Supplementary Figure 7: Potential H2B protein sequence obtained from the S. 
lalandi transcriptomic library aligned against a rainbow trout (Oncorhynchus 
mykiss; Accession umber, P69069.2), tetra (Astyanax mexicanus; Accession number, 
XP_007253844.1) and zebrafish (Danio rerio; Accession number, NP_001013481) 
H2B protein. 
 
Haemoglobin Derived Alignment 
Potential HbβP S. lalandi       -GXXEDAERAAIISLWGKIDVGEIGPQALTRLLIVYGQGERHFTTFGNVS 
HbβP Japanese Amberjack         MVDWTDAERAAITSLWGKIDVGEIGPQALTRLLIVYPWTQRHFTTFGNVS 
HbβP Mandarin Fish              MVKWTDAERSAITSLWGSIDVGEIGPQALSRLLIVYPWTQRHFSSFGNIS 
                                     ****:** ****.***********:******   :***::***:* 
 
Potential HbβP S. lalandi       TNAAILGNPKVAQHGKTVMGGLENAVKNLDDIKNTYAKLSRMHSEKLHVD 
HbβP Japanese Amberjack         TNAAILGNPKVAQHGKTVMGGLENAVKNLDDIKNTYAKLSRMHSEKLHVD 
HbβP Mandarin Fish              TNAAILGNPKVAHHGKVVMGGLENAVKNMDDIKNAYAKLSVMHSEKLHVD 
                                ************:***.***********:*****:***** ********* 
 
Potential HbβP S. lalandi       PDNFRALAECISVCVAAKFGKQVFTADVQEAWQKFLSVVVSALGRQXHXG 
HbβP Japanese Amberjack         PDNFRALAECISVCVAAKFGKQAFTADVQEAWQKFLSAVVSALGRQYH-- 
HbβP Mandarin Fish              PDNFRLLAECISVCVAAKFGPSVFTADAQEAWQKFLAVVVSALGKQ---- 
                                ***** ************** ..****.********:.******:*     
 
Potential HbβP S. lalandi       SXDAVHPSK 
HbβP Japanese Amberjack         --------- 
HbβP Mandarin Fish              ---------  
Supplementary Figure 8: Potential haemoglobin derived protein sequence obtained 
from the S. lalandi transcriptomic library aligned against a Japenese amberjack 
(Seriola quinqueradiata; Accession number, Q9PVM1.3) and mandarin fish 








Potential NK-lysin S. lalandi     -------------------------------------------------- 
NK-Lysin Pufferfish               ------MATSSILLLCILVTCSVWTVQARNLKV-STDDDDEDQDELAIEA 
NK-lysin Channel Catfish          MFWNLLVASFFIGSACAMHMEYLRVDSAEELLDGSLDSTDEDEDLAMSET 
                                                                                     
 
Potential NK-lysin S. lalandi     --------------KXIKKIIGKNTTAEEVKSKLNTVCNEIGLLKDLCRK 
NK-Lysin Pufferfish               GRLPGVCWACKWALKKVKIIIGNNSNSEAIKAKLMSICNQIGLLKSLCRK 
NK-lysin Channel Catfish          QLLPGACWACQWAMKKVKKQLGNNPTVDIIKAQLKKVCNSIGFLRGLCKK 
                                                * :*  :*:*.. : :*::* .:**.**:*:.**:* 
 
Potential NK-lysin S. lalandi     FVKKHLGELIEELTTSDDVRMICVNTKACKPKELSHLIFYPXXXDXXXXX 
NK-Lysin Pufferfish               FVTKHLGVLIEELTTSDDVRTICVNVKACKPKELEELFQSGFSSQLEMNE 
NK-lysin Channel Catfish          MINKYLDTLVEELSTTDDPTTICGNLGICKSLSMLELFQAFPQHHKQI-- 
                                  ::.*:*. *:***:*:**   ** *   **. .: .*:      .      
 
Potential NK-lysin S. lalandi     XXXXPC 
NK-Lysin Pufferfish               YA---- 
NK-lysin Channel Catfish          ------  
Supplementary Figure 9: Potential NK-lysin protein sequence obtained from the S. 
lalandi transcriptomic library aligned against a channel catfish (Ictalurus punctatus; 
Accession number, NP_001187137.1) and pufferfish (Takifugu rubripes; Accession 






Appendix VI - G. australis Phylogenetic Tree 
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Supplementary Figure 10: Phylogenetic tree showing all identified G. australis 





Appendix VII - G. australis Alignments 
Haemoglobin Derived Alignment 
Potential HbβP G. australis         -------------TNKPMRKSGCG-------HPG----EVLHHHPPLLQA 
Haemoglobin Chain A River Lamprey   PIVDSGSVAPLSAAEKTKIRSAWAPVYSNYETSGVDILVKFFTSTPAAQE 
                                                 ::*.  :*. .        .*      :.  .*  *  
 
Potential HbβP G. australis         FFPKFKGMTSAEDLKKSADVRWHAERIINAVNDAVASMDDTEKMSMKLTQ 
Haemoglobin Chain A River Lamprey   FFPKFKGMTSADQLKKSADVRWHAERIINAVNDAVASMDDTEKMSMKLRD 
                                    ***********::*********************************** : 
 
Potential HbβP G. australis         LSTKHANSFQVDPQYFKV------------------------------- 
Haemoglobin Chain A River Lamprey   LSGKHAKSFQVDPQYFKVLAAVIADTVAAGDAGFEKLMSMICILLRSAY 
                                    ** ***:***********                                 
Supplementary Figure 11: Potential haemoglobin derived protein sequence obtained 
from the G. australis transcriptomic library aligned against a river lamprey 
(Lametra fluviatilis; Accession number, P02207.2) haemoglobin derived chain A 
protein. 
 
Histone Derived H2A Alignment 
Potential H2A G. australis     ---TPSTCGRS-------TTRXGX---VGRVHRLLRKGNYAERVGAGAPV 
H2A Zebrafish                  MSGRGKTGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPV 
                                    .* *::       ::* *    *********************** 
 
Potential H2A G. australis     YLAAVLEYLSAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLMGG 
H2A Zebrafish                  YLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGG 
                               *********:*************************************:** 
 
Potential H2A G. australis     VTIAQGGVLPNIQAVLLPKKTSQAXXXNXXXXXXXPIHNGSFRAT 
H2A Zebrafish                  VTIAQGGVLPNIQAVLLPKKTGQAAASSGKSGKKGSSQSQEY--- 
                               *********************.**   .       . :. .:     
Supplementary Figure 12: Potential H2A protein sequence obtained from the G. 
australis transcriptomic library aligned against a zebrafish (Danio rerio; Accession 
number, NP_957367.1) H2A protein. 
 
Histone Derived H2B Alignment 
Potential H2B G. australis     ILPRQRALGRPRLPPPKRAQRRL-PRLPAKTQRSDATAERRATPFTSTR- 
H2B African Clawed Frog        -MP---ELGKSALAPKKGSKKAV-TKAQKKDGKKRKRSRKESYSVYVYKV 
                                :*    **:. *.* * ::: : .:   *  :.   :.:.: ..   :  
 
Potential H2B G. australis     -SRFTPTPXISSKAMSIMNSFVNDIFERIASEASRLAHYNKRSTRTX--- 
H2B African Clawed Frog        -LKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREI 
                                .:. * . ******.**************.************* *     
 
Potential H2B G. australis     -----------------SRGXXAIRYRPSSRPK 
H2B African Clawed Frog        -QTAVRLLLPGELAKHAVSEGTKAVTKYTSAK-- 
                                                *.*  *:   .*::    
Supplementary Figure 13: Potential H2B sequence obtained from the G. australis 
transcriptomic library aligned against a African clawed frog (Xenopus laevis; 





Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               MARPLILGLLSLLGLLAAAVASPVLWQKECAKGPEVWCQSIRTASQCGAL 
                                                                                       
 
Potential NK-Lysin G. australis     ----------------------------------------VKAYLDSACS 
Saposin Common Canary               KHCQQNVWNKPAVSSIPCDLCKELVTVAGKILKDNGTEDEIRSYLEKTCE 
                                                                            :::**:.:*. 
 
Potential NK-Lysin G. australis     MLPDPGLVSQCRELVENYLDTVIDMLKQEMD-PSVVCTALQVCKTQQSV- 
Saposin Common Canary               FLPDPGLVSECKEIVDSYLPTIMDMIKEELDKPEVVCSALALCHSLQKHL 
                                    :********:*:*:*:.** *::**:*:*:* *.***:** :*:: *.   
 
Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               AAMKLQKQLQTNKIPELDFSELASPFMANVPLLLYPQDKPKQKPKASGDV 
                                                                                       
 
Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               CQDCIQLVTDVQEAVKTNSSFVKSLVAHAKEECDRLGPGMSDMCKSYISE 
                                                                                       
 
Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               YSDLAIQMMMHMKDQQPKDICAMVGFCSSVKSVPLQPLVPAQVVHEVKVE 
                                                                                       
 
Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               IVEKAAVQEKTFSLCEICETMVKEVTGLLESNKTEEEIVHEMEVVCHLFP 
                                                                                       
 
Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               GSVKDQCKDFIEVYGQAVIDMLLEATNPEAVCAMLKCCAASKLPQQPVVV 
                                                                                       
 
Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               KPAGGFCDICKMVVAYADKELEKNATTAEIEALLEKVCHFLPESVSEQCV 
                                                                                       
 
Potential NK-Lysin G. australis     -------------------------------------------------- 
Saposin Common Canary               QFVEQYEPVVVQLLAEVMDPTFVCTKLGVCESAKEPLLGNDACVWGPGYW 
                                                                                       
 
Potential NK-Lysin G. australis     ---------------------- 
Saposin Common Canary               CKNMDTAAQCNAVDHCKRHVWN  
Supplementary Figure 14: Potential NK-lysin protein sequence obtained from the G. 
australis transcriptomic library aligned against a common canary (Serinus canaria; 





Appendix VIII - GenScript Ladder 









Appendix IX - Real-Time PCR Raw Data 
 
B-actin GAPDH Geometric Mean Moronecidin Hepcidin
Gill 1 18.66 18.91 18.78 15.5 33.99
Gill 1 18.6 18.99 18.79 15.44 33.46
Gill 2 18.47 18.77 18.62 15.8 35.78
Gill 2 18.47 18.68 18.57 15.76 33.82
Gill 3 18.37 18.54 18.45 15.81 34.49
Gill 3 18.35 18.54 18.44 15.81 33.87
Liver 1 25.16 22.38 23.73 24.4 34.53
Liver 1 25.07 22.44 23.72 23.84 31.15
Liver 2 24.61 21.95 23.24 24.65 32.35
Liver 2 24.68 22.06 23.33 24.71 32.3
Liver 3 25 22.47 23.70 24.44 33.57
Liver 3 25.06 22.36 23.67 24.37 32.5
Spleen 1 18.26 19.29 18.77 15.3 38.67
Spleen 1 18.25 19.34 18.79 15.36 37.84
Spleen 2 18.2 19.37 18.78 15.37 36.95
Spleen 2 18.22 19.26 18.73 15.25 36.87
Spleen 3 17.97 18.96 18.46 15.37 37.39





Appendix X - Real-Time PCR Data Analysis 
 
Gill Tissue 
B-actin GAPDH Geometric mean Moronecidin Tag-HK Mean RE Hepcidin Tag-HK Mean RE
Gill 1 18.66 18.91 18.78 15.5 3.28 3.32 9.98 33.99 -15.21 -14.94 0.000032
Gill 1 18.6 18.99 18.79 15.44 3.35 33.46 -14.67
Gill 2 18.47 18.77 18.62 15.8 2.82 2.82 7.05 35.78 -17.16 -16.20 0.000013
Gill 2 18.47 18.68 18.57 15.76 2.81 33.82 -15.25
Gill 3 18.37 18.54 18.45 15.81 2.64 2.64 6.23 34.49 -16.04 -15.73 0.000018
Gill 3 18.35 18.54 18.44 15.81 2.63 33.87 -15.43
Average 7.75 0.000021
SE 1.14 0.000006  
 
Liver Tissue 
B-actin GAPDH Geometric mean Moronecidin Tag-HK Mean RE Hepcidin Tag-HK Mean RE
Liver 1 25.16 22.38 23.73 24.4 -0.67 -0.40 0.76 34.53 -10.80 -9.12 0.001802
Liver 1 25.07 22.44 23.72 23.84 -0.12 31.15 -7.43
Liver 2 24.61 21.95 23.24 24.65 -1.41 -1.39 0.38 32.35 -9.11 -9.04 0.001903
Liver 2 24.68 22.06 23.33 24.71 -1.38 32.3 -8.97
Liver 3 25 22.47 23.70 24.44 -0.74 -0.72 0.61 33.57 -9.87 -9.35 0.001534
Liver 3 25.06 22.36 23.67 24.37 -0.70 32.5 -8.83
Average 0.58 0.001746
SE 0.11 0.000110  
 
Spleen Tissue 
B-actin GAPDH Geometric mean Moronecidin Tag-HK Mean RE Hepcidin Tag-HK Mean RE
Spleen 1 18.26 19.29 18.77 15.3 3.47 3.45 10.91 38.67 -19.90 -19.48 0.000001
Spleen 1 18.25 19.34 18.79 15.36 3.43 37.84 -19.05
Spleen 2 18.2 19.37 18.78 15.37 3.41 3.44 10.89 36.95 -18.17 -18.16 0.000003
Spleen 2 18.22 19.26 18.73 15.25 3.48 36.87 -18.14
Spleen 3 17.97 18.96 18.46 15.37 3.09 3.12 8.69 37.39 -18.93 -18.77 0.000002
Spleen 3 17.98 18.73 18.35 15.2 3.15 36.96 -18.61
Average 10.16 0.000002





Appendix XI - PCR Screen 
 
 
Supplementary Figure 15: Gel image showing a PCR screen on ten transformed E. 
cloni colonies, none of them show the presence of a genetic insert. 
 
